<SEC-DOCUMENT>0001213900-26-029129.txt : 20260317
<SEC-HEADER>0001213900-26-029129.hdr.sgml : 20260317
<ACCEPTANCE-DATETIME>20260317163026
ACCESSION NUMBER:		0001213900-26-029129
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		21
CONFORMED PERIOD OF REPORT:	20260316
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20260317
DATE AS OF CHANGE:		20260317

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cyngn Inc.
		CENTRAL INDEX KEY:			0001874097
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMPUTER PROGRAMMING SERVICES [7371]
		ORGANIZATION NAME:           	06 Technology
		EIN:				462007094
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40932
		FILM NUMBER:		26762472

	BUSINESS ADDRESS:	
		STREET 1:		1344 TERRA BELLA AVENUE
		CITY:			MOUNTAIN VIEW
		STATE:			CA
		ZIP:			94043
		BUSINESS PHONE:		650-924-5905

	MAIL ADDRESS:	
		STREET 1:		1344 TERRA BELLA AVENUE
		CITY:			MOUNTAIN VIEW
		STATE:			CA
		ZIP:			94043

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Cyngn, Inc.
		DATE OF NAME CHANGE:	20210721
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea0282043-8k_cyngn.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:CYN="http://cyngn.com/20260316">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_039_CYN_cyngn.com_20260316 -->
<!-- Field: Set; Name: xdx; ID: xdx_04A_20260316_20260316 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_054_edei%2D%2DEntityCentralIndexKey_0001874097 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body>
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2026-03-16" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2026-03-16" id="Fact000004" name="dei:EntityCentralIndexKey">0001874097</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="cyn-20260316.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2026-03-16">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2026-03-16</xbrli:startDate>
        <xbrli:endDate>2026-03-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_90C_edei--DocumentType_c20260316__20260316_zKnQvEnxen0a"><ix:nonNumeric contextRef="AsOf2026-03-16" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported):
<span id="xdx_909_edei--DocumentPeriodEndDate_c20260316__20260316_zKkPLGZPtrWd"><ix:nonNumeric contextRef="AsOf2026-03-16" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">March 16, 2026</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_906_edei--EntityRegistrantName_c20260316__20260316_zII1oC96EvYh"><ix:nonNumeric contextRef="AsOf2026-03-16" id="Fact000011" name="dei:EntityRegistrantName">CYNGN INC.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 32%"><span style="font-size: 10pt"><b><span id="xdx_90E_edei--EntityIncorporationStateCountryCode_c20260316__20260316_zeMSDj9vlxJi"><ix:nonNumeric contextRef="AsOf2026-03-16" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="text-align: center; width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 32%"><span style="font-size: 10pt"><b><span id="xdx_90F_edei--EntityFileNumber_c20260316__20260316_z76xax7EaJ32"><ix:nonNumeric contextRef="AsOf2026-03-16" id="Fact000013" name="dei:EntityFileNumber">001-40932</ix:nonNumeric></span></b></span></td>
    <td style="text-align: center; width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 32%"><span style="font-size: 10pt"><b><span id="xdx_907_edei--EntityTaxIdentificationNumber_c20260316__20260316_zz0U9i5gfSo6"><ix:nonNumeric contextRef="AsOf2026-03-16" id="Fact000014" name="dei:EntityTaxIdentificationNumber">46-2007094</ix:nonNumeric></span></b></span></td></tr>
  <tr>
    <td style="text-align: center"><span style="font-size: 10pt">(State or other jurisdiction<br/>
of incorporation)</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">(Commission File Number) </span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">(IRS Employer<br/>
Identification No.)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_901_edei--EntityAddressAddressLine1_c20260316__20260316_zGxR8uYVYPL"><ix:nonNumeric contextRef="AsOf2026-03-16" id="Fact000015" name="dei:EntityAddressAddressLine1">1344 Terra Bella Avenue</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90B_edei--EntityAddressCityOrTown_c20260316__20260316_zmdLhNjW7Bh3"><ix:nonNumeric contextRef="AsOf2026-03-16" id="Fact000016" name="dei:EntityAddressCityOrTown">Mountain View</ix:nonNumeric></span>, <span id="xdx_90B_edei--EntityAddressStateOrProvince_c20260316__20260316_zIi54Q4fIiQb"><ix:nonNumeric contextRef="AsOf2026-03-16" id="Fact000017" name="dei:EntityAddressStateOrProvince">CA</ix:nonNumeric></span> <span id="xdx_901_edei--EntityAddressPostalZipCode_c20260316__20260316_zpvJucY20Ta8"><ix:nonNumeric contextRef="AsOf2026-03-16" id="Fact000018" name="dei:EntityAddressPostalZipCode">94043</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices) (Zip Code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(<span id="xdx_90F_edei--CityAreaCode_c20260316__20260316_ziGaxkigbz6a"><ix:nonNumeric contextRef="AsOf2026-03-16" id="Fact000019" name="dei:CityAreaCode">650</ix:nonNumeric></span>) <span id="xdx_90B_edei--LocalPhoneNumber_c20260316__20260316_zEnlGPIlMZy5"><ix:nonNumeric contextRef="AsOf2026-03-16" id="Fact000020" name="dei:LocalPhoneNumber">924-5905</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Registrant&#8217;s telephone number, including
area code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Not Applicable</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed since
last report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<span style="text-decoration: underline">see</span>
General Instruction A.2. below):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--WrittenCommunications_c20260316__20260316_zE0cQFZDB1xc"><ix:nonNumeric contextRef="AsOf2026-03-16" format="ixt:booleanfalse" id="Fact000021" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--SolicitingMaterial_c20260316__20260316_zcDiK43HhZxl"><ix:nonNumeric contextRef="AsOf2026-03-16" format="ixt:booleanfalse" id="Fact000022" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_edei--PreCommencementTenderOffer_c20260316__20260316_z8FpIleaBXWa"><ix:nonNumeric contextRef="AsOf2026-03-16" format="ixt:booleanfalse" id="Fact000023" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--PreCommencementIssuerTenderOffer_c20260316__20260316_zohhwmwmFgF3"><ix:nonNumeric contextRef="AsOf2026-03-16" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Securities registered pursuant to Section 12(b)
of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 32%"><span style="font-size: 10pt"><b>Title of each class</b></span></td>
    <td style="text-align: center; width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 32%"><span style="font-size: 10pt"><b>Trading Symbol(s)</b></span></td>
    <td style="text-align: center; width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 32%"><span style="font-size: 10pt"><b>Name of each exchange on which registered</b></span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font-size: 10pt"><span id="xdx_90A_edei--Security12bTitle_c20260316__20260316_zbk9ueqtRWJ6"><ix:nonNumeric contextRef="AsOf2026-03-16" id="Fact000025" name="dei:Security12bTitle">Common Stock</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt"><span id="xdx_907_edei--TradingSymbol_c20260316__20260316_zIgNcyzSaEJ1"><ix:nonNumeric contextRef="AsOf2026-03-16" id="Fact000026" name="dei:TradingSymbol">CYN</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">The <span id="xdx_90D_edei--SecurityExchangeName_c20260316__20260316_zBCX4e8esog3"><ix:nonNumeric contextRef="AsOf2026-03-16" format="ixt-sec:exchnameen" id="Fact000027" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC (The Nasdaq Capital Market)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (&#167; 240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Emerging growth company <span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_edei--EntityEmergingGrowthCompany_c20260316__20260316_z0rnN2Kfw336"><ix:nonNumeric contextRef="AsOf2026-03-16" format="ixt:booleantrue" id="Fact000028" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: Times New Roman, Times, Serif"><span id="xdx_902_edei--EntityExTransitionPeriod_c20260316__20260316_zpgBIKNARhIg"><ix:nonNumeric contextRef="AsOf2026-03-16" format="ixt:booleanfalse" id="Fact000029" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt; text-align: right"></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 1.01 Entry into a Material Definitive Agreement.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">On March 16, 2026, Cyngn
Inc. (the &#8220;Company&#8221;) entered into a securities purchase agreement (the &#8220;Purchase Agreement&#8221;) with the investors
named on the signature page thereto, pursuant to which the Company agreed to sell and issue, in a registered direct offering (the &#8220;Offering&#8221;),
1,686,788 shares (the &#8220;Shares&#8221;) of its common stock, par value $0.00001 per share (&#8220;Common Stock&#8221;), at a purchase
price of $1.93 per share and 3,313,212 pre-funded warrants (the &#8220;Pre-Funded Warrants&#8221;) to purchase shares of Common Stock,
at a purchase price of $1.92999 per Pre-Funded Warrant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Offering was made
pursuant to that certain Registration Statement on Form S-3, as amended (File No. 333-290079), which was originally filed on September
5, 2025, and declared effective by the Securities and Exchange Commission on September 18, 2025, including the Prospectus contained therein
and a prospectus supplement dated March 16, 2026 filed with the Securities and Exchange Commission on March 17, 2026.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The closing of the Offering
occurred on March 17, 2026. The Company received net proceeds of approximately $8.8 million from the Offering, after deducting the estimated
offering expenses payable by the Company, including the placement agent fees. The Company intends to use the net proceeds from the Offering
for general corporate purposes, including working capital.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In connection with the
Offering, the Company entered into a Placement Agent Agreement (the &#8220;Placement Agent Agreement&#8221;) with Aegis Capital Corp.
(the &#8220;Placement Agent&#8221;), as the exclusive placement agent in connection with the Offering. As compensation to the Placement
Agent, the Company paid the Placement Agent a cash fee of 7% of the aggregate gross proceeds raised in the Offering and reimbursed certain
expenses of the Placement Agent.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The foregoing summaries
of the Pre-Funded Warrants, Purchase Agreement and the Placement Agent Agreement do not purport to be complete and are subject to, and
qualified in their entirety by, copies of such documents attached as Exhibits 4.1, 10.1 and 10.2 to this Current Report on Form 8-K, which
are incorporated by reference herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Immediately after the
issuance of the Shares and shares of Common Stock issued after the full exercise of the Pre-Funded Warrants issued in the offering, the
Company will have 16,896,493 shares of Common Stock issued and outstanding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Item 8.01 Other Events.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">On March 16, 2026, the
Company issued a press release announcing the pricing of the Offering, a copy of which is attached as Exhibit 99.1 to this Current Report
on Form 8-K and is hereby incorporated by reference herein. Also, on March 17, 2026, the Company issued a press release announcing the
closing of the Offering, a copy of which is attached as Exhibit 99.2 to this Current Report on Form 8-K and is hereby incorporated by
reference herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Item 9.01 Financial
Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>(d) Exhibits</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The following exhibits
are being filed herewith:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 9%"><span style="font-size: 10pt"><b>Exhibit No.</b></span></td>
    <td style="text-align: center; width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 90%"><span style="font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">4.1</span></td>
    <td>&#160;</td>
    <td><a href="ea028204301ex4-1.htm"><span style="font-size: 10pt">Form of Pre-Funded Warrant</span></a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">5.1</span></td>
    <td>&#160;</td>
    <td><a href="ea028204301ex5-1.htm"><span style="font-size: 10pt">Opinion of Kaufman &amp; Canoles, P.C.</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">10.1</span></td>
    <td>&#160;</td>
    <td><a href="ea028204301ex10-1.htm"><span style="font-size: 10pt">Form of Securities Purchase Agreement by and between Cyngn Inc. and the Purchasers</span></a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">10.2</span></td>
    <td>&#160;</td>
    <td><a href="ea028204301ex10-2.htm"><span style="font-size: 10pt">Placement Agent Agreement between the Company and Aegis Capital Corp. dated March 16, 2026</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">23.1</span></td>
    <td>&#160;</td>
    <td><a href="ea028204301ex5-1.htm"><span style="font-size: 10pt">Consent of Kaufman &amp; Canoles, P.C. (contained in Exhibit 5.1)</span></a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">99.1</span></td>
    <td>&#160;</td>
    <td><a href="ea028204301ex99-1.htm"><span style="font-size: 10pt">Press Release issued by the Company on March 16, 2026</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">99.2</span></td>
    <td>&#160;</td>
    <td><a href="ea028204301ex99-2.htm"><span style="font-size: 10pt">Press Release issued by the Company on March 17, 2026</span></a></td></tr>
  <tr style="background-color: White">
    <td><span style="font-size: 10pt">104</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt; text-align: right"></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: March 17, 2026</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td>&#160;</td>
    <td colspan="2"><span style="font-size: 10pt"><b>CYNGN INC.</b></span></td>
    </tr>
  <tr>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    </tr>
  <tr>
    <td style="width: 60%">&#160;</td>
    <td style="width: 5%"><span style="font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid; width: 35%"><span style="font-size: 10pt"><i>/s/ Natalie Russell</i></span></td>
    </tr>
  <tr>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt"><i>Natalie Russell</i></span></td>
    </tr>
  <tr>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Chief Financial Officer</span></td>
    </tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">2</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjdEKwjAMRb9g/xD6LNpNcbA3HSriFBkivhYXpbg1I63TfZJ/abchhkBI7j25QozEhta6RIbLMs/ghFVdKoeQ4w0ZzRW9I93uEvAzx7u2jpVx/foDU/IMemY+nil/752NtlgkIKeTMJ5Ec5BhImNY7EXQ6SmZmy7QOK1KUKaAI1PNGp3idvhwUm8yVLV90hnZajIJhGM5yB+IZBjBgRr1In5YyLJUBKO+ArFhetbetXo7NB0JqxIrH2cH+t/BF8Q3Sk8= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>ea028204301ex4-1.htm
<DESCRIPTION>FORM OF PRE-FUNDED WARRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 4.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REGISTERED PRE-FUNDED WARRANT TO PURCHASE COMMON
STOCK</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CYNGN INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Warrant Shares: [&#9679;]</P></TD>
    <TD STYLE="width: 40%; font-size: 10pt">Initial Exercise Date: March 16, 2026</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Issuance Date: March 17, 2026</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>THIS PRE-FUNDED WARRANT
TO PURCHASE COMMON STOCK</B> (the &ldquo;<B><U>Warrant</U></B>&rdquo;) certifies that, for value received, [&#9679;] or its assigns (the
&ldquo;<B><U>Holder</U></B>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter
set forth, at any time until this Warrant is exercised in full (the &ldquo;<B><U>Termination Date</U></B>&rdquo;), to subscribe for and
purchase from Cyngn Inc., a Delaware corporation (the &ldquo;<B><U>Company</U></B>&rdquo;), up to [&#9679;] shares (as subject to adjustment
hereunder, the &ldquo;<B><U>Warrant Shares</U></B>&rdquo;) of Common Stock. Subject to the provisions of Section 2.3, the purchase price
of one (1) share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2.2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left">1.</TD><TD STYLE="text-align: justify"><B><U>Definitions</U></B>. In addition to the terms defined
elsewhere in this Warrant or in the Securities Purchase Agreement dated March 16, 2026 by and among the Company and the investors (the
&ldquo;<B><U>Purchasers</U></B>&rdquo;) referred to therein (the &ldquo;<B><U>Securities Purchase Agreement</U></B>&rdquo;), the following
terms have the meanings indicated in this Section 1:</TD>
</TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.1. &ldquo;<B><U>Affiliate</U></B>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.2. &ldquo;<B><U>Bid
Price</U></B>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or a
similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of Common Stock so
reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected
in good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the
fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.3. &ldquo;<B><U>Board
of Directors</U></B>&rdquo; means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.4. &ldquo;<B><U>Business
Day</U></B>&rdquo; means a Calendar Day other than a Saturday, Sunday or any other Calendar Day which is a federal legal holiday in the
United States or any Calendar Day on which the commercial banks in the City of New York are required by law or other governmental action
to close, provided that the commercial banks in the City of New York shall not be deemed to be required to be closed due to a &ldquo;stay
at home,&rdquo; &ldquo;shelter in place,&rdquo; &ldquo;non-essential employee&rdquo; or similar orders or restrictions or the closure
of any physical branch locations at the direction of any governmental authority so long as the electronic funds transfer systems (including
for wire transfers) of commercial banks in the City of New York generally are open for use by customers on such Calendar Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.5. &ldquo;<B><U>Calendar
Day</U></B>&rdquo; means each and every day of the week (Sunday, Monday, Tuesday, Wednesday, Thursday, Friday and Saturday).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.6. &ldquo;<B><U>Commission</U></B>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.7. &ldquo;<B><U>Common
Stock</U></B>&rdquo; means the common stock of the Company, $0.00001 par value per share, and any other class of securities into which
such securities may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.8. &ldquo;<B><U>Common
Stock Equivalents</U></B>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.9. &ldquo;<B><U>Exchange
Act</U></B>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.10. &ldquo;<B><U>Person</U></B>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.11. &ldquo;<B><U>Registration
Statement</U></B>&rdquo; means the Company&rsquo;s registration statement on Form S-3 (File No. 333-290079).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.12. &ldquo;<B><U>Securities
Act</U></B>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.13. &ldquo;<B><U>Subsidiary</U></B>&rdquo;
means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company formed
or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.14. &ldquo;<B><U>Trading
Day</U></B>&rdquo; means a Calendar Day on which the principal Trading Market is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.15. &ldquo;<B><U>Trading
Market</U></B>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the
date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York
Stock Exchange, OTCQB or OTCQX (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.16. &ldquo;<B><U>Transfer
Agent</U></B>&rdquo; means Continental Stock Transfer &amp; Trust Company, the current transfer agent of the Company, with a mailing address
of 1 State Street, 30th Floor, New York, NY 10004-1561, and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.17. &ldquo;<B><U>VWAP</U></B>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)&nbsp;if OTCQB or OTCQX is not a Trading Market, the volume weighted
average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock
is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market
(or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of Common Stock
so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left">2.</TD><TD STYLE="text-align: justify"><B><U>Exercise</U></B>.</TD>
</TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.1. <B><U>Exercise
of Warrant</U></B>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times
on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted
by e-mail (or e-mail attachment) of the Notice of Exercise substantially in the form attached hereto as <U>Exhibit 2.1</U> (the &ldquo;<B><U>Notice
of Exercise</U></B>&rdquo;). Within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard
Settlement Period (as defined in Section 2.5.1 herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate
Exercise Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on
a United States bank unless the cashless exercise procedure specified in Section 2.3 below is specified in the applicable Notice of Exercise.
No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of
any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender
this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised
in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days after the
date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a
portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant
Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall
maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection
to any Notice of Exercise within one (1) Trading Day after receipt of such notice. <B>The Holder and any assignee, by acceptance of this
Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant
Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on
the face hereof.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.2. <B><U>Exercise
Price</U></B>. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.00001 per Warrant Share, subject
to adjustment hereunder (such nominal exercise price, the &ldquo;<B><U>Exercise Price</U></B>&rdquo;), was pre-funded to the Company on
or prior to the Initial Exercise Date and, consequently, no additional consideration (other than such Exercise Price) shall be required
to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund
of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever. The remaining unpaid
exercise price per Warrant Share is $0.00001.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.3. <B><U>Cashless
Exercise</U></B>. This Warrant may also be exercised, in whole or in part, by means of a &ldquo;cashless exercise&rdquo; in which the
Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(A) =</TD><TD STYLE="text-align: justify">as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice
of Exercise if such Notice of Exercise is (1) delivered pursuant to Section 2.1 hereof on a Calendar Day that is not a Trading Day or
(2) delivered pursuant to Section 2.1 hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined
in Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder,
either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the highest Bid Price
of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. within two (2) hours of the Holder&rsquo;s delivery
of the Notice of Exercise pursuant to Section 2.1 hereof if such Notice of Exercise is delivered during &ldquo;regular trading hours,&rdquo;
or within two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day or (iii) the VWAP on the date of the applicable
Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is delivered pursuant to Section
2.1 hereof two (2) or more hours following the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(B) =</TD><TD STYLE="text-align: justify">the Exercise Price of this Warrant, as adjusted hereunder; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(X) =</TD><TD STYLE="text-align: justify">the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the
terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.4. <B><U>Holding
Period for Cashless Exercise</U></B>. If Warrant Shares are issued in a cashless exercise, the parties acknowledge and agree that in accordance
with Section 3(a)(9) of the Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised.
The Company agrees not to take any position contrary to this Section 2.4.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.5. <B><U>Mechanics
of Exercise</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">2.5.1. <B><U>Delivery
of Warrant Shares upon Exercise</U></B>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer
Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company
through its Deposit or Withdrawal at Custodian system (&ldquo;<B><U>DWAC</U></B>&rdquo;) if the Company is then a participant in such
system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant
Shares by Holder or (B) this Warrant is being exercised via cashless exercise and otherwise by physical delivery of a certificate or by
electronic delivery (at the election of the Holder), for the number of Warrant Shares to which the Holder is entitled pursuant to such
exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earlier of (i) one (1) Trading Day after
the delivery to the Company of the Notice of Exercise and (ii) the number of Trading Days comprising the Standard Settlement Period after
the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<B><U>Warrant Share Delivery Date</U></B>&rdquo;). Upon delivery
of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares
with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment
of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) one (1) Trading
Day and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. Notwithstanding
anything herein to the contrary, upon delivery of the Notice of Exercise, the Holder shall immediately be deemed for purposes of Regulation
SHO under the Exchange Act to have become the holder of the Warrant Shares irrespective of the date of delivery of the Warrant Shares.
If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery
Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject
to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing
to $20 per Trading Day on the third (3rd) Trading Day after the Warrant Share Delivery Date) for each Trading Day after such Warrant Share
Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a Transfer Agent
that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<B><U>Standard
Settlement Period</U></B>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary
Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise. Notwithstanding the foregoing,
with respect to any Notice(s) of Exercise delivered on or prior to 2:00 p.m. (New York City time) on the Initial Exercise Date, which
may be delivered at any time after the time of execution of the Securities Purchase Agreement, the Company agrees to deliver the Warrant
Shares subject to such notice(s) by 4:00 p.m. (New York City time) on the Initial Exercise Date and the Initial Exercise Date shall be
the Warrant Share Delivery Date for purposes hereunder, provided that payment of the aggregate Exercise Price (other than in the case
of a cashless exercise) is received by such Warrant Share Delivery Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">2.5.2. <B><U>Delivery
of New Warrants Upon Exercise</U></B>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder
and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects
be identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">2.5.3. <B><U>Rescission
Rights</U></B>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2.5.1
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">2.5.4. <B><U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares upon Exercise</U></B>. In addition to any other rights available to the Holder,
if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
2.5.1 above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by its
broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common
Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise
(a &ldquo;<B><U>Buy-In</U></B>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s
total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained
by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise
at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the
Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored and
return any amount received by the Company in respect of the Exercise Price for those Warrant Shares (in which case such exercise shall
be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely
complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase
price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving
rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay
the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the
Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue
any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or
injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock upon exercise of the Warrant as
required pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">2.5.5. <B><U>No
Fractional Shares or Scrip</U></B>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of
this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Exercise Price or round up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">2.5.6. <B><U>Charges,
Taxes and Expenses</U></B>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other
incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and
such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto as <U>Exhibit 2.5.6</U> duly executed by the Holder
and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto.
The Company shall pay all Transfer Agent fees required for same-Trading Day processing of any Notice of Exercise and all fees to the Depository
Trust Company (or another established clearing corporation performing similar functions) required for same-Trading Day electronic delivery
of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">2.5.7. <B><U>Closing
of Books</U></B>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this
Warrant, pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.6. <B><U>Holder&rsquo;s
Exercise Limitations</U></B>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise
as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting
as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<B><U>Attribution Parties</U></B>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, unexercised portion of this Warrant beneficially
owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or unconverted
portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject to a limitation
on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution
Parties. Except as set forth in the preceding sentence, for purposes of this Section 2.6, beneficial ownership shall be calculated in
accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder
that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the
Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation contained
in this Section 2.6 applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder
together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion
of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination of whether this Warrant
is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which
portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation
to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall
be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes
of this Section 2.6, in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares
of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with the Commission, as the case may
be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting
forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company shall within one (1)
Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any case, the number
of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company,
including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares
of Common Stock was reported. The &ldquo;<B><U>Beneficial Ownership Limitation</U></B>&rdquo; shall be 4.99% (or, upon election by a Holder
prior to the issuance of any Warrants, 9.99%) of the number of shares of Common Stock outstanding immediately after giving effect to the
issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease
the Beneficial Ownership Limitation provisions of this Section 2.6, provided that the Beneficial Ownership Limitation in no event exceeds
9.99% of the number of Ordinary Shares outstanding immediately after giving effect to the issuance of Ordinary Shares upon exercise of
this Warrant held by the Holder and the provisions of this Section 2.6 shall continue to apply. Any increase in the Beneficial Ownership
Limitation will not be effective until sixty-one (61) Calendar Days after such notice is delivered to the Company. The provisions of this
paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2.6 to correct
this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein
contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained
in this paragraph shall apply to a successor holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">3.</TD><TD STYLE="text-align: justify"><B><U>Certain Adjustments</U></B>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">3.1. <B><U>Stock
Dividends and Splits</U></B>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on shares of Common Stock or any other equity or equity equivalent securities payable in shares of Common
Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this Warrant),
(ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock split)
outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of Common Stock any shares
of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be
the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator
shall be the number of shares of Common Stock outstanding immediately after such event, and the number of Shares issuable upon exercise
of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment
made pursuant to this Section 3.1 shall become effective immediately after the record date for the determination of stockholders entitled
to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision,
combination or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">3.2. <B><U>Subsequent
Rights Offerings</U></B>. In addition to any adjustments pursuant to Section 3.1 above, if at any time the Company grants, issues or sells
any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to all (or substantially all)
of the record holders of any class of shares of Common Stock (the &ldquo;<B><U>Purchase Rights</U></B>&rdquo;), then the Holder will be
entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired
if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations
on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is
taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders
of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, that, to the extent
that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership
Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such
shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance
for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">3.3. <B><U>Pro
Rata Distributions</U></B>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other
distribution of its assets (or rights to acquire its assets) to all (or substantially all) holders of shares of Common Stock, by way of
return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options
by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<B><U>Distribution</U></B>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (provided,
however, that, to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding
the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the
beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution
shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder
exceeding the Beneficial Ownership Limitation). To the extent that this Warrant has not been partially or completely exercised at the
time of such Distribution, such portion of the Distribution shall be held in abeyance for the benefit of the Holder until the Holder has
exercised this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">3.4. <B><U>Fundamental
Transaction</U></B>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related
transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company or any Subsidiary, directly
or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of
its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether
by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their
shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock or 50%
or more of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one or more related transactions
effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which
the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly,
in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without
limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby
such other Person or group acquires 50% or more of the outstanding shares of Common Stock or 50% or more of the voting power of the common
equity of the Company (each a &ldquo;<B><U>Fundamental Transaction</U></B>&rdquo;), then, upon any subsequent exercise of this Warrant,
the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior
to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2.6 on the
exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is
the surviving corporation, and any additional consideration (the &ldquo;<B><U>Alternate Consideration</U></B>&rdquo;) receivable as a
result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately
prior to such Fundamental Transaction (without regard to any limitation in Section 2.6 on the exercise of this Warrant). For purposes
of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration
based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the
Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any
different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property
to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives
upon any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything to the contrary, in the event of a
Fundamental Transaction, the Company or any Successor Entity (as defined below) shall, at the Holder&rsquo;s option, exercisable at any
time concurrently with, or within 30 Trading Days after, the consummation of the Fundamental Transaction (or, if later, the date of the
public announcement of the applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the Holder an amount
of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on the date of the consummation
of such Fundamental Transaction; provided, however, that, if the Fundamental Transaction is not within the Company&rsquo;s control, including
not approved by the Company&rsquo;s Board of Directors, the Holder shall only be entitled to receive from the Company or any Successor
Entity the same type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of this
Warrant, that is being offered and paid to the holders of Common Stock of the Company in connection with the Fundamental Transaction,
whether that consideration be in the form of cash, stock or any combination thereof, or whether the holders of Common Stock are given
the choice to receive from among alternative forms of consideration in connection with the Fundamental Transaction; provided, further,
that if holders of Common Stock of the Company are not offered or paid any consideration in such Fundamental Transaction, such holders
of Common Stock will be deemed to have received common stock/shares of the Successor Entity (which Entity may be the Company following
such Fundamental Transaction) in such Fundamental Transaction. &ldquo;<B><U>Black Scholes Value</U></B>&rdquo; means the value of this
Warrant based on the Black-Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function on Bloomberg, L.P. (&ldquo;<B><U>Bloomberg</U></B>&rdquo;)
determined as of the Trading Day of consummation of the applicable contemplated Fundamental Transaction for pricing purposes and reflecting
(A) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public announcement
of the applicable contemplated Fundamental Transaction and the Termination Date, (B) an expected volatility equal to the greater of (1)
100% and (2) the 100 day volatility as obtained from the HVT function on Bloomberg (determined utilizing a 365 day annualization factor)
as of the Trading Day immediately following the public announcement of the applicable contemplated Fundamental Transaction, (C) the underlying
price per share used in such calculation shall be the greater of (i) the sum of the price per share being offered in cash, if any, plus
the value of any non-cash consideration, if any, being offered in such Fundamental Transaction and (ii) the highest VWAP during the period
beginning on the Trading Day immediately preceding the public announcement of the applicable contemplated Fundamental Transaction (or
the consummation of the applicable Fundamental Transaction, if earlier) and ending on the Trading Day of the Holder&rsquo;s request pursuant
to this Section 3.4 and (D) a remaining option time equal to the time between the date of the public announcement of the applicable contemplated
Fundamental Transaction and the Termination Date and (E) a zero cost of borrow. The payment of the Black Scholes Value will be made by
wire transfer of immediately available funds (or such other consideration) within the later of (i) five (5) Business Days after the Holder&rsquo;s
election and (ii) the date of consummation of the Fundamental Transaction. The Company shall cause any successor entity in a Fundamental
Transaction in which the Company is not the survivor (the &ldquo;<B><U>Successor Entity</U></B>&rdquo;) to assume in writing all of the
obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this Section 3.4
pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable
delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant
a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant that
is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the
shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this
Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of
capital stock (but taking into account the relative value of the shares of Common Stock prior to such Fundamental Transaction and the
value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting
the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory
in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to the
term &ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction,
each and every provision of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead
to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor Entities,
jointly and severally with the Company, may exercise every right and power of the Company prior thereto and the Successor Entity or Successor
Entities shall assume all of the obligations of the Company prior thereto under this Warrant and the other Transaction Documents with
the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally, had been named as the Company
herein. For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this Section 3.4 regardless of (i)
whether the Company has sufficient authorized shares of Common Stock for the issuance of Warrant Shares and/or (ii) whether a Fundamental
Transaction occurs prior to the Initial Exercise Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">3.5. <B><U>Calculations</U></B>.
All calculations under this Section 3 shall be made to the nearest fraction of a cent as in the initial Exercise Price or the nearest
1/100th of a share, as the case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding
as of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">3.6. <B><U>Notice
to Holder</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.6.1. <B><U>Adjustment
to Exercise Price</U></B>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number
of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.6.2. <B><U>Notice
to Allow Exercise by Holder</U></B>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common
Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall
authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock
of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification
of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of
all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall
appear upon the Warrant Register of the Company, at least twenty (20) Calendar Days prior to the applicable record or effective date hereinafter
specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption,
rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to
such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation,
merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders
of the Common Stock of record shall be entitled to exchange their shares of Common Stock for securities, cash or other property deliverable
upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice
or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such
notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the
Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report
on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the
effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">4.</TD><TD STYLE="text-align: justify"><B><U>Transfer of Warrant</U></B>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">4.1. <B><U>Transferability</U></B>.
This Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part,
upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this
Warrant substantially in the form attached hereto as <U>Exhibit 2.5.6</U> duly executed by the Holder or its agent or attorney and funds
sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the
Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination
or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this
Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall
not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case,
the Holder shall surrender this Warrant to the Company within three (3) Trading Days after the date on which the Holder delivers an assignment
form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new
holder for the purchase of Warrant Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">4.2. <B><U>New
Warrants</U></B>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the
Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder
or its agent or attorney. Subject to compliance with Section 4.1, as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance
with such notice. All Warrants issued on transfers or exchanges shall be dated the initial Issuance Date of this Warrant and shall be
identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">4.3. <B><U>Warrant
Register</U></B>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<B><U>Warrant
Register</U></B>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">5.</TD><TD STYLE="text-align: justify"><B><U>Miscellaneous</U></B>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.1. <B><U>No
Rights as Stockholder until Exercise; No Settlement in Cash</U></B>. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2.5.1, except as expressly set forth
in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to Section
2.3 or to receive cash payments pursuant to Section 2.5.1 and Section 2.5.4 herein, in no event shall the Company be required to net cash
settle an exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.2. <B><U>Loss,
Theft, Destruction or Mutilation of Warrant</U></B>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.3. <B><U>Saturdays,
Sundays, Holidays, etc</U></B>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Trading Day, then such action may be taken, or such right may be exercised, on the next succeeding Trading Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.4. <B><U>Authorized
Shares</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">5.4.1. <B><U>Reservation
of Authorized and Unissued Shares</U></B>. The Company covenants that, while the Warrant is outstanding, it will <FONT STYLE="font-family: Times New Roman, Times, Serif">reserv</FONT>e
from its authorized and unissued Common Stock a sufficient number of shares of Common Stock to provide for the issuance of the Warrant
Shares upon the exercise of any purchase rights under this Warrant. The Company further covenants that its issuance of this Warrant shall
constitute full authority to its officers who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the
purchase rights under this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares
may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon
which the Common Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase
rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant
Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable (which means that no further sums are
required to be paid by the holders thereof in connection with the issue thereof) and free from all taxes, liens and charges created by
the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).
If the Company does not have a sufficient number of authorized and unissued shares of Common Stock available to honor the exercise of
Warrants, the Company shall allocate the available number of Warrant Shares on a pro rata basis among all Holders exercising Warrants,
until such time as the Company has a sufficient number of authorized Common Stock to issue all Warrant Shares in full.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">5.4.2. <B><U>Noncircumvention</U></B>.
Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation,
amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue
or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this
Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may
be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality
of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">5.4.3. <B><U>Authorizations,
Exemptions and Consents</U></B>. Before taking any action that would result in an adjustment in the number of Warrant Shares for which
this Warrant is exercisable or in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents
thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.5. <B><U>Governing
Law</U></B>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed by
and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts
of law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Warrant (whether brought against a party hereto or their respective affiliates, directors, officers, stockholders,
partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York.
Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough
of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed
herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally
subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding.
Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding
by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address
in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient service of process and
notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted
by law. If either party shall commence an action, suit or proceeding to enforce any provisions of this Warrant, the prevailing party in
such action, suit or proceeding shall be reimbursed by the other party for their reasonable attorneys&rsquo; fees and other costs and
expenses incurred with the investigation, preparation and prosecution of such action or proceeding. Notwithstanding the foregoing, nothing
in this paragraph shall limit or restrict the federal district court in which a Holder may bring a claim under the federal securities
laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.6. <B><U>Restrictions</U></B>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.7. <B><U>Nonwaiver
and Expenses</U></B>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate
as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. No provision of this Warrant shall be
construed as a waiver by the Holder of any rights which the Holder may have under the federal securities laws and the rules and regulations
of the Commission thereunder. Without limiting any other provision of this Warrant or the Securities Purchase Agreement, if the Company
willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the Holder, the Company
shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable
attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto
or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.8. <B><U>Notices</U></B>.
Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation, any Notice
of Exercise, shall be in writing and delivered personally, by e-mail, or sent by a nationally recognized overnight courier service, addressed
to the Company, at 1344 Terra Bella Avenue, Mountain View, CA 94043, Attention: Lior Tal, Chief Executive Officer, email address: ltal@cyngn.com,
or such other email address or address as the Company may specify for such purposes by notice to the Holders. Any and all notices or other
communications or deliveries to be provided by the Company hereunder shall be in writing and delivered personally, by e-mail, or sent
by a nationally recognized overnight courier service addressed to each Holder at the e-mail address or address of such Holder appearing
on the books of the Company. Any notice or other communication or deliveries hereunder shall be deemed given and effective on the earliest
of (i) the time of transmission, if such notice or communication is delivered via e-mail at the e-mail address set forth in this Section
5.8 prior to 5:30 p.m. (New York City time) on any date, (ii) the next Trading Day after the time of transmission, if such notice or communication
is delivered via e-mail at the e-mail address set forth in this Section 5.8 on a Calendar Day that is not a Trading Day or later than
5:30 p.m. (New York City time) on any Trading Day, (iii) the second Trading Day following the date of mailing, if sent by U.S. nationally
recognized overnight courier service, or (iv) upon actual receipt by the party to whom such notice is required to be given. To the extent
that any notice provided hereunder constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries,
the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.9. <B><U>Limitation
of Liability</U></B>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase
Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for
the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.10. <B><U>Remedies</U></B>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.11. <B><U>Successors
and Assigns</U></B>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to
the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.12. <B><U>Amendment</U></B>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on the one hand, and
a majority-in-interest of Holders of the Warrants, on the other hand. No modification or amendment of the provisions hereof may be waived
in a manner that is more favorable to other holder(s) of Warrants, as applicable, or to treat any holder(s) of Warrants in a manner that
is in any respect not equal to the treatment of all other holder(s) of Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.13. <B><U>Severability</U></B>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.14. <B><U>Headings</U></B>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[CYN Investor Registered Pre-Funded Warrant
Signature Page Follows]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[CYN Investor Registered Pre-Funded Warrant
Signature Page]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the Company
has caused this Registered Pre-Funded Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">CYNGN INC.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>Lior Tal</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Its:</TD>
    <TD>Chief Executive Officer</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in">&nbsp;</P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><U>Exhibit 2.1</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="text-transform: uppercase">To:</FONT></TD><TD STYLE="text-align: justify">CYNGN INC.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(1) The
undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised
in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(2) Payment
shall take the form of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.65in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9744;</TD><TD STYLE="text-align: justify">in lawful money of the United States.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.65in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9744;</TD><TD STYLE="text-align: justify">if permitted the cancellation of such number of Warrant
Shares as is necessary, in accordance with the formula set forth in Section 2.3, to exercise this Warrant with respect to the maximum
number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in Section 2.3.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(3) Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt -0.5in; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.65in">The Warrant Shares shall be
delivered to the following DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt -0.5in; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt -0.5in; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt -0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt -0.5in; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>[CYN Investor Registered Pre-Funded Warrant
Exercise Notice &ndash; Investor Signature Page]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: bottom; width: 40%; text-align: left">Name of Investing Entity: </TD>
    <TD STYLE="vertical-align: top; width: 60%; border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; text-align: left">Signature of Authorized Signatory of Investing Entity:</TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; text-align: left">Name of Authorized Signatory: </TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; text-align: left">Title of Authorized Signatory: </TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; text-align: left">Date: </TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><U>Exhibit 2.5.6</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ASSIGNMENT FORM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(To assign the foregoing Warrant,
execute this form and supply required information. Do not use this form to exercise the Warrant to purchase shares of Common Stock.)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">FOR VALUE RECEIVED, the foregoing
Warrant and all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: bottom; width: 40%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Name:</P></TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: top; width: 60%">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">Address:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">Phone Number:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">Email Address: </TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: top; font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">Date:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: top; font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">Holder&rsquo;s Signature:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: top; font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">Holder&rsquo;s Address:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: top; font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 18; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>ea028204301ex5-1.htm
<DESCRIPTION>OPINION OF KAUFMAN & CANOLES, P.C.
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Exhibit
5.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><IMG SRC="ea028204301_ex5-1img1.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">March
17, 2026</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cyngn Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">1344 Terra
Bella Avenue</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Mountain
View, CA 94043</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; width: 0.5in; font-size: 10pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Re:</FONT></TD>
    <TD STYLE="padding-right: 0.7pt; font-size: 10pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Registered
    Direct Offering Pursuant to Registration Statement on Form S-3</U></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Ladies and
Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
have acted as counsel to Cyngn Inc., a Delaware corporation (the &ldquo;Company&rdquo;), in connection with the Securities Purchase Agreement
dated March 16, 2026 (the &ldquo;Purchase Agreement&rdquo;), by and between the Company and the purchasers signatories thereto (the &ldquo;Purchasers&rdquo;),
relating to the issuance and sale of (i) 1,686,788 shares (the &ldquo;Shares&rdquo;) of common stock, par value $0.00001 per share of
the Company, and (ii) up to 3,313,212 shares of common stock (the &ldquo;Pre-Funded Warrant Shares&rdquo;) upon the exercise of pre-funded
warrants (the &ldquo;Pre-funded Warrants&rdquo;) to purchase shares of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">This
opinion is being delivered in accordance with the requirements of Item 601(b)(5) of Regulation S-K under the Securities Act of 1933,
as amended (the &ldquo;Securities Act&rdquo;), and no opinion is expressed herein as to any matter pertaining to the contents of the
Registration Statement or the prospectus forming a part thereof, other than as to the issue of the Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You
have requested our opinion as to the matters set forth below in connection with the Registration Statement. For purposes of rendering
the opinions set forth below, we have examined originals or copies, certified or otherwise identified to our satisfaction, of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The Amended and Restated Certificate of
    Incorporation of the Company, as amended;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The Amended and Restated Bylaws of the Company,
    as amended;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The Purchase Agreement;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Registration Statement on Form S-3 (File
    No. 333-290079) filed by the Company with the Securities and Exchange Commission (the &ldquo;Commission&rdquo;) on September 5, 2025,
    in the form in which it became effective on September 18, 2025 (the &ldquo;Registration Statement&rdquo;) pursuant to the Securities
    Act;</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The prospectus supplement dated March 16,
    2026, filed with the Commission pursuant to Rule 424(b)(5) promulgated under the Securities Act (the &ldquo;Prospectus Supplement&rdquo;),
    together with the base prospectus dated September 5, 2025;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Kaufman &amp; Canoles, P.C.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Two James Center</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1021 East Cary Street &bull; Suite 1400 &bull;
    Richmond, VA 23219</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">t: (804) 771.5700</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">f: (888) 360.9092</FONT></TD></TR>
  </TABLE>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="text-align: right; margin: 0"><IMG SRC="ea028204301_ex5-1img2.jpg" ALT="" STYLE="width: 180px; height: 175px"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cyngn Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">March 17,
2026</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Page 2</FONT></P>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">6.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The placement agent agreement by and between
    the Company and Aegis Capital Corp. dated March 16, 2026; and</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">7.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Unanimous Written Consent of the Board of
    Directors of the Company approving the Purchase Agreement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
have examined and relied upon certificates of public officials and, as to certain matters of fact that are material to our opinions,
we have also relied on a certificate of an officer of the Company.&nbsp;&nbsp;We have not independently established any of the facts
so relied on.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">For
the purposes of this opinion letter, we have made assumptions that are customary in opinions of this kind, including the assumptions
of the accuracy and completeness of each document submitted to us, the genuineness of all signatures on original documents, the authenticity
of all documents submitted to us as originals, the conformity to originals of all documents submitted to us as copies thereof, and the
due execution and delivery of all documents where due execution and delivery are prerequisites to the effectiveness thereof.&nbsp;We
have further assumed the legal capacity of natural persons, and we have assumed that each party to the documents we have examined or
relied on (other than the Company) has the legal capacity or authority and has satisfied all legal requirements that are applicable to
that party to the extent necessary to make such documents enforceable against that party.&nbsp;&nbsp;We have not verified any of those
assumptions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
opinions expressed in this opinion letter are limited to the General Corporation Law of the State of Delaware (the &ldquo;DGCL&rdquo;)
and, solely in connection with the opinions given in numbered paragraphs 1 and 2 below, the laws of the State of New York.&nbsp;&nbsp;We
are not opining on, and we assume no responsibility for, the applicability to or effect on any of the matters covered herein of (a) any
other laws; (b) the laws of any other jurisdiction; or (c) the laws of any county, municipality or other political subdivision or local
governmental agency or authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Based
upon and subject to the foregoing, we are of the opinion that: (1) when the Shares have been delivered to and paid for by the Purchasers
as contemplated by the Purchase Agreement, the Shares will be duly authorized, validly issued, fully paid and non-assessable; and (2)
the Pre-Funded Warrants constitute the valid and binding obligation of the Company, enforceable against the Company in accordance with
its terms, subject to applicable bankruptcy, insolvency, fraudulent conveyance, moratorium and similar laws affecting creditors&rsquo;
rights generally and equitable principles of general applicability and upon exercise the Common Stock when issued and delivered by the
Company against payment therefor in accordance with the terms of the Pre-Funded Warrants, will be duly authorized, validly issued, fully
paid and non-assessable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
opinions set forth above are subject to the following additional assumptions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)
the Registration Statement, any amendments thereto (including post-effective amendments) and any additional registration statement filed
under Rule 462 under the Securities Act, will have been declared effective under the Securities Act and such effectiveness shall not
have been terminated, suspended or rescinded;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cyngn Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">March 17,
2026</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Page 3</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)
all Shares will be issued and sold in compliance with applicable federal and state securities laws, rules and regulations and solely
in the manner provided in the Registration Statement and the appropriate Prospectus Supplement and there will not have occurred any change
in law or fact affecting the validity of any of the opinions rendered herein;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)
in the case of an agreement pursuant to which any Shares are to be issued or governed, there will have been no additions, deletions or
modifications of the terms or provisions contained in the forms thereof included as exhibits to the Registration Statement that would
affect the validity of any of the opinions rendered herein;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(d)
a definitive purchase, underwriting or similar agreement and any other necessary agreements with respect to any Shares offered or issued
will have been duly authorized and duly executed and delivered by the Company and the other parties thereto;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(e)
in the case of any supplement or amendment thereto, underwriting or purchase agreement, certificate of designation, amendment to the
Certificate of Incorporation, or other agreement pursuant to which any Shares are to be issued or governed, there shall be no terms or
provisions contained therein which would affect the validity of any of the opinions rendered herein;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(f)
the final terms of any of the Shares (including any Shares comprising the same or subject thereto), and when issued, the issuance, sale
and delivery thereof by the Company, and the incurrence and performance of the Company&rsquo;s obligations thereunder or in respect thereof
in accordance with the terms thereof, and any consideration received by the Company for any such issuance, sale and delivery, will comply
with, and will not violate, the Company&rsquo;s Certificate of Incorporation, as amended or supplemented, or its Bylaws, as amended,
or any applicable law, rule or regulation, or any applicable public policy, or be subject to any defense in law or equity, or result
in a default under or breach of any agreement or instrument binding upon the Company, and will comply with any requirement or restriction
imposed by any court or governmental body having jurisdiction over the Company or to which the issuance, sale and delivery of such Shares
or the incurrence and performance of such obligations may be subject;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(g)
the Company shall have taken any action required to be taken by the Company to authorize the offer and issuance thereof, and such authorization
shall remain in effect and unchanged at all times during which the Shares are offered and issued and shall not have been modified or
rescinded (subject to the further assumption that the sale of any Shares take place in accordance with such authorization), the board
of directors of the Company (or an authorized committee thereof) shall have duly established the terms of such Shares and duly authorized
and taken any other necessary corporate action to approve the issuance and sale of such Shares in conformity with the Certificate of
Incorporation of the Company, as amended or supplemented, and its Bylaws, as amended (subject to the further assumption that the Certificate
of Incorporation, as amended or supplemented, and the Bylaws have not been amended from the date hereof in a manner that would affect
the validity of any of the opinions rendered herein), and such authorization shall remain in effect and unchanged at all times during
which the Shares are offered and issued and shall not have been modified or rescinded (subject to the further assumption that the sale
of any Shares take place in accordance with such authorization); and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cyngn Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">March 17,
2026</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Page 4</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(h)
to the extent they purport to relate to liabilities resulting from or based upon gross negligence, recklessness or other conduct committed
or omitted willfully or in bad faith or any violation of federal or state securities or blue sky laws, we express no opinions concerning
the enforceability of indemnification provisions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
opinions above are subject to the effects of (a) bankruptcy, insolvency, fraudulent conveyance, fraudulent transfer, reorganization,
receivership, moratorium and other similar laws relating to or affecting enforcement of creditors&rsquo; rights or remedies generally;
(b) general principles of equity, whether such principles are considered in a proceeding of law or at equity; and (c) an implied covenant
of good faith, reasonableness and fair dealing and standards of materiality.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
hereby consent to the filing of this opinion with the Commission as an exhibit to the Company&rsquo;s Current Report on Form 8-K being
filed on the date hereof and incorporated by reference into the Registration Statement. We also hereby consent to the reference to our
firm under the caption &ldquo;Legal Matters&rdquo; in the Prospectus Supplement. In giving this consent, we do not thereby admit that
we are within the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of
the Commission promulgated thereunder. This opinion is expressed as of the date hereof unless otherwise expressly stated, and we disclaim
any undertaking to advise you of any subsequent changes in the facts stated or assumed herein or of any subsequent changes in applicable
laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 40%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Very truly yours,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I><U>/s/ Kaufman &amp; Canoles, P.C.</U></I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">KAUFMAN &amp; CANOLES, P.C.</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>4
<FILENAME>ea028204301ex10-1.htm
<DESCRIPTION>FORM OF SECURITIES PURCHASE AGREEMENT BY AND BETWEEN CYNGN INC. AND THE PURCHASERS
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.1<FONT STYLE="text-transform: uppercase">&nbsp;</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>SECURITIES
PURCHASE AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Securities Purchase Agreement
(this &ldquo;<B><U>Agreement</U></B>&rdquo;) is dated as of March 16, 2026, between Cyngn Inc., a Delaware corporation (the &ldquo;<B><U>Company</U></B>&rdquo;),
and each purchaser identified on the signature pages hereto (including their respective successors and assigns, each a &ldquo;<B><U>Purchaser</U></B>&rdquo;
and collectively, the &ldquo;<B><U>Purchasers</U></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, subject to
the terms and conditions set forth in this Agreement and pursuant to an effective shelf registration statement under the Securities Act
of 1933, as amended (the &ldquo;<B><U>Securities Act</U></B>&rdquo;), the Company desires to issue and sell to each Purchaser, and each
Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>NOW, THEREFORE, IN CONSIDERATION</B>
of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy of which
are hereby acknowledged, the Company and each Purchaser agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.</TD><TD STYLE="text-align: justify"><B><U>Definitions</U></B>. In addition to the terms defined elsewhere in this Agreement, for all purposes
of this Agreement, the following terms have the meanings set forth in this Section 1:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>Acquiring Person</U></B>&rdquo; shall have the meaning ascribed to such term in Section 4.5.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>Action</U></B>&rdquo; shall have the meaning ascribed to such term in Section 3.1.5.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>Affiliate</U></B>&rdquo; means any Person that, directly or indirectly through one or more intermediaries, controls
or is controlled by or is under common control with a Person, as such terms are used in and construed under Rule 405 under the Securities
Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>Agreement</U></B>&rdquo; shall have the meaning ascribed to such term in the preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>BHCA</U></B>&rdquo; shall have the meaning ascribed to such term in Section 3.1.35.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.6.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>Board of Directors</U></B>&rdquo; means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.7.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>Business Day</U></B>&rdquo; means a Calendar Day other than a Saturday, Sunday or any other Calendar Day which is
a federal legal holiday in the United States or any Calendar Day on which the commercial banks in the City of New York are required by
law or other governmental action to close, provided that the commercial banks in the City of New York shall not be deemed to be required
to be closed due to a &ldquo;stay at home,&rdquo; &ldquo;shelter in place,&rdquo; &ldquo;non-essential employee&rdquo; or similar orders
or restrictions or the closure of any physical branch locations at the direction of any governmental authority so long as the electronic
funds transfer systems (including for wire transfers) of commercial banks in the City of New York generally are open for use by customers
on such Calendar Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.8.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>Calendar Day</U></B>&rdquo; means each and every day of the week (Sunday, Monday, Tuesday, Wednesday, Thursday, Friday
and Saturday).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: right; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.9.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT> &ldquo;<B><U>Closing</U></B>&rdquo; means the closing of the purchase and sale of the Securities pursuant to Section 2.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.10.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>Closing Date</U></B>&rdquo; means the Trading Day on which all of the Transaction Documents have been executed and
delivered by the applicable parties thereto, and all conditions precedent to (i) the Purchasers&rsquo; obligations to pay the Subscription
Amount and (ii) the Company&rsquo;s obligations to deliver the Securities, in each case, have been satisfied or waived, but in no event
later than the second (2nd) Trading Day following the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.11.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>Code</U></B>&rdquo; means the Internal Revenue Code of 1986, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.12.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>Commission</U></B>&rdquo; means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.13.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>Common Stock</U></B>&rdquo; means the common stock of the Company, $0.00001 par value per share, and any other class
of securities into which such securities may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.14.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>Common Stock Equivalents</U></B>&rdquo; means any securities of the Company or the Subsidiaries which would entitle
the holder thereof to acquire at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant
or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof
to receive, Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.15.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>Company</U></B>&rdquo; shall have the meaning ascribed to such term in the preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.16.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>Company Counsel</U></B>&rdquo; means with respect to U.S. federal securities law and New York law, Kaufman &amp; Canoles,
P.C., Two James Center, 14th Floor, 1021 East Cary St., Richmond, Virginia 23219.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.17.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>Disclosure Schedules</U></B>&rdquo; means the Disclosure Schedules of the Company delivered concurrently herewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.18.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>Disclosure Time</U></B>&rdquo; means, (i) if this Agreement is signed on a Calendar Day that is not a Trading Day
or after 9:00 a.m. (New York City time) and before midnight (New York City time) on any Trading Day, 9:01 a.m. (New York City time) on
the Trading Day immediately following the date hereof, unless otherwise instructed as to an earlier time by the Placement Agent, and (ii)
if this Agreement is signed between midnight (New York City time) and 9:00 a.m. (New York City time) on any Trading Day, no later than
9:01 a.m. (New York City time) on the date hereof, unless otherwise instructed as to an earlier time by the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.19.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>DVP</U></B>&rdquo; shall have the meaning ascribed to such term in Section 2.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.20.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>Evaluation Date</U></B>&rdquo; shall have the meaning ascribed to such term in Section 3.1.14.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.21.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>Exchange Act</U></B>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated
thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: right; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.22.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT> &ldquo;<B><U>Exempt Issuance</U></B>&rdquo; means (i) any conventional bank loans that are not convertible into, or exercisable
or exchangeable for, shares of Common Stock or Common Stock Equivalents and do not involve any issuance of any shares of Common Stock
or Common Stock Equivalents or other security of the Company in connection therewith; (ii) shares of Common Stock or options issued to
employees, officers or directors of the Company pursuant to the Company&rsquo;s equity incentive plans or pursuant to the compensation
agreements previously authorized by the Board of Directors; (iii) securities issued upon the exercise or exchange of or conversion of
any Securities issued hereunder and/or other securities exercisable or exchangeable for or convertible into shares of Common Stock issued
and outstanding on the date of this Agreement, provided that such securities have not been amended since the date of this Agreement to
increase the number of such securities or to decrease the exercise price, exchange price or conversion price of such securities (other
than in connection with stock splits or combinations) or to extend the term of such securities; and (iv) securities issued pursuant to
acquisitions or strategic transactions (whether by merger, consolidation, purchase of equity, purchase of assets, reorganization or otherwise)
approved by a majority of the disinterested directors of the Company, provided that such securities are issued as &ldquo;restricted securities&rdquo;
(as defined in Rule 144) and carry no registration rights that require or permit the filing of any registration statement in connection
therewith during the sixty (60) days following the Closing Date, and provided that any such issuance shall only be to a Person (or to
the equityholders of a Person) which is, itself or through its subsidiaries, an operating company or an owner of an asset in a business
synergistic with the business of the Company and shall provide to the Company additional benefits in addition to the investment of funds,
but shall not include a transaction in which the Company is issuing securities primarily for the purpose of raising capital or to an entity
whose primary business is investing in securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.23.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>FCPA</U></B>&rdquo; means the Foreign Corrupt Practices Act of 1977, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.24.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>Federal Reserve</U></B>&rdquo; shall have the meaning ascribed to such term in Section 3.1.35.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.25.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>GAAP</U></B>&rdquo; shall have the meaning ascribed to such term in Section 3.1.3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.26.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>Indebtedness</U></B>&rdquo; shall have the meaning ascribed to such term in Section 3.1.22.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.27.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>Intellectual Property Rights</U></B>&rdquo; shall have the meaning ascribed to such term in Section 3.1.11.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.28.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>IT Systems and Data</U></B>&rdquo; shall have the meaning ascribed to such term in Section 3.1.38.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.29.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>Liens</U></B>&rdquo; means a lien, charge pledge, security interest, encumbrance, right of first refusal, preemptive
right or other restriction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.30.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>Lock-Up Agreement</U></B>&rdquo; means each Lock-Up Agreement, dated as of the date hereof, by and between the Company
and each of the directors, executive officers, employees and stockholders holding at least ten percent (10%) of the outstanding shares
of Common Stock, in the form of <B><U>Exhibit 1.30</U></B> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: right; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.31.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT> &ldquo;<B><U>Material Adverse Effect</U></B>&rdquo; shall have the meaning assigned to such term in Section 3.1.2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.32.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>Material Permits</U></B>&rdquo; shall have the meaning ascribed to such term in Section 3.1.9.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.33.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>Money Laundering Laws</U></B>&rdquo; shall have the meaning ascribed to such term in Section 3.1.36.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.34.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>OFAC</U></B>&rdquo; shall have the meaning ascribed to such term in Section 3.1.33.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.35.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>Per Share Purchase Price</U></B>&rdquo; equals $1.93 (less $0.00001 for each Pre-Funded Warrant), subject to adjustment
for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur
after the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.36.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>Person</U></B>&rdquo; means an individual or corporation, partnership, trust, incorporated or unincorporated association,
joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any
kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.37.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>PFIC</U></B>&rdquo; shall have the meaning ascribed to such term in Section 4.15.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.38.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>Placement Agent</U></B>&rdquo; means Aegis Capital Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.39.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>Placement Agent Agreement</U></B>&rdquo; means the placement agent agreement, dated on or about the date hereof, between
the Company and the Placement Agent relating to the purchase and sale of the Securities under this Agreement and the purchase and sale
of Securities to other accredited investors pursuant to the terms of such Placement Agent Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.40.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>Pre-Funded Warrants</U></B>&rdquo; means the pre-funded Common Stock purchase warrants, in the form of <B><U>Exhibit
1.40.1</U></B> attached hereto delivered to the Purchasers at the Closing in accordance with Section 2.2.1 hereof, which Pre-Funded Warrants
shall be exercisable immediately and shall expire when exercised in full.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.41.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>Proceeding</U></B>&rdquo; means an action, claim, suit, investigation or proceeding (including, without limitation,
an informal investigation or partial proceeding, such as a deposition), whether commenced or threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.42.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>Prospectus</U></B>&rdquo; means the final base prospectus filed for the Shelf Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.43.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>Prospectus Supplement</U></B>&rdquo; means the supplement to the Prospectus complying with Rule 424(b) of the Securities
Act that is filed with the Commission and delivered by the Company to each Purchaser at the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.44.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>Purchaser</U></B>&rdquo; shall have the meaning ascribed to such term in the preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.45.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>Purchaser Party</U></B>&rdquo; shall have the meaning ascribed to such term in Section 4.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: right; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.46.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT> &ldquo;<B><U>Required Approvals</U></B>&rdquo; shall have the meaning ascribed to such term in Section 3.1.5.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.47.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>Rule 144</U></B>&rdquo; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule
may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially
the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.48.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>Rule 424</U></B>&rdquo; means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule
may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially
the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.49.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>SEC Reports</U></B>&rdquo; shall have the meaning ascribed to such term in Section 3.1.3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.50.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>Securities</U></B>&rdquo; means the Shares, the Warrants and the Warrant Shares purchased pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.51.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>Securities Act</U></B>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated
thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.52.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>Shares</U></B>&rdquo; means the shares of Common Stock issued or issuable to each Purchaser pursuant to this Agreement,
but excluding the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.53.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>Shelf Registration Statement</U></B>&rdquo; means the effective registration statement on Form S-3 with Commission
(File No. 333-290079), including all information, documents and exhibits filed with or incorporated by reference into such registration
statement, which registers the sale of the Securities to the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.54.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>Short Sales</U></B>&rdquo; means all &ldquo;short sales&rdquo; as defined in Rule 200 of Regulation SHO under the
Exchange Act (but shall not be deemed to include locating and/or borrowing shares of Common Stock).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.55.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>Subscription Amount</U></B>&rdquo; means, as to each Purchaser, the aggregate amount to be paid for the Securities
purchased hereunder as specified below such Purchaser&rsquo;s name on the signature page of this Agreement and next to the heading &ldquo;Subscription
Amount,&rdquo; in United States dollars and in immediately available funds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.56.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>Subsidiary</U></B>&rdquo; means any subsidiary of the Company as set forth in Schedule 3.1.1 and shall, where applicable,
also include any direct or indirect subsidiary of the Company formed or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.57.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>Trading Day</U></B>&rdquo; means a Calendar Day on which the principal Trading Market is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.58.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>Trading Market</U></B>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed
or quoted for trading on the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global
Select Market, the New York Stock Exchange, the OTCQB,
OTCQX, Pink Open Market (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: right; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.59.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>Transaction Documents</U></B>&rdquo; means this Agreement, the Securities, the Lock-Up Agreements and all exhibits
and schedules thereto and hereto and any other documents or agreements executed in connection with the transactions contemplated hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.60.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>Transfer Agent</U></B>&rdquo; means Continental Stock Transfer &amp; Trust Company, the current transfer agent of
the Company, with a mailing address of 1 State Street, 30th Floor, New York, NY 10004-1561.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.61.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>Warrants</U></B>&rdquo; means the Pre-Funded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">1.62.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B><U>Warrant Shares</U></B>&rdquo; means the shares of Common Stock underlying the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.</TD><TD STYLE="text-align: justify"><B><U>Purchase and Sale</U></B>.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Closing</U></B>. On the Closing Date, upon the terms and subject to the conditions set forth herein, substantially concurrent
with the execution and delivery of this Agreement by the parties hereto, the Company agrees to sell, and the Purchasers, severally and
not jointly, agree to purchase, up to an aggregate of approximately $9.65 million of Shares and Warrants; provided, however, that a Purchaser
in its sole discretion, may elect to purchase Pre-Funded Warrants in lieu of Shares in such manner to result in the same aggregate purchase
price being paid by such Purchaser less $0.00001 per Pre-Funded Warrant. Each Purchaser shall make such Purchaser&rsquo;s Subscription
Amount as set forth on the signature page hereto executed by such Purchaser available to be delivered to the Company (or its designee)
via DVP (as defined below), and the Company shall deliver to each Purchaser its respective Securities, as determined pursuant to Section
2.2.1, and the Company and each Purchaser shall deliver the other items set forth in Section 2.2.2 deliverable at the Closing. Upon satisfaction
of the covenants and conditions set forth in Sections 2.3.1 and 2.3.2, the Closing shall occur at the offices of counsel to the Placement
Agent or such other location (or remotely by electronic means) as the parties shall mutually agree. Unless otherwise directed by the Placement
Agent, settlement of the Shares shall occur via &ldquo;Delivery Versus Payment&rdquo; (&ldquo;<B><U>DVP</U></B>&rdquo;) (i.e., on the
Closing Date, the Company shall issue the Shares registered in the Purchasers&rsquo; names and addresses and released by the Transfer
Agent directly to the account(s) at the Placement Agent identified by each Purchaser; upon receipt of such Shares, the Placement Agent
shall promptly electronically deliver such Shares to the applicable Purchaser, and payment therefor shall be made by the Placement Agent
(or its clearing firm) by wire transfer to the Company). Notwithstanding anything herein to the contrary, if at any time on or after the
time of execution of this Agreement by the Company and an applicable Purchaser, through and including the time immediately prior to the
Closing (the &ldquo;<B><U>Pre-Settlement Period</U></B>&rdquo;), if such Purchaser sells to any Person all, or any portion, of any Shares
to be issued hereunder to such Purchaser at the Closing (collectively, the &ldquo;<B><U>Pre-Settlement Shares</U></B>&rdquo;), such Purchaser
shall, automatically hereunder (without any additional required actions by such Purchaser or the Company), be deemed to be unconditionally
bound to purchase, and the Company shall be deemed unconditionally bound to sell to such Purchaser, such Pre-Settlement Shares at the
Closing; provided, that the Company shall not
be required to deliver any Pre-Settlement Shares to such Purchaser prior to the Company&rsquo;s receipt of the purchase price for such
Pre-Settlement Shares hereunder, and provided further that the Company hereby acknowledges and agrees that the foregoing shall not constitute
a representation or covenant by such Purchaser as to whether or not such Purchaser will elect to sell any Pre-Settlement Shares during
the Pre-Settlement Period. The decision to sell any Pre-Settlement Shares will be made in the sole discretion of such Purchaser from time
to time, including during the Pre-Settlement Period. Notwithstanding the foregoing, with respect to any Notice(s) of Exercise (as defined
in the Prefunded Warrants) delivered on or prior to 2:00 p.m. (New York City time) on the Closing Date, which may be delivered at any
time after the time of execution of this Agreement, the Company agrees to deliver the Warrant Shares subject to such notice(s) by 4:00
p.m. (New York City time) on the Closing Date and the Closing Date shall be the Warrant Share Delivery Date (as defined in the Prefunded
Warrants) for purposes hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: right; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Deliveries</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">2.2.1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company shall deliver or cause to be delivered to each Purchaser or the Placement Agent, as appropriate, the following at the
times stated:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">2.2.1.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT>on the date hereof:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: 0in">2.2.1.1.1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>this Agreement duly executed by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: 0in">2.2.1.1.2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>the Placement Agent Agreement, duly executed by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: 0in">2.2.1.1.3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>a certificate executed by the Chief Financial Officer of the Company in customary form reasonably satisfactory to the Placement
Agent and its counsel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: 0in">2.2.1.1.4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>the Lock-Up Agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">2.2.1.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT>on or prior to the Closing Date:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: 0in">2.2.1.2.1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>a legal opinion of Company Counsel, addressed to the Placement Agent and the Purchasers, in form and substance reasonably acceptable
to the Placement Agent and the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: 0in">2.2.1.2.2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>for each Purchaser of Pre-Funded Warrants pursuant to Section 2.1, a Pre-Funded Warrant registered in the name of such Purchaser
to purchase up to a number of shares of Common Stock equal to the portion of such Purchaser&rsquo;s Subscription Amount applicable to
Pre-Funded Warrants divided by the Per Unit Purchase Price, with an exercise price equal to $0.00001, subject to adjustment as provided
therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: right; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: 0in">2.2.1.2.3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT> subject to the provisions of Section 2.1 regarding settlement via DVP, the Company&rsquo;s wire instructions, on Company letterhead
and executed by the Chief Executive Officer or Chief Financial Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: 0in">2.2.1.2.4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>a duly executed and delivered Officers&rsquo; Certificate, in customary form reasonably satisfactory to the Placement Agent and
its counsel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: 0in">2.2.1.2.5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>the Prospectus and Prospectus Supplement (which may be delivered in accordance with Rule 172 under the Securities Act).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">2.2.2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Each Purchaser, and the Placement Agent, as applicable, shall deliver or cause to be delivered to the Company the following at
the times stated:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">2.2.2.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT>on the date hereof, this Agreement duly executed by such Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">2.2.2.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT>on or prior to the Closing Date:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: 0in">2.2.2.2.1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>such Purchaser&rsquo;s Subscription Amount shall be made available for DVP settlement with the Company or its designee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: 0in">2.2.2.2.2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>the Placement Agent Agreement, duly executed by the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">2.3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Closing Conditions</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">2.3.1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The obligations of the Company hereunder in connection with the Closing are subject to each of the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">2.3.1.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT>the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material
Adverse Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Purchasers contained herein
(unless as of a specific date therein in which case they shall be accurate as of such date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">2.3.1.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT>all obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have
been performed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">2.3.1.3<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT>the delivery by each Purchaser of the items set forth in Section 2.2.2 of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">2.3.2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The respective obligations of the Purchasers hereunder in connection with the Closing are subject to each of the following conditions
being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: right; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">2.3.2.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT> the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material
Adverse Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein
(unless as of a specific date therein in which case they shall be accurate as of such date).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">2.3.2.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT>all obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been
performed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">2.3.2.3<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT>the delivery by the Company of the items set forth in Section 2.2.1 of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">2.3.2.4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT>there shall have been no Material Adverse Effect with respect to the Company since the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">2.3.2.5<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT>from the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company&rsquo;s
principal Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall
not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such
service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities
nor shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such magnitude
in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of such Purchaser,
makes it impracticable or inadvisable to purchase the Securities at the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.</TD><TD STYLE="text-align: justify"><B><U>Representations and Warranties</U></B>.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">3.1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Representations and Warranties of the Company</U></B>. The Company hereby makes the following representations and warranties
to each Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.1.1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Subsidiaries</U></B>. All of the direct and indirect subsidiaries of the Company are set forth on Schedule 3.1.1. The Company
owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all
of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free
of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to
the Subsidiaries or any of them in the Transaction Documents shall be disregarded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: right; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.1.2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT><B><U>Organization
and Qualification</U></B>. Each of the Company and each of its operating Subsidiaries is an entity duly incorporated or otherwise
organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with the
requisite power and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither
the Company nor any Subsidiary is in violation nor default of any of the provisions of its respective certificate or articles of
incorporation, bylaws or other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to
conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the
business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified or in
good standing, as the case may be, could not have or reasonably be expected to result in: (i) a material adverse effect on the
legality, validity or enforceability of any Transaction Document, (ii) a material adverse effect on the results of operations,
assets, business, prospects or condition (financial or otherwise) of the Company and the Subsidiaries, taken as a whole, or (iii) a
material adverse effect on the Company&rsquo;s ability to perform in any material respect on a timely basis its obligations under
any Transaction Document (any of (i), (ii) or (iii), a &ldquo;<B><U>Material Adverse Effect</U></B>&rdquo;; provided, however, that
&ldquo;<B><U>Material Adverse Effect</U></B>&rdquo; shall not include any event, occurrence, fact, condition or change, directly or
indirectly, arising out of or attributable to: (i) the announcement, pendency or completion of the transactions contemplated by the
Transaction Documents or (ii) any action required or permitted by the Transaction Documents or any action taken (or omitted to be
taken) with the written consent of or at the written request of Purchaser). As to all Company and Subsidiary power, authority and
qualification, no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke,
limit or curtail such power and authority or qualification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.1.3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Authorization; Enforcement</U></B>. The Company has the requisite corporate power and authority to enter into and to consummate
the transactions contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations
hereunder and thereunder. The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and
the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part
of the Company and no further action is required by the Company, the Board of Directors or the Company&rsquo;s stockholders in connection
herewith or therewith other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which
it is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms
hereof and thereof, will constitute the legal, valid and binding obligation of the Company enforceable against the Company in accordance
with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium
and other laws of general application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to
the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution
provisions may be limited by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.1.4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>No Conflicts</U></B>. The execution, delivery and performance by the Company of this Agreement and the other Transaction
Documents to which it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated
hereby and thereby do not and will not (i) conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate
or articles of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or
an event that with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties
or assets of the Company or any Subsidiary, or give to others any rights of termination,
amendment, anti-dilution or similar adjustments, acceleration or cancellation (with or without notice, lapse of time or both) of, any
agreement, credit facility, debt or other instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding to
which the Company or any Subsidiary is a party or by which any property or asset of the Company or any Subsidiary is bound or affected,
or (iii) subject to the Required Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction,
decree or other restriction of any court or governmental authority to which the Company or a Subsidiary is subject (including federal
and state securities laws and regulations), or by which any property or asset of the Company or a Subsidiary is bound or affected; except
in the case of each of clauses (ii) and (iii), such as could not have or reasonably be expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: right; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.1.5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Filings, Consents and Approvals</U></B>. The Company is not required to obtain any consent, waiver, authorization or order
of, give any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority
or other Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i)
the filings required pursuant to Section 4.4 of this Agreement, (ii) the filing with the Commission of the Prospectus Supplement to the
Shelf Registration Statement, and (iii) the notice and/or application(s) to each applicable Trading Market for the issuance and sale of
the Securities and the listing of the Shares and Warrant Shares for trading thereon in the time and manner required thereby and such other
filings as are required to be made under applicable state securities laws (the &ldquo;<B><U>Required Approvals</U></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">3.1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Issuance of the Securities; Registration</U></B>. The Securities are duly authorized and, when issued and paid for in accordance
with the applicable Transaction Documents, will be duly and validly issued, fully paid and nonassessable (which means that no further
sums are required to be paid by the holders thereof in connection with the issue thereof), free and clear of all Liens imposed by the
Company other than restrictions on transfer provided for in the Transaction Documents and applicable law. The Warrant Shares, when issued
in accordance with the terms of the Transaction Documents, will be validly issued, fully paid and nonassessable (which means that no further
sums are required to be paid by the holders thereof in connection with the issue thereof), free and clear of all Liens imposed by the
Company other than restrictions on transfer provided for in the Transaction Documents and applicable law. As of the date hereof, the Company
has reserved and the Company shall continue to reserve and keep available at all times, free of preemptive rights, a sufficient number
of shares of Common Stock for the purpose of enabling the Company to issue Shares pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.1.1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Registration Statement</U></B>. The Company has prepared and filed the Shelf Registration Statement in conformity with the
requirements of the Securities Act, which became effective on June 13, 2023, including the Prospectus, and such amendments and supplements
thereto as may have been required to the date of this Agreement. The Shelf Registration Statement is effective under the Securities Act
and no stop order preventing or suspending the effectiveness of the Shelf Registration Statement or suspending or preventing the use of
the Prospectus has been issued by the Commission and no proceedings for that purpose have been instituted or, to the knowledge of the
Company, are threatened by the Commission. The
Company, if required by the rules and regulations of the Commission, shall file the Prospectus Supplement with the Commission pursuant
to Rule 424(b). At the time the Shelf Registration Statement and any amendments thereto became effective, at the date of this Agreement
and at the Closing Date, the Shelf Registration Statement and any amendments thereto conformed and will conform in all material respects
to the requirements of the Securities Act and did not and will not contain any untrue statement of a material fact or omit to state any
material fact required to be stated therein or necessary to make the statements therein not misleading; and the Prospectus and any amendments
or supplements thereto, at the time the Prospectus or any amendment or supplement thereto was issued and at the Closing Date, conformed
and will conform in all material respects to the requirements of the Securities Act and did not and will not contain an untrue statement
of a material fact or omit to state a material fact necessary in order to make the statements therein, in light of the circumstances under
which they were made, not misleading. The Company was at the time of the filing of the Shelf Registration Statement eligible to use Form
S-3. The Company is eligible to use Form S-3 under the Securities Act and it meets the requirements with respect to the aggregate market
value of securities being sold pursuant to this offering and during the twelve (12) months prior to this offering, as set forth in General
Instruction I.B.1 of Form S-3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: right; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.1.2. <B><U>Capitalization</U></B>.
The capitalization of the Company as of the date hereof is as set forth on Schedule 3.1.2, which Schedule 3.1.2 shall also include
the number of shares of Common Stock owned beneficially, and of record, by Affiliates of the Company as of the date hereof. Other
than as stated in Schedule 3.1.2, the Company has not issued any capital stock since its most recently filed periodic report under
the Exchange Act, other than pursuant to the exercise of employee stock options under the Company&rsquo;s stock option plans, the
issuance of shares of Common Stock to employees pursuant to the Company&rsquo;s employee stock purchase plans and pursuant to the
conversion and/or exercise of Common Stock Equivalents outstanding as of the date of the most recently filed periodic report under
the Exchange Act. No Person has any right of first refusal, preemptive right, right of participation, or any similar right to
participate in the transactions contemplated by the Transaction Documents. Except as set forth in Schedule 3.1.2, or pursuant to
this Agreement, there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character
whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving any
Person any right to subscribe for or acquire, any shares of Common Stock or the capital stock of any Subsidiary, or contracts,
commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to issue additional shares
of Common Stock or Common Stock Equivalents or capital stock of any Subsidiary. The issuance and sale of the Securities will not
obligate the Company or any Subsidiary to issue shares of Common Stock or other securities to any Person (other than the
Purchasers). Except as set forth in Schedule 3.1.2, there are no outstanding securities or instruments of the Company or any
Subsidiary with any provision that adjusts the exercise, conversion, exchange or reset price of such security or instrument upon an
issuance of securities by the Company or any Subsidiary. Except as set forth in Schedule 3.1.2, there are no outstanding securities
or instruments of the Company or any Subsidiary that contain any redemption or similar provisions, and there are no contracts,
commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to redeem a security of
the Company or such Subsidiary. The Company does not have any stock appreciation rights or &ldquo;phantom stock&rdquo; plans or
agreements or any similar plan or agreement. All of the outstanding shares of capital stock of the Company are duly authorized,
validly issued, fully paid and nonassessable, have been issued in compliance with all federal and state securities laws, and none of
such outstanding shares was issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities.
No further approval or authorization of any stockholder, the Board of Directors or others is required for the issuance and sale of
the Securities. There are no stockholders&rsquo; agreements, voting agreements or other similar agreements with respect to the
Company&rsquo;s capital stock to which the Company is a party or, to the knowledge of the Company, between or among any of the
Company&rsquo;s stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.1.3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>SEC Reports; Financial Statements</U></B>. The Company has filed all reports, schedules, forms, statements and other documents
required to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof,
for the two years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material)
(the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, together with the Prospectus
and the Prospectus Supplement, being collectively referred to herein as the &ldquo;<B><U>SEC Reports</U></B>&rdquo;) on a timely basis
or has received a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension.
As of their respective dates, the SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange
Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material
fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which
they were made, not misleading. The Company has never been an issuer subject to Rule 144(i) under the Securities Act. The financial statements
of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements and the rules and regulations
of the Commission with respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance
with United States generally accepted accounting principles applied on a consistent basis during the periods involved (&ldquo;<B><U>GAAP</U></B>&rdquo;),
except as may be otherwise specified in such financial statements or the notes thereto, and fairly present in all material respects the
financial position of the Company and its consolidated Subsidiaries as of and for the dates thereof and the results of operations and
cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: right; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.1.4. <B><U>Material
Changes; Undisclosed Events, Liabilities or Developments</U></B>. Since the date of the latest audited financial statements included
within the SEC Reports, except as set forth on Schedule 3.1.4, (i) there has been no event, occurrence or development that has had
or that could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities
(contingent or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent
with past practice and (B) liabilities not required to be reflected in the Company&rsquo;s financial statements pursuant to GAAP or
disclosed in filings made with the Commission, (iii) the Company has not altered its method of accounting, (iv) the Company has not
declared or made any dividend or distribution of cash or other property to its stockholders or purchased, redeemed or made any
agreements to purchase or redeem any shares of its capital stock and (v) the Company has not issued any equity securities to any
officer, director or Affiliate, except pursuant to existing Company stock option plans. The Company does not have pending before the
Commission any request for confidential treatment of information. Except for the issuance of the Securities contemplated by this
Agreement, no event, liability, fact, circumstance, occurrence or development has occurred or exists or is reasonably expected to
occur or exist with respect to the Company or its Subsidiaries or their respective businesses, prospects, properties, operations,
assets or financial condition that would be required to be disclosed by the Company under applicable securities laws at the time
this representation is made or deemed made that has not been publicly disclosed at least one (1) Trading Day prior to the date that
this representation is made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.1.5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Litigation</U></B>. Except as set forth in Schedule 3.1.5, there is no action, suit, inquiry, notice of violation, proceeding
or investigation pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their
respective properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state,
county, local or foreign) (collectively, an &ldquo;<B><U>Action</U></B>&rdquo;). None of the Actions set forth on Schedule 3.1.5, (i)
adversely affects or challenges the legality, validity or enforceability of any of the Transaction Documents or (ii) would, if there were
an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any Subsidiary,
nor any director or officer thereof, is or has been the subject of any Action involving a claim of violation of or liability under federal
or state securities laws or a claim of breach of fiduciary duty. There has not been, and to the knowledge of the Company, there is not
pending or contemplated, any investigation by the Commission involving the Company or any current or former director or officer of the
Company, except in the ordinary course of business that would not have a Material Adverse Effect. The Commission has not issued any stop
order or other order suspending the effectiveness of any registration statement filed by the Company or any Subsidiary under the Exchange
Act or the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.1.6.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Labor Relations</U></B>. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of
the employees of the Company, which could reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or
its Subsidiaries&rsquo; employees is a member of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary,
and neither the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries
believe that their relationships with their employees are good. To the knowledge of the Company, no executive officer of the Company or
any Subsidiary is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure
or proprietary information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor
of any third party, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries
to any liability with respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance with all U.S. federal,
state, local and foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and
wages and hours, except where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have
a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: right; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.1.7.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Compliance</U></B>. Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has
occurred that has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary
under), nor has the Company or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any
indenture, loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties
is bound (whether or not such default or violation has been waived), (ii) is in violation of any judgment, decree, or order of any court,
arbitrator or other governmental authority or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental
authority, including without limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational
health and safety, product quality and safety and employment and labor matters, except in each case as could not have or reasonably be
expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.1.8.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Environmental Laws</U></B>. The Company and its Subsidiaries (i) are in compliance with all federal, state, local and foreign
laws relating to pollution or protection of human health or the environment (including ambient air, surface water, groundwater, land surface
or subsurface strata), including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants,
or toxic or hazardous substances or wastes (collectively, &ldquo;<B><U>Hazardous Materials</U></B>&rdquo;) into the environment, or otherwise
relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials,
as well as all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters,
orders, permits, plans or regulations, issued, entered, promulgated or approved thereunder (&ldquo;<B><U>Environmental Laws</U></B>&rdquo;);
(ii) have received all permits licenses or other approvals required of them under applicable Environmental Laws to conduct their respective
businesses; and (iii) are in compliance with all terms and conditions of any such permit, license or approval where in each clause (i),
(ii) and (iii), the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.1.9.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Regulatory Permits</U></B>. The Company and the Subsidiaries possess all certificates, authorizations and permits issued
by the appropriate federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses as described
in the SEC Reports, except where the failure to possess such permits could not reasonably be expected to result in a Material Adverse
Effect (&ldquo;<B><U>Material Permits</U></B>&rdquo;), and neither the Company nor any Subsidiary has received any notice of proceedings
relating to the revocation or modification of any Material Permit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.1.10.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT><B><U>Title to Assets</U></B>. The Company and the Subsidiaries have good and marketable title in fee simple to, or have valid
and marketable rights to lease or otherwise use, all real property and all personal property that is material to the business of the Company
and the Subsidiaries, in each case free and clear of all Liens, except for (i) Liens that do not materially affect the value
of such property and do not materially interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries
and (ii) Liens for the payment of federal, state or other taxes, for which appropriate reserves have been made in accordance with GAAP,
and the payment of which is neither delinquent nor subject to penalties. Neither the Company nor any of its Subsidiaries has received
any written notice of any claim of any sort that has been asserted by anyone adverse to the rights of the Company or its Subsidiaries
under any of the leases or subleases or licenses or with respect to the properties mentioned above, or affecting or questioning the rights
of the Company or any Subsidiary to the continued possession or use of the leased or subleased or licensed premises or the properties
mentioned above, other than such claims which would not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: right; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.1.11.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT><B><U>Intellectual Property</U></B>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications,
trademarks, trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual
property rights and similar rights necessary or required for use in connection with their respective businesses as described in the SEC
Reports and which the failure to so have could have a Material Adverse Effect (collectively, the &ldquo;<B><U>Intellectual Property Rights</U></B>&rdquo;).
None of, and neither the Company nor any Subsidiary has received notice (written or otherwise) that any of, the Intellectual Property
Rights has expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years after the
date of this Agreement. Neither the Company nor any Subsidiary has received, since the date of the latest audited financial statements
included within the SEC Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate
or infringe upon the rights of any Person, except as could not have or reasonably be expected to not have a Material Adverse Effect. To
the knowledge of the Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person
of any of the Intellectual Property Rights. The Company and its Subsidiaries have taken reasonable security measures to protect the secrecy,
confidentiality and value of all of their intellectual properties, except where failure to do so could not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.1.12.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT><B><U>Insurance</U></B>. The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against
such losses and risks and in such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are
engaged, including, but not limited to, directors and officers insurance coverage in amount deemed prudent by the Company. Neither the
Company nor any Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when such
coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business without a significant
increase in cost.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.1.13.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT><B><U>Transactions with Affiliates and Employees</U></B>. Except as set forth on Schedule 3.1.13, during the past three fiscal
years and the subsequent interim period through the date of this Agreement, none of the officers or directors of the Company or any Subsidiary
and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party
to any transaction with the Company or any Subsidiary (other than for services as employees, officers and directors), including any contract,
agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to
or from, providing for the borrowing of money from or lending of money to or otherwise requiring payments to or from any officer, director
or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial
interest or is an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 other than for (i) payment
of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other
employee benefits, including stock option agreements under any stock option plan of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: right; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.1.14.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT><B><U>Sarbanes-Oxley; Internal Accounting Controls</U></B>. The Company and the Subsidiaries are in material compliance with any
and all applicable requirements of the Sarbanes-Oxley Act of 2002, as amended, that are effective as of the date hereof, and any and all
applicable rules and regulations promulgated by the Commission thereunder that are effective as of the date hereof and as of the Closing
Date. Except as set forth on Schedule 3.1.14, the Company and the Subsidiaries maintain a system of internal accounting controls sufficient
to provide reasonable assurance that: (i) transactions are executed in accordance with management&rsquo;s general or specific authorizations,
(ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset
accountability, (iii) access to assets is permitted only in accordance with management&rsquo;s general or specific authorization, and
(iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken
with respect to any differences. The Company and the Subsidiaries have established disclosure controls and procedures (as defined in Exchange
Act Rules 13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and designed such disclosure controls and procedures to ensure
that information required to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded, processed,
summarized and reported, within the time periods specified in the Commission&rsquo;s rules and forms. The Company&rsquo;s certifying officers
have evaluated the effectiveness of the disclosure controls and procedures of the Company and the Subsidiaries as of the end of the period
covered by the most recently filed periodic report under the Exchange Act (such date, the &ldquo;<B><U>Evaluation Date</U></B>&rdquo;).
The Company presented in its most recently filed periodic report under the Exchange Act the conclusions of the certifying officers about
the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date. Since the Evaluation
Date, there have been no changes in the internal control over financial reporting (as such term is defined in the Exchange Act) of the
Company and its Subsidiaries that have materially affected, or is reasonably likely to materially affect, the internal control over financial
reporting of the Company and its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.1.15.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT><B><U>Certain Fees</U></B>. Except for the fees and expenses of the Placement Agent, no brokerage or finder&rsquo;s fees or commissions
are or will be payable by the Company or any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment
banker, bank or other Person with respect to the transactions contemplated by the Transaction Documents. The Purchasers shall have no
obligation with respect to any fees or with respect to any claims made
by or on behalf of other Persons for fees of a type contemplated in this Section 3.1.15 that may be due in connection with the transactions
contemplated by the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: right; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.1.16.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT><B><U>Investment Company</U></B>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for
the Securities, will not be or be an Affiliate of, an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act
of 1940, as amended. The Company shall conduct its business in a manner so that it will not become an &ldquo;investment company&rdquo;
subject to registration under the Investment Company Act of 1940, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.1.17.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT><B><U>Registration Rights</U></B>. Except as disclosed on Schedule 3.1.17, no Person has any right to cause the Company or any
Subsidiary to effect the registration under the Securities Act of any securities of the Company or any Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.1.18.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT><B><U>Listing and Maintenance Requirements</U></B>. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange
Act, and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration
of the Common Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating
such registration. The Company has not, in the 12 months preceding the date hereof, received notice from any Trading Market on which the
Common Stock is or has been listed or quoted to the effect that the Company is not in compliance with the listing or maintenance requirements
of such Trading Market. The Company is, and has no reason to believe that it will not in the foreseeable future continue to be, in compliance
with all such listing and maintenance requirements. The Common Stock is currently eligible for electronic transfer through the Depository
Trust Company or another established clearing corporation and the Company is current in payment of the fees to the Depository Trust Company
(or such other established clearing corporation) in connection with such electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.1.19.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT><B><U>Application of Takeover Protections</U></B>. The Company and the Board of Directors have taken all necessary action, if any,
in order to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights
agreement) or other similar anti-takeover provision under the Company&rsquo;s certificate of incorporation (or similar charter documents)
or the laws of its state of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and the Company
fulfilling their obligations or exercising their rights under the Transaction Documents, including without limitation as a result of the
Company&rsquo;s issuance of the Securities and the Purchasers&rsquo; ownership of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.1.20.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT><B><U>Disclosure</U></B>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction
Documents, the Company confirms that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their
agents or counsel with any information that it believes constitutes or might constitute material, non-public information. The Company
understands and confirms that the Purchasers will rely on the foregoing representation in effecting transactions in securities of the
Company. All of the disclosure furnished by or on behalf of the Company to the Purchasers regarding the Company and
its Subsidiaries, their respective businesses and the transactions contemplated hereby, is true and correct and does not contain any untrue
statement of a material fact or omit to state any material fact necessary in order to make the statements made therein, in the light of
the circumstances under which they were made, not misleading. The press releases disseminated by the Company during the twelve months
preceding the date of this Agreement taken as a whole do not contain any untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which
they were made and when made, not misleading. The Company acknowledges and agrees that no Purchaser makes or has made any representations
or warranties with respect to the transactions contemplated hereby other than those specifically set forth in Section 3.2 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: right; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.1.21.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT><B><U>No Integrated Offering</U></B>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in
Section 3.2, neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly,
made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering
of the Securities to be integrated with prior offerings by the Company for purposes of any applicable stockholder approval provisions
of any Trading Market on which any of the securities of the Company are listed or designated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.1.22.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT><B><U>Solvency</U></B>. Based on the consolidated financial condition of the Company as of the Closing Date, after giving effect
to the receipt by the Company of the proceeds from the sale of the Securities hereunder, (i) the fair saleable value of the Company&rsquo;s
assets exceeds the amount that will be required to be paid on or in respect of the Company&rsquo;s existing debts and other liabilities
(including known contingent liabilities) as they mature, (ii) the Company&rsquo;s assets do not constitute unreasonably small capital
to carry on its business as now conducted and as proposed to be conducted including its capital needs taking into account the particular
capital requirements of the business conducted by the Company, consolidated and projected capital requirements and capital availability
thereof, and (iii) the current cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all
of its assets, after taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of
its liabilities when such amounts are required to be paid. The Company does not intend to incur debts beyond its ability to pay such
debts as they mature (taking into account the timing and amounts of cash to be payable on or in respect of its debt). The Company has
no knowledge of any facts or circumstances which lead it to believe that it will file for reorganization or liquidation under the bankruptcy
or reorganization laws of any jurisdiction within one year after the Closing Date. Schedule 3.1.22 sets forth as of the date hereof all
outstanding secured and unsecured Indebtedness of the Company or any Subsidiary, or for which the Company or any Subsidiary has commitments.
For the purposes of this Agreement, &ldquo;<B><U>Indebtedness</U></B>&rdquo; means (x) any liabilities for borrowed money or amounts
owed in excess of $50,000 (other than trade accounts payable incurred in the ordinary course of business), (y) all guaranties, endorsements
and other contingent obligations in respect of indebtedness of others, whether or not the same are or should be reflected in the Company&rsquo;s
consolidated balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments for deposit or collection
or similar transactions in the ordinary course of business; and (z) the present value of any lease payments in excess of $50,000 due
under leases required to be capitalized in accordance with GAAP. Neither the Company nor any Subsidiary is in default with respect to
any Indebtedness.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: right; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.1.23.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT><B><U>Tax Status</U></B>. Except as disclosed in Schedule 3.1.23, the Company and its Subsidiaries each (i) has made or filed all
material United States federal, state and local income and all foreign income and franchise tax returns, reports and declarations required
by any jurisdiction to which it is subject, (ii) has paid all material taxes and other governmental assessments and charges that are material
in amount, shown or determined to be due on such returns, reports and declarations and (iii) has set aside on its books provision reasonably
adequate for the payment of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply.
There are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the
Company or of any Subsidiary know of no basis for any such claim.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.1.24.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT><B><U>Foreign Corrupt Practices Act</U></B>. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any
Subsidiary, any agent or other person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds
for unlawful contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made
any unlawful payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns
from corporate funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting
on its behalf of which the Company is aware) which is in violation of law or (iv) violated in any material respect any provision of FCPA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.1.25.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT><B><U>Accountants</U></B>. The Company&rsquo;s accounting firm is Marcum LLP, with offices at 1 Montgomery Street, Suite 1700,
San Francisco, CA 94104. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as
required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company&rsquo;s
Annual Report for the now current fiscal year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.1.26.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT><B><U>No Disagreements with Accountants and Lawyers</U></B>. There are no disagreements of any kind presently existing, or reasonably
anticipated by the Company to arise, between the Company and the accountants and lawyers formerly or presently employed by the Company
and the Company is current with respect to any fees owed to its accountants and lawyers which could affect the Company&rsquo;s ability
to perform any of its obligations under any of the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.1.27.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp; </FONT><B><U>Acknowledgment
Regarding Purchasers&rsquo; Purchase of Securities</U></B>. The Company acknowledges and agrees that each of the Purchasers is
acting solely in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions
contemplated thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the
Company (or in any similar capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or
any of their respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby
is merely incidental to the Purchasers&rsquo; purchase of the Securities. The Company further represents to each Purchaser that the Company&rsquo;s
decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the transactions
contemplated hereby by the Company and its representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: right; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.1.28.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT><B><U>Acknowledgment Regarding Purchaser&rsquo;s Trading Activity</U></B>. Notwithstanding anything in this Agreement or elsewhere
herein to the contrary (except for Sections 3.2.6 and 4.13 hereof), it is understood and acknowledged by the Company that: (i) none of
the Purchasers has been asked by the Company to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and/or
short, securities of the Company, or &ldquo;derivative&rdquo; securities based on securities issued by the Company or to hold the Securities
for any specified term, (ii) past or future open market or other transactions by any Purchaser, specifically including, without limitation,
Short Sales or &ldquo;derivative&rdquo; transactions, before or after the closing of this or future private placement transactions, may
negatively impact the market price of the Company&rsquo;s publicly-traded securities, (iii) any Purchaser, and counter-parties in &ldquo;derivative&rdquo;
transactions to which any such Purchaser is a party, directly or indirectly, presently may have a &ldquo;short&rdquo; position in the
Common Stock and (iv) each Purchaser shall not be deemed to have any affiliation with or control over any arm&rsquo;s length counter-party
in any &ldquo;derivative&rdquo; transaction. The Company further understands and acknowledges that (y) one or more Purchasers may engage
in hedging activities at various times during the period that the Securities are outstanding, including, without limitation, during the
periods that the value of the Warrant Shares deliverable with respect to Securities are being determined, and (z) such hedging activities
(if any) could reduce the value of the existing stockholders&rsquo; equity interests in the Company at and after the time that the hedging
activities are being conducted. The Company acknowledges that such aforementioned hedging activities do not constitute a breach of any
of the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.1.29.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT><B><U>Regulation M Compliance</U></B>. The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly
or indirectly, any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company
to facilitate the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or paid any compensation for soliciting purchases
of, any of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other
securities of the Company, other than, in the case of clauses (ii) and (iii), compensation paid to the Company&rsquo;s placement agent
in connection with the placement of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.1.30.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT><B><U>Officers&rsquo; Certificate</U></B>. Any certificate signed by any duly authorized officer of the Company and delivered to
the Purchasers shall be deemed a representation and warranty by the Company to the Purchasers as to the matters covered thereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.1.31.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT><B><U>D&amp;O Questionnaires</U></B>. To the Company&rsquo;s knowledge, all information contained in the questionnaires most recently
completed by each of the Company&rsquo;s directors and officers and beneficial owner of 5% or more of the shares of Common Stock or Common
Stock Equivalents is true and correct in all respects and the Company has not become aware of any information which
would cause the information disclosed in such questionnaires become inaccurate and incorrect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: right; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.1.32.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT><B><U>Stock Option Plans</U></B>. Each stock option granted by the Company under the Company&rsquo;s stock option plan, if any,
was granted (i) in accordance with the terms of the Company&rsquo;s stock option plan and (ii) with an exercise price at least equal to
the fair market value of the Common Stock on the date such stock option would be considered granted under GAAP and applicable law. No
stock option granted under the Company&rsquo;s stock option plan has been backdated. The Company has not knowingly granted, and there
is no and has been no Company policy or practice to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant
of stock options with, the release or other public announcement of material information regarding the Company or its Subsidiaries or their
financial results or prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.1.33.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT><B><U>Office of Foreign Assets Control</U></B>. Neither the Company nor any Subsidiary nor, to the Company&rsquo;s knowledge, any
director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered
by the Office of Foreign Assets Control of the U.S. Treasury Department (&ldquo;<B><U>OFAC</U></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.1.34.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT><B><U>U.S. Real Property Holding Corporation</U></B>. The Company is not and has never been a U.S. real property holding corporation
within the meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&rsquo;s
request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.1.35.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT><B><U>Bank Holding Company Act</U></B>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding
Company Act of 1956, as amended (the &ldquo;<B><U>BHCA</U></B>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve
System (the &ldquo;<B><U>Federal Reserve</U></B>&rdquo;). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls,
directly or indirectly, five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent (25%)
or more of the total equity of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the
Company nor any of its Subsidiaries or Affiliates exercises a controlling influence over the management or policies of a bank or any entity
that is subject to the BHCA and to regulation by the Federal Reserve.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.1.36.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT><B><U>Money Laundering</U></B>. The operations of the Company and its Subsidiaries are and have been conducted at all times in
compliance with applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act
of 1970, as amended, applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the &ldquo;<B><U>Money
Laundering Laws</U></B>&rdquo;), and no Action or Proceeding by or before any court or governmental agency, authority or body or any arbitrator
involving the Company or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any
Subsidiary, threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: right; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.1.37.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT> <B><U>Other Covered Persons</U></B>. Other than the Placement Agent, the Company is not aware of any person that has been or will
be paid (directly or indirectly) remuneration for solicitation of purchasers in connection with the sale of any Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.1.38.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT><B><U>Cybersecurity</U></B>. (i) (a) There has been no security breach or other compromise of or relating to any of the Company&rsquo;s
or any Subsidiary&rsquo;s information technology and computer systems, networks, hardware, software, data (including the data of its respective
customers, employees, suppliers, vendors and any third party data maintained by or on behalf of it), equipment or technology (collectively,
&ldquo;<B><U>IT Systems and Data</U></B>&rdquo;) and (b) the Company and the Subsidiaries have not been notified of, and has no knowledge
of any event or condition that would reasonably be expected to result in, any security breach or other compromise to its IT Systems and
Data; (ii) the Company and the Subsidiaries are presently in compliance with all applicable laws or statutes and all judgments, orders,
rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations
relating to the privacy and security of IT Systems and Data and to the protection of such IT Systems and Data from unauthorized use, access,
misappropriation or modification, except, in the case of clauses (i) and (ii) herein, as would not, individually or in the aggregate,
have a Material Adverse Effect; (iii) the Company and the Subsidiaries have implemented and maintained commercially reasonable safeguards
to maintain and protect its material confidential information and the integrity, continuous operation, redundancy and security of all
IT Systems and Data; and (iv) the Company and the Subsidiaries have implemented backup and disaster recovery technology consistent with
industry standards and practices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.1.39.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT><B><U>Separate and Independent Purchasers</U></B>. The Company further (a) represents and warrants and acknowledges and agrees
that, to the knowledge of the Company (i) each Purchaser is participating in the offering of Securities contemplated hereby separately
and independently of each other Purchaser, (ii) no Purchaser has communicated directly with any other Purchaser, (iii) all communications
by each Purchaser concerning the Transaction Documents and the transactions contemplated thereby and any matters related thereto were
solely conducted separately and independently with the Placement Agent without the involvement or inclusion of any other Purchaser and
(iv) the Purchasers do not constitute a &ldquo;group&rdquo; as that term is used under Section 13(d) of the Exchange Act, and (b) covenants
and agrees not to take a position to the contrary to the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">3.2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Representations and Warranties of the Purchasers</U></B>. Each Purchaser, for itself and for no other Purchaser, hereby represents
and warrants as of the date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which
case they shall be accurate as of such date):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.2.1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Organization; Authority</U></B>. Such Purchaser is either an individual or an entity duly incorporated or formed, validly
existing and in good standing under the law of the jurisdiction of its incorporation or formation with full right, corporate, partnership,
limited liability company or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction
Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance by such Purchaser
of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate, partnership, limited
liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to which it is a party has
been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof, will constitute the legal,
valid and binding obligation of such Purchaser, enforceable against it in accordance with its terms, except (i) as limited by general
equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting
enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive
relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: right; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.2.2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Own Account</U></B>. Such Purchaser is acquiring the Securities as principal for its own account and has no present intention
of distributing any of such Securities (this representation and warranty shall not limit such Purchaser&rsquo;s right to sell the Securities
pursuant to a registration statement or otherwise in compliance with applicable federal and state securities laws). Such Purchaser is
acquiring the Securities hereunder in the ordinary course of its business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.2.3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Purchaser Status</U></B>. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is,
and on each date on which it exercises any Warrants, it will be either: (i) an &ldquo;accredited investor&rdquo; as defined in Rule 501(a)(1),
(a)(2), (a)(3), (a)(7), (a)(8), (a)(9), (a)(12), or (a)(13) under the Securities Act or (ii) a &ldquo;qualified institutional buyer&rdquo;
as defined in Rule 144A(a)(1) under the Securities Act. Such Purchaser hereby represents that neither such Purchaser nor any of its Rule
506(d) Related Parties (as defined below) is a &ldquo;bad actor&rdquo; within the meaning of Rule 506(d) promulgated under the Securities
Act. For purposes of this Agreement, &ldquo;Rule 506(d) Related Party&rdquo; shall mean a person or entity covered by the &ldquo;Bad Actor
disqualification&rdquo; provision of Rule 506(d) of the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.2.4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Experience of Such Purchaser</U></B>. Such Purchaser, either alone or together with its representatives, has such knowledge,
sophistication and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective
investment in the Securities, and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic
risk of an investment in the Securities and, at the present time, is able to afford a complete loss of such investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.2.5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Access to Information</U></B>. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents
(including all exhibits and schedules thereto) and the SEC Reports and has been afforded (i) the opportunity to ask such questions as
it has deemed necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering
of the Securities and the merits and risks of investing in the Securities; (ii) access to information about the Company and its financial
condition, results of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and
(iii) the opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that
is necessary to make an informed investment decision with respect to the investment. Such Purchaser acknowledges and agrees that neither
the Placement Agent nor any Affiliate of the Placement Agent has provided such Purchaser with any information or advice with respect to
the Securities nor is such information or advice necessary or desired. Neither the Placement Agent nor any Affiliate has made or makes
any representation as to the Company or the quality of the Securities and the Placement Agent and any Affiliate may have acquired non-public
information with respect to the Company which such Purchaser agrees need not be and has not been provided to it (other than with respect
to the transactions contemplated by the Transaction Documents). In connection with the issuance of the Securities to such Purchaser, neither
the Placement Agent nor any of its Affiliates has acted as a financial advisor or fiduciary to such Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: right; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.2.6.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Certain Transactions and Confidentiality</U></B>. Other than consummating the transactions contemplated hereunder, such Purchaser
has not, nor has any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed
any purchases or sales, including Short Sales, of the securities of the Company during the period commencing as of the time that such
Purchaser first received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the
material terms of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing,
in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of
such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers
managing other portions of such Purchaser&rsquo;s assets, the representation set forth above shall only apply with respect to the portion
of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. Other
than to other Persons party to this Agreement or to such Purchaser&rsquo;s representatives, including, without limitation, its officers,
directors, partners, legal and other advisors, employees, agents and Affiliates, such Purchaser has maintained the confidentiality of
all disclosures made to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding
the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions,
with respect to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.2.7.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>No Intent to Effect a Change of Control</U></B>. Such Purchaser has no present intent to effect a &ldquo;change of control&rdquo;
of the Company as such term is interpreted and understood under the rules promulgated pursuant to Section 13(d) of the 1934 Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company acknowledges and agrees that the representations
contained in this Section 3.2 shall not modify, amend or affect such Purchaser&rsquo;s right to rely on the Company&rsquo;s representations
and warranties contained in this Agreement or any representations and warranties contained in any other Transaction Document or any other
document or instrument executed and/or delivered in connection with this Agreement or the consummation of the transactions contemplated
hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty,
or preclude any actions, with respect to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: right; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.</TD><TD STYLE="text-align: justify"><B><U>Other Agreements of the Parties</U></B>.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">4.1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Warrant Shares</U></B>. If all or any portion of a Warrant is exercised at a time when there is an effective registration
statement to cover the issuance or resale of the Warrant Shares or if the Warrant is exercised via cashless exercise, the Warrant Shares
issued pursuant to any such exercise shall be issued free of all legends. If at any time following the date hereof the Shelf Registration
Statement (or any subsequent registration statement registering the sale or resale of the Warrant Shares) is not effective or is not otherwise
available for the sale or resale of the Warrant Shares, the Company shall immediately notify the holders of the Warrants in writing that
such registration statement is not then effective and thereafter shall promptly notify such holders when the registration statement is
effective again and available for the sale or resale of the Warrant Shares (it being understood and agreed that the foregoing shall not
limit the ability of the Company to issue, or any Purchaser to sell, any of the Warrant Shares in compliance with applicable federal and
state securities laws). The Company shall use best efforts to keep a registration statement (including the Shelf Registration Statement)
registering the issuance or resale of the Warrant Shares effective during the term of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">4.2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Furnishing of Information</U></B>. Until no Purchaser owns any Securities and the Warrants have terminated, the Company covenants
to maintain the effectiveness of the registration of the Common Stock under Section 12(b) or 12(g) of the Exchange Act and to use reasonable
best efforts to timely file (or obtain extensions in respect thereof and file within the applicable grace period) all reports required
to be filed by the Company after the date hereof pursuant to the Exchange Act even if the Company is not then subject to the reporting
requirements of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">4.3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Integration</U></B>. The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect
of any security (as defined in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities for
purposes of the rules and regulations of any Trading Market such that it would require stockholder approval prior to the closing of such
other transaction unless stockholder approval is obtained before the closing of such subsequent transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">4.4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Securities Laws Disclosure; Publicity</U></B>. The Company shall (a) by the Disclosure Time, issue a press release disclosing
the material terms of the transactions contemplated hereby, and (b) file, within the time required by the Exchange Act, a Current Report
on Form 8-K, including the Transaction Documents as exhibits thereto, with the Commission. From and after the issuance of such press release,
the Company represents to the Purchasers that it shall have publicly disclosed all material, non-public information delivered to any of
the Purchasers by the Company or any of its Subsidiaries, or any of their respective officers, directors, employees or agents (including,
without limitation, the Placement Agent) in connection with the transactions contemplated by the Transaction Documents. In addition, effective
upon the issuance of such press release, the Company acknowledges and agrees that any and all confidentiality or similar obligations under
any agreement, whether written or oral, between the Company, any of its Subsidiaries, or any of their respective officers, directors,
agents (including, without limitation, the Placement Agent), employees or Affiliates on the one hand, and any of the Purchasers or any
of their Affiliates on the other hand, shall terminate and
be of no further force or effect. The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant
in effecting transactions in securities of the Company. The Company and each Purchaser shall consult with each other in issuing any other
press releases with respect to the transactions contemplated hereby, and neither the Company nor any Purchaser shall issue any such press
release nor otherwise make any such public statement without the prior consent of the Company, with respect to any press release of any
Purchaser, or without the prior consent of each Purchaser, with respect to any press release of the Company, which consent shall not unreasonably
be withheld or delayed, except if such disclosure is required by law, in which case the disclosing party shall promptly provide the other
party with prior notice of such public statement or communication. Notwithstanding the foregoing, the Company shall not publicly disclose
the name of any Purchaser, or include the name of any Purchaser in any filing with the Commission or any regulatory agency or Trading
Market, without the prior written consent of such Purchaser, except (a) to the extent required by federal securities law in connection
with the filing of final Transaction Documents with the Commission and (b) to the extent such disclosure is required by law or Trading
Market regulations, in which such cases the Company shall (x) obtain prior advice of competent counsel that such disclosure is required,
(y) provide the Purchasers with prior notice of such disclosure permitted under this Section 4.4 and (z) reasonably cooperate with such
Purchasers regarding such disclosure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: right; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">4.5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Stockholder Rights Plan</U></B>. No claim will be made or enforced by the Company or, with the consent of the Company, any
other Person, that any Purchaser is an &ldquo;<B><U>Acquiring Person</U></B>&rdquo; under any control share acquisition, business combination,
poison pill (including any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter
adopted by the Company, or that any Purchaser could be deemed to trigger the provisions of any such plan or arrangement, by virtue of
receiving Securities under the Transaction Documents or under any other agreement between the Company and the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">4.6.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Non-Public Information</U></B>. Except with respect to the material terms and conditions of the transactions contemplated
by the Transaction Documents, which shall be disclosed pursuant to Section 4.4, the Company covenants and agrees that neither it, nor
any other Person acting on its behalf will provide any Purchaser or its agents or counsel with any information that constitutes, or the
Company reasonably believes constitutes, material non-public information, unless prior thereto such Purchaser shall have consented in
writing to the receipt of such information and agreed in writing with the Company to keep such information confidential. The Company understands
and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. To
the extent that the Company, any of its Subsidiaries, or any of their respective officers, directors, agents, employees or Affiliates
delivers any material, non-public information to a Purchaser without such Purchaser&rsquo;s consent, the Company hereby covenants and
agrees that such Purchaser shall not have any duty of confidentiality to the Company, any of its Subsidiaries, or any of their respective
officers, directors, agents, employees or Affiliates, or a duty to the Company, any of its Subsidiaries or any of their respective officers,
directors, agents, employees or Affiliates not to trade on the basis of, such material, non-public information, provided that the Purchaser
shall remain subject to applicable law. To the extent that any
notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public information regarding the Company
or any Subsidiaries, the Company shall simultaneously with the delivery of such notice file such notice with the Commission pursuant to
a Current Report on Form 8-K. The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting
transactions in securities of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: right; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">4.7.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Use of Proceeds</U></B>. The Company shall use the net proceeds from the sale of the Securities hereunder for general corporate
purposes (which for the avoidance of doubt may include acquisitions, in the Company&rsquo;s discretion), including working capital. The
Company shall not use such proceeds: (a) for the satisfaction of any portion of the Company&rsquo;s debt (other than payment of trade
payables in the ordinary course of the Company&rsquo;s business and prior practices), (b) for the redemption of any shares of Common Stock
or Common Stock Equivalents, (c) for the settlement of any outstanding litigation or (d) in violation of FCPA or OFAC regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">4.8. <B><U>Indemnification
of each Purchaser</U></B>. Subject to the provisions of this Section 4.8, the Company will indemnify and hold each Purchaser and its
directors, officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent
role of a Person holding such titles notwithstanding a lack of such title or any other title), each Person who controls such
Purchaser (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers,
shareholders, agents, members, partners or employees (and any other Persons with a functionally equivalent role of a Person holding
such titles notwithstanding a lack of such title or any other title) of such controlling persons (each, a &ldquo;<B><U>Purchaser
Party</U></B>&rdquo;) harmless from any and all losses, liabilities, obligations, claims, contingencies, damages, costs and
expenses, including all judgments, amounts paid in settlements, court costs and reasonable attorneys&rsquo; fees and costs of
investigation that any such Purchaser Party may suffer or incur as a result of or relating to (a) any breach of any of the
representations, warranties, covenants or agreements made by the Company in this Agreement or in the other Transaction Documents,
(b) any action instituted against the Purchaser Parties in any capacity (including a Purchaser Party&rsquo;s status as an investor),
or any of them or their respective Affiliates, by the Company or any stockholder of the Company who is not an Affiliate of such
Purchaser Party, arising out of or relating to any of the transactions contemplated by the Transaction Documents. For the avoidance
of doubt, the indemnification provided herein is intended to, and shall also cover, direct claims brought by the Company against the
Purchaser Parties; provided, however, that such indemnification shall not cover any loss, claim, damage or liability to the extent
it is finally judicially determined to be attributable to such Purchaser Party&rsquo;s material breach of any of the
representations, warranties or covenants made by such Purchaser Party in any Transaction Document or any conduct by such Purchaser
Party which is finally judicially determined to constitute fraud, gross negligence or willful misconduct). If any action shall be
brought against any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such Purchaser Party
shall promptly notify the Company in writing, and, except with respect to direct claims brought by the Company, the Company shall
have the right to assume the defense thereof with counsel of its own choosing reasonably acceptable to the Purchaser Party. Any
Purchaser Party shall have the right to employ separate counsel in any such action and participate in the defense thereof, but the
fees and expenses of such counsel shall be at the expense of such Purchaser Party except to the extent that (i) the employment
thereof has been specifically authorized by the Company in writing, (ii) the Company has failed after a reasonable period of time to
assume such defense and to employ counsel or (iii) in such action there is, in the reasonable opinion of counsel to the applicable
Purchaser Party (which may be internal counsel), a material conflict on any material issue between the position of the Company and
the position of such Purchaser Party, in which case the Company shall be responsible for the reasonable fees and expenses of no more
than one such separate counsel. The Company will not be liable to any Purchaser Party under this Agreement for any settlement by a
Purchaser Party effected without the Company&rsquo;s prior written consent, which shall not be unreasonably withheld or delayed. In
addition, if any Purchaser Party takes actions to collect amounts due under any Transaction Documents or to enforce the provisions
of any Transaction Documents, then the Company shall pay the costs incurred by such Purchaser Party for such collection, enforcement
or action, including, but not limited to, attorneys&rsquo; fees and disbursements. The indemnification and other payment obligations
required by this Section 4.8 shall be made by periodic payments of the amount thereof during the course of the investigation,
defense, collection, enforcement or action, as and when bills are received or are incurred; provided, however, that if any Purchaser
Party is finally judicially determined not to be entitled to indemnification or payment under this Section 4.8, such Purchaser Party
shall promptly reimburse the Company for any payments that are advanced under this sentence. The indemnity agreements contained
herein shall be in addition to any cause of action or similar right of any Purchaser Party against the Company or others and any
liabilities the Company may be subject to pursuant to law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: right; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">4.9.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Listing of Common Stock</U></B>. The Company hereby agrees to use its best efforts to maintain the listing or quotation of
the Common Stock on the Trading Market on which it is currently listed, and concurrently with the Closing, the Company shall apply to
list or quote all of the Shares and Warrant Shares on such Trading Market and promptly secure the listing of all of the Shares and Warrant
Shares on such Trading Market. The Company further agrees, if the Company applies to have the Common Stock traded on any other Trading
Market, it will then include in such application all of the Shares and Warrant Shares, and will take such other action as is necessary
to cause all of the Shares and Warrant Shares to be listed or quoted on such other Trading Market as promptly as possible. The Company
will then take all action reasonably necessary to continue the listing and trading of its Common Stock on a Trading Market and will comply
in all respects with the Company&rsquo;s reporting, filing and other obligations under the bylaws or rules of the Trading Market. The
Company agrees to maintain the eligibility of the Common Stock for electronic transfer through the Depository Trust Company or another
established clearing corporation, including, without limitation, by timely payment of fees to the Depository Trust Company or such other
established clearing corporation in connection with such electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">4.10.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Subsequent Equity Sales</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">4.10.1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp; </FONT>From
the date hereof until sixty (60) days after the Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any
agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii)
file any registration statement or any amendment or supplement thereto, in each case other than solely with respect to securities
issued pursuant to any share or option plan duly adopted for such purpose by the Board of Directors or a committee of non-employee
directors established for such purpose for services rendered to the Company, on Form S-8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">4.10.2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT>Notwithstanding the foregoing, this Section 4.10 shall not apply in respect of an Exempt Issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">4.11.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Certain Transactions and Confidentiality</U></B>. Each Purchaser, severally and not jointly with the other Purchasers, covenants
that neither it, nor any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or sales,
including Short Sales, of any of the Company&rsquo;s securities during the period commencing with the execution of this Agreement and
ending at such time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release
as described in Section 4.4. Each Purchaser, severally and not jointly with the other Purchasers, covenants that until such time as the
transactions contemplated by this Agreement are publicly disclosed by the Company pursuant to the initial press release as described in
Section 4.4, such Purchaser will maintain the confidentiality of the existence and terms of this transaction. Notwithstanding the foregoing
and notwithstanding anything contained in this Agreement to the contrary, the Company expressly acknowledges and agrees that (i) no Purchaser
makes any representation, warranty or covenant hereby that it will not engage in effecting transactions in any securities of the Company
after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release
as described in Section 4.4, (ii) no Purchaser shall be restricted or prohibited from effecting any transactions in any securities of
the Company in accordance with applicable securities laws from and after the time that the transactions contemplated by this Agreement
are first publicly announced pursuant to the initial press release as described in Section 4.4 and (iii) no Purchaser shall have any duty
of confidentiality or duty not to trade in the securities of the Company to the Company, any of its Subsidiaries, or any of their respective
officers, directors, employees, agents or Affiliates after the issuance of the initial press release as described in Section 4.4. Notwithstanding
the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate
portions of such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the
portfolio managers managing other portions of such Purchaser&rsquo;s assets, the covenant set forth above shall only apply with respect
to the portion of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: right; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">4.12.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Capital Changes</U></B>. Until the date that is sixty (60) days after the Closing Date, the Company shall not undertake a
reverse or forward stock split or reclassification of the Common Stock without the prior written consent of the Purchasers holding a majority
in interest of the Shares and Pre-Funded Warrants, based on the initial Subscription Amounts hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">4.13.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT> <B><U>Acknowledgment of Dilution</U></B>. The Company acknowledges that the issuance of the Securities may result in dilution
of the outstanding shares of Common Stock, which dilution may be substantial under certain market conditions. The Company further acknowledges
that its obligations under the Transaction Documents, including, without limitation, its obligation to issue the Shares and Warrant Shares
pursuant to the Transaction Documents, are unconditional and absolute and not subject to any right of set off, counterclaim, delay or
reduction, regardless of the effect of any such dilution or any claim the Company may have against any Purchaser and regardless of the
dilutive effect that such issuance may have on the ownership of the other stockholders of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">4.14.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Lock-Up Agreements</U></B>. The Company shall not amend, modify, waive or terminate any provision of any of the Lock-Up Agreements
(and any lock-up agreements contemplated in the Lock-Up Agreements) except to extend the term of the lock-up period and shall enforce
the provisions of each Lock-Up Agreement (and any lock-up agreements contemplated in the Lock-Up Agreements) in accordance with its terms.
If any party to a Lock-Up Agreement (and any lock-up agreements contemplated in the Lock-Up Agreements) breaches any provision of a Lock-Up
Agreement, the Company shall promptly use its best efforts to seek specific performance of the terms of such Lock-Up Agreement (and any
lock-up agreements contemplated in the Lock-Up Agreements).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">4.15.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>QEF Election</U></B>. If a Purchaser so requests in writing for any taxable year of the Company, the Company, after consulting
with its outside accounting firm, shall within fifteen (15) Business Days notify such Purchaser in writing that either (A) neither the
Company nor any of its Subsidiaries was a &ldquo;passive foreign investment company&rdquo; as defined in Section 1297 of the Code (&ldquo;<B><U>PFIC</U></B>&rdquo;)
for such year, or (B) the Company and/or one or more of its Subsidiaries was a PFIC for such year, in which event the Company shall provide
to such Purchaser, upon the reasonable written request of such Purchaser, the information reasonably necessary to allow such Purchaser
to elect to treat each of the Company and any applicable Subsidiaries (if any), respectively, as a &ldquo;qualified electing fund&rdquo;
(within the meaning of Section 1295 of the Code for such year, including a &ldquo;PFIC Annual Information Statement&rdquo; as described
in Treasury Regulation Section 1.1295-1(g)(1) (or any successor Treasury Regulation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">4.16.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Reservation of Common Stock</U></B>. As of the date hereof, the Company has reserved and the Company shall continue to reserve
and keep available at all times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling
the Company to issue Shares pursuant to this Agreement and the maximum number of Warrant Shares pursuant to any exercise of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">4.17.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Exercise Procedures</U></B>. The form of Notice of Exercise included in the Warrants set forth the totality of the procedures
required of the Purchasers in order to exercise the Warrants. No additional legal opinion, other information or instructions shall be
required of the Purchasers to exercise their Warrants. Without limiting the preceding sentences, no ink-original Notice of Exercise shall
be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required
in order to exercise the Warrants. The Company shall honor exercises of the Warrants and shall deliver Warrant Shares in accordance
with the terms, conditions and time periods set forth in the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: right; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>5.</B></TD><TD STYLE="text-align: justify"><B><U>Miscellaneous</U></B>.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Termination</U></B>. This Agreement may be terminated by any Purchaser, as to such Purchaser&rsquo;s obligations hereunder
only and without any effect whatsoever on the obligations between the Company and the other Purchasers, by written notice to the other
parties, if the Closing has not been consummated on or before the fifth (5th) Trading Day following the date hereof; <U>provided</U>,
<U>however</U>, that no such termination will affect the right of any party to sue for any breach by any other party (or parties).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Fees and Expenses</U></B>. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay
the fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident
to the negotiation, preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees
(including, without limitation, any fees required for same-Calendar Day processing of any instruction letter delivered by the Company
and any exercise notice delivered by a Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery of any
Securities to the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Entire Agreement</U></B>. The Transaction Documents, together with the exhibits and schedules thereto, the Prospectus and
the Prospectus Supplement, contain the entire understanding of the parties with respect to the subject matter hereof and thereof and supersede
all prior agreements and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged
into such documents, exhibits and schedules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Notices</U></B>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder
shall be in writing and shall be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication
is delivered via email at the email address as set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York City
time) on a Trading Day, (b) the next Trading Day after the time of transmission, if such notice or communication is delivered via email
at the email address as set forth on the signature pages attached hereto on a Calendar Day that is not a Trading Day or later than 5:30
p.m. (New York City time) on any Trading Day, (c) the second (2<SUP>nd</SUP>) Trading Day following the date of mailing, if sent by U.S.
nationally recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is required to be given. The
address for such notices and communications shall be as set forth on the signature pages attached hereto. To the extent that any notice
provided pursuant to any Transaction Document constitutes, or contains material, non-public information regarding the Company or any of
the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: right; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.5. <B><U>Amendments;
Waivers</U></B>. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument
signed, in the case of an amendment, by the Company and Purchasers which purchased at least 50.1% in interest of the Shares and
Pre-Funded Warrants based on the initial Subscription Amounts hereunder (or, prior to Closing, the Company and each Purchaser) or,
in the case of a waiver, by the party against whom enforcement of any such waived provision is sought, provided that if any
amendment, modification or waiver disproportionately and adversely impacts a Purchaser (or multiple Purchasers), the consent of such
disproportionately impacted Purchaser (or multiple Purchasers) shall also be required. No waiver of any default with respect to any
provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any
subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of any party
to exercise any right hereunder in any manner impair the exercise of any such right. Any proposed amendment or waiver that
disproportionately, materially and adversely affects the rights and obligations of any Purchaser relative to the comparable rights
and obligations of the other Purchasers shall require the prior written consent of such adversely affected Purchaser. Any amendment
effected in accordance with this Section 5.5 shall be binding upon each Purchaser and holder of Securities and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.6.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Headings</U></B>. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not
be deemed to limit or affect any of the provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.7.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Successors and Assigns</U></B>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors
and permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent
of each Purchaser (other than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom
such Purchaser assigns or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the transferred
Securities, by the provisions of the Transaction Documents that apply to the &ldquo;Purchasers.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.8.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>No Third-Party Beneficiaries</U></B>. The Placement Agent shall be the third party beneficiary of the representations and
warranties of the Company in Section 3.1 and the representations and warranties of the Purchasers in Section 3.2. This Agreement is intended
for the benefit of the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any
provision hereof be enforced by, any other Person, except as otherwise set forth in Section 4.8 and this Section 5.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: right; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.9. <B><U>Governing
Law</U></B>. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall
be governed by and construed and enforced in accordance with the law of the State of New York without regard to the principles of
conflicts of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and defense of
the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its
respective affiliates, directors, officers, stockholders, partners, members, employees or agents) shall be commenced exclusively in
the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of
the state and federal courts sitting in the City and County of New York for the adjudication of any dispute hereunder or in
connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of
any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any Action or Proceeding, any claim
that it is not personally subject to the jurisdiction of any such court, that such Action or Proceeding is improper or is an
inconvenient venue for such Proceeding. Each party hereby irrevocably waives personal service of process and consents to process
being served in any such Action or Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with
evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service
shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any
way any right to serve process in any other manner permitted by law. If any party shall commence an Action or Proceeding to enforce
any provisions of the Transaction Documents, then, in addition to the obligations of the Company under Section 4.8, the prevailing
party in such Action or Proceeding shall be reimbursed by the non-prevailing party for its reasonable attorneys&rsquo; fees and
other costs and expenses incurred with the investigation, preparation and prosecution of such Action or Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.10.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Survival</U></B>. The representations and warranties contained herein shall survive the Closing and the delivery of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.11.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Execution</U></B>. This Agreement may be executed in two or more counterparts, all of which when taken together shall be
considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each
other party, it being understood that the parties need not sign the same counterpart. If any signature is delivered by e-mail delivery
of a &ldquo;.pdf&rdquo; format data file, such signature shall create a valid and binding obligation of the party executing (or on whose
behalf such signature is executed) with the same force and effect as if such &ldquo;.pdf&rdquo; signature page were an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.12.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Severability</U></B>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction
to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall
remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by
such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would
have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared
invalid, illegal, void or unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.13.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Rescission and Withdrawal Right</U></B>. Notwithstanding anything to the contrary contained in (and without limiting any
similar provisions of) any of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under
a Transaction Document and the Company does not timely perform its related obligations within the periods therein provided, then such
Purchaser may rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand
or election in whole or in part without prejudice to its future actions and rights; <U>provided</U>, <U>however</U>, that,
in the case of a rescission of an exercise of a Warrant, the applicable Purchaser shall be required to return any shares of Common Stock
subject to any such rescinded exercise notice concurrently with the return to such Purchaser of the aggregate exercise price paid to the
Company for such Shares and the restoration of such Purchaser&rsquo;s right to acquire such Shares pursuant to such Purchaser&rsquo;s
Warrant (including, issuance of a replacement warrant certificate evidencing such restored right).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: right; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.14.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Replacement of Securities</U></B>. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen
or destroyed, the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case
of mutilation), or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably
satisfactory to the Company of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances
shall also pay any reasonable third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.15.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Remedies</U></B>. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery
of damages, each of the Purchasers and the Company will be entitled to specific performance under the Transaction Documents. The parties
agree that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in
the Transaction Documents and hereby agree to waive and not to assert in any Action for specific performance of any such obligation the
defense that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.16.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Payment Set Aside</U></B>. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction
Document or a Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement
or exercise or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged
by or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law
(including, without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent
of any such restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force
and effect as if such payment had not been made or such enforcement or setoff had not occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.17.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Independent Nature of Purchasers&rsquo; Obligations and Rights</U></B>. The obligations of each Purchaser under any Transaction
Document are several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the
performance or non-performance of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in
any other Transaction Document, and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers
as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any
way acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction Documents. Each
Purchaser shall be entitled to independently protect and enforce its rights including, without limitation, the rights arising out of this
Agreement or out of the other Transaction Documents,
and it shall not be necessary for any other Purchaser to be joined as an additional party in any Proceeding for such purpose. Each Purchaser
has been represented by its own separate legal counsel in its review and negotiation of the Transaction Documents. For reasons of administrative
convenience only, each Purchaser and its respective counsel have chosen to communicate with the Company through the legal counsel to the
Placement Agent. The legal counsel of the Placement Agent does not represent any of the Purchasers and only represents the Placement Agent.
The Company has elected to provide all Purchasers with the same terms and Transaction Documents for the convenience of the Company and
not because it was required or requested to do so by any of the Purchasers. It is expressly understood and agreed that each provision
contained in this Agreement and in each other Transaction Document is between the Company and a Purchaser, solely, and not between the
Company and the Purchasers collectively and not between and among the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: right; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.18.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Liquidated Damages</U></B>. The Company&rsquo;s obligations to pay any partial liquidated damages or other amounts owing
under the Transaction Documents is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated
damages and other amounts have been paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated
damages or other amounts are due and payable shall have been canceled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.19.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Saturdays, Sundays, Holidays, etc</U></B>. If the last or appointed Calendar Day for the taking of any action or the expiration
of any right required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the
next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.20.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>Construction</U></B>. The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity
to revise the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved
against the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition,
each and every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse
and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the
date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">5.21.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B><U>WAIVER OF JURY TRIAL. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY,
THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY,
IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY. </U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[CYN Securities Purchase Agreement Signature
Pages Follows]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: right; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[CYN Securities Purchase Agreement &ndash; Company
Signature Page]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the parties
hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first
indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: left"><FONT STYLE="text-decoration: none"><B>CYNGN INC.</B></FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="text-decoration: none"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="text-align: left"><B><U>Address for Notice:</U></B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; text-align: left"><FONT STYLE="text-decoration: none">&nbsp;</FONT></TD>
    <TD STYLE="width: 35%; text-align: left"><FONT STYLE="text-decoration: none">&nbsp;</FONT></TD>
    <TD STYLE="width: 20%; text-align: left"><FONT STYLE="text-decoration: none">&nbsp;</FONT></TD>
    <TD STYLE="width: 40%; text-align: left"><FONT STYLE="text-decoration: none">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="text-decoration: none">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"><FONT STYLE="text-decoration: none">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="text-decoration: none">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="text-decoration: none">Email: ltal@cyngn.com</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="text-decoration: none">Name:</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="text-decoration: none">Lior Tal</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="text-decoration: none">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="text-decoration: none">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="text-decoration: none">Title:</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="text-decoration: none">Chief Executive Officer</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="text-decoration: none">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="text-decoration: none">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: right; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[CYN Securities Purchase Agreement &ndash; Investor
Signature Page]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the undersigned
has caused this Securities Purchase Agreement to be duly executed by its authorized signatory as of the date first indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: left">Name of Purchaser:</TD>
    <TD STYLE="width: 50%; border-bottom: black 1pt solid; text-align: left">[&#9679;]</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">Signature of Authorized Signatory of Purchaser:</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">Name of Authorized Signatory:</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: left">[&#9679;]</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">Title of Authorized Signatory:</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: left">[&#9679;]</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">Email Address of Authorized Signatory:</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: left">[&#9679;]</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">Address for Notice to Purchaser:</TD>
    <TD STYLE="text-align: left">[&#9679;]</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">Address for Delivery of Securities to Purchaser (if not same as address for notice):</TD>
    <TD STYLE="text-align: left">[&#9679;]</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">Subscription Amount: </TD>
    <TD STYLE="text-align: left">[&#9679;]</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">Shares:</TD>
    <TD STYLE="text-align: left">[&#9679;]</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">Pre-funded Warrants:</TD>
    <TD STYLE="text-align: left">[&#9679;]</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"> Beneficial Ownership Blocker:</TD>
    <TD STYLE="text-align: left">[&#9679;]</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">[&#9679;]</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">Employer Identification Number: </TD>
    <TD STYLE="text-align: left">[&#9679;]</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: right; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Exhibit 1.30</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Form of Lock-Up Agreement</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: right; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Exhibit 1.40.1</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Form of Pre-Funded Warrant</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">38</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>5
<FILENAME>ea028204301ex10-2.htm
<DESCRIPTION>PLACEMENT AGENT AGREEMENT BETWEEN THE COMPANY AND AEGIS CAPITAL CORP. DATED MARCH 16, 2026
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;<IMG SRC="ea028204301_ex10-2img1.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">March 16, 2026</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>PERSONAL AND CONFIDENTIAL</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mr. Lior Tal, Chief Executive Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Cyngn Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1344 Terra Bella Avenue</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mountain View, CA 94043</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>Re:</B></TD><TD STYLE="text-align: justify"><B><U>CYN | Registered Direct Shelf Takedown | Placement Agent Agreement</U></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dear Mr. Tal:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The purpose of this placement
agent agreement is to outline our agreement pursuant to which Aegis Capital Corp. (&ldquo;<B><U>Aegis</U></B>&rdquo;) will act as the
placement agent on a &ldquo;best efforts&rdquo; basis in connection with the proposed Registered Direct Shelf Takedown (the &ldquo;<B><U>Placement</U></B>&rdquo;)
by Cyngn Inc. (collectively, with its subsidiaries and affiliates, the &ldquo;<B><U>Company</U></B>&rdquo;) of its shares of Common Stock
(the &ldquo;<B><U>Securities</U></B>&rdquo;). This placement agent agreement sets forth certain conditions and assumptions upon which
the Placement is premised. The Company expressly acknowledges and agrees that Aegis&rsquo;s obligations hereunder are on a reasonable
&ldquo;best efforts&rdquo; basis only and that the execution of this Agreement does not constitute a commitment by Aegis to purchase the
Securities and does not ensure the successful placement of the Securities or any portion thereof or the success of Aegis with respect
to securing any other financing on behalf of the Company. The Company confirms that entry into this placement agent agreement and completion
of the Placement with Aegis will not breach or otherwise violate the Company&rsquo;s obligations to any other party or require any payments
to such other party. For the sake of clarity, such obligations may include but not be limited to obligations under an engagement letter,
placement agency agreement, underwriting agreement, advisory agreement, right of first refusal, tail fee obligation or other agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The terms of our agreement
are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.</TD><TD STYLE="text-align: justify"><B><U>Engagement</U></B>. The Company hereby engages Aegis, for the period beginning on the date hereof
and ending fifteen (15) days thereafter or upon the completion of the Placement, whichever is sooner (the &ldquo;<B><U>Engagement Period</U></B>&rdquo;),
to act as the Company&rsquo;s exclusive investment bank in connection with the proposed Placement. During the Engagement Period or until
the consummation of the Placement, and as long as Aegis is proceeding in good faith with preparations for the Placement, the Company agrees
not to solicit, negotiate with or enter into any agreement with any other source of financing (whether equity, debt or otherwise), any
underwriter, potential underwriter, placement agent, financial advisor, investment banking firm or any other person or entity in connection
with an offering of the Company&rsquo;s debt or equity securities or any other financing by the Company. Aegis will use its reasonable
&ldquo;best efforts&rdquo; to solicit offers to purchase the Securities from the Company on the terms, and subject to the conditions,
set forth in the Prospectus (as defined below). Aegis shall use commercially reasonable efforts to assist the Company in obtaining performance
by each Purchaser (as defined below) whose offer to purchase Securities has been solicited by Aegis, but Aegis shall not, except as otherwise
provided in this Agreement, be obligated to disclose the identity of any potential purchaser or have any liability to the Company in the
event any such purchase is not consummated for any reason. The Company acknowledges that under no circumstances will Aegis be obligated
to underwrite or purchase any Securities for its own account and, in soliciting purchases of the Securities, Aegis shall act solely as
an agent of the Company. The services provided pursuant to this placement agent agreement shall be on an &ldquo;agency&rdquo; basis and
not on a &ldquo;principal&rdquo; basis.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>1345
Avenue of the Americas </B></FONT><B><FONT STYLE="font-family: Symbol">&middot;</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif">New
York, New York </FONT><FONT STYLE="font-family: Symbol">&middot;</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif">10105</FONT></B></P>

<P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>(212)
813-1010 </B></FONT><B><FONT STYLE="font-family: Symbol">&middot;</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif">Fax
(212) 813-1047</FONT> <FONT STYLE="font-family: Symbol">&middot;</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif">Member
FINRA, SIPC</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ea028204301_ex10-2img2.jpg" ALT=""></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.</TD><TD STYLE="text-align: justify"><B><U>The Placement</U></B>. The Placement is expected to consist of a sale of approximately $9.65 million
of the Company&rsquo;s Securities. Aegis will act as placement agent for the Placement subject to, among other matters referred to herein
and additional customary conditions, completion of Aegis&rsquo;s due diligence examination of the Company and its affiliates, listing
approval by the Nasdaq Capital Market (&ldquo;<B><U>Exchange</U></B>&rdquo;) of the Securities to be issued, and the execution of a definitive
Securities Purchase Agreement in connection with the Placement (the &ldquo;<B><U>Securities Purchase Agreement</U></B>&rdquo;). The actual
size of the Placement, the precise number of Securities to be offered by the Company and the offering price will be the subject of continuing
negotiations between the Company and the investors thereto. In connection with the entry into the Securities Purchase Agreement, the Company
(i) will meet with Aegis and its representatives to discuss such due diligence matters and to provide such documents as Aegis may require;
(ii) will not file with the Commission any document regarding the Placement without the prior approval of Aegis and its counsel; (iii)
will deliver to Aegis and the investors in the Placement such legal and accounting opinions and letters (including, without limitation,
accounting comfort letters, legal opinions, negative assurance letters, good standing certificates and officers&rsquo; and secretary certificates)
as Aegis may require, all in form and substance acceptable to Aegis and (iv) will ensure that Aegis is a third party beneficiary of all
representations, warranties, covenants, closing conditions and deliverables in connection with the Placement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.</TD><TD STYLE="text-align: justify"><B><U>Placement Compensation</U></B>. The placement commission will be 7.0% for the Placement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.</TD><TD STYLE="text-align: justify"><B><U>Registration Statement</U></B>. To the extent the Company decides to proceed with the Placement,
the Company will, as soon as practicable, prepare and file with the Securities and Exchange Commission (the &ldquo;<B><U>Commission</U></B>&rdquo;)
a Registration Statement on Form S-3 (the &ldquo;<B><U>Registration Statement</U></B>&rdquo;) under the Securities Act of 1933, as amended
(the &ldquo;<B><U>Securities Act</U></B>&rdquo;) and a prospectus and prospectus supplement included therein (together, the &ldquo;<B><U>Prospectus</U></B>&rdquo;)
covering the Securities to be offered and sold in the Placement. The Registration Statement (including the Prospectus therein), and all
amendments and supplements thereto, will be in form reasonably satisfactory to Aegis and counsel to Aegis. Other than any information
provided by Aegis in writing specifically for inclusion in the Registration Statement or the Prospectus, the Company will be solely responsible
for the contents of its Registration Statement and Prospectus and any and all other written or oral communications provided by or on behalf
of the Company to any actual or prospective investor of the Securities, and the Company represents and warrants that such materials and
such other communications will not, as of the date of the offer or sale of the Securities, contain any untrue statement of a material
fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of
the circumstances under which they were made, not misleading. If at any time prior to the completion of the offer and sale of the Securities
an event occurs that would cause the Registration Statement or Prospectus (as supplemented or amended) to contain an untrue statement
of a material fact or to omit to state a material fact necessary in order to make the statements therein, in light of the circumstances
under which they were made, not misleading, the Company will notify Aegis immediately of such event and Aegis will suspend solicitations
of the prospective purchasers of the Securities until such time as the Company shall prepare a supplement or amendment to the Registration
Statement or Prospectus that corrects such statement or omission.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ea028204301_ex10-2img2.jpg" ALT=""></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.</TD><TD STYLE="text-align: justify"><B><U>Lock-Ups</U></B>. In connection with the Placement, the Company&rsquo;s directors, executive officers,
employees and shareholders holding at least ten percent (10%) of the outstanding common stock will enter into customary &ldquo;lock-up&rdquo;
agreements in favor of the Placement Agent for a period of sixty (60) days after the Closing of the Placement (the &ldquo;<B><U>Lock-Up
Period</U></B>&rdquo;); provided, however, that any sales by parties to the lock-ups shall be subject to the lock-up agreements and provided
further, that none of such common stock shall be saleable in the public market until the expiration of the Lock-Up Period.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.</TD><TD STYLE="text-align: justify"><B><U>Company Standstill</U></B>. In connection with the Placement, without the prior written consent
of the investors, the Company will not, for a period of sixty (60) days after the Closing of the Placement (the &ldquo;<B><U>Standstill
Period</U></B>&rdquo;), (a) offer, sell, issue, or otherwise transfer or dispose of, directly or indirectly, any equity of the Company
or any securities convertible into or exercisable or exchangeable for equity of the Company; (b) file or caused to be filed any registration
statement with the Commission relating to the offering of any equity of the Company or any securities convertible into or exercisable
or exchangeable for equity of the Company; or (c) enter into any agreement or announce the intention to effect any of the actions described
in subsections (a) or (b) hereof (all of such matters, the &ldquo;<B><U>Standstill Restrictions</U></B>&rdquo;). So long as none of such
equity securities shall be saleable in the public market until the expiration of the Standstill Period, the following matters shall not
be prohibited by the Standstill Restrictions: (i) the adoption of an equity incentive plan and the grant of awards or equity pursuant
to any equity incentive plan, and the filing of a registration statement on Form S-8; (ii) securities issued pursuant to agreements, options,
restricted share units or convertible securities existing as of the date hereof provided the terms are not modified; and (iii) securities
issued pursuant to acquisitions or strategic transactions (whether by merger, consolidation, purchase of equity, purchase of assets, reorganization
or otherwise) approved by a majority of the disinterested directors of the Company, provided that such securities are issued as &ldquo;restricted
securities&rdquo; (as defined in Rule 144) and carry no registration rights that require or permit the filing of any registration statement
in connection therewith during the Standstill Period, and provided that any such issuance shall only be to a person or entity (or to the
equityholders of an entity) which is, itself or through its subsidiaries, an operating company or an owner of an asset in a business synergistic
with the business of the Company and shall provide to the Company additional benefits in addition to the investment of funds, but shall
not include a transaction in which the Company is issuing securities primarily for the purpose of raising capital or to an entity whose
primary business is investing in securities. In no event should any equity transaction during the Standstill Period result in the sale
of equity at an offering price to the public less than that of the Placement referred herein.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ea028204301_ex10-2img2.jpg" ALT=""></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">7.</TD><TD STYLE="text-align: justify"><B><U>Expenses</U></B>. The Company will be responsible for and will pay all expenses relating to the
Placement, including, without limitation, (a) all filing fees and expenses relating to the registration of the Securities with the Commission;
(b) all FINRA Public Offering filing fees; (c) all fees and expenses relating to the listing of the Company&rsquo;s equity or equity-linked
securities on an Exchange; (d) all fees, expenses and disbursements relating to the registration or qualification of the Securities under
the &ldquo;blue sky&rdquo; securities laws of such states and other jurisdictions as Aegis may reasonably designate (including, without
limitation, all filing and registration fees, and the reasonable fees and disbursements of the Company&rsquo;s &ldquo;blue sky&rdquo;
counsel, which will be Aegis&rsquo;s counsel) unless such filings are not required in connection with the Company&rsquo;s proposed Exchange
listing; (e) any fees for counsel to lead investors in the Placement; (f) all fees, expenses and disbursements relating to the registration,
qualification or exemption of the Securities under the securities laws of such foreign jurisdictions as Aegis may reasonably designate;
(g) the costs of all mailing and printing of the Placement documents; (h) transfer and/or stamp taxes, if any, payable upon the transfer
of Securities from the Company to Aegis; (i) the fees and expenses of the Company&rsquo;s accountants; and (j) $75,000 for reasonable
legal fees and disbursements for Aegis&rsquo;s counsel.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">8.</TD><TD STYLE="text-align: justify"><B><U>Closing; Closing Deliverables</U></B>. Unless otherwise directed by the Placement Agent, settlement
of the Securities shall occur via &ldquo;Delivery Versus Payment&rdquo; (&ldquo;<B><U>DVP</U></B>&rdquo;) (i.e., on the Closing Date,
the Company shall cause the Depositary to issue the Securities directly to the clearing firm designated by the Placement Agent; upon receipt
of such Securities, the Placement Agent shall promptly electronically deliver such Securities to the applicable Purchaser, and payment
therefor shall be made by the Placement Agent (or its clearing firm) by wire transfer to the Company).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">8.1.&nbsp;<B><U>Company
Deliveries</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">8.1.1.&nbsp;On
the date hereof, the Company shall deliver each of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">8.1.1.1&nbsp;This
Agreement duly executed by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">8.1.1.2&nbsp;A
certificate executed by the Chief Financial Officer of the Company in customary form reasonably satisfactory to the Placement Agent and
its counsel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">8.1.1.3&nbsp;The
Lock-Up Agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">8.1.2.&nbsp;On
or prior to the Closing Date, the Company shall deliver each the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">8.1.2.1&nbsp;A
legal opinion of Kaufman &amp; Canoles, P.C., addressed to the Placement Agent and the Purchasers, in form and substance reasonably acceptable
to the Placement Agent and Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ea028204301_ex10-2img2.jpg" ALT=""></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">8.1.2.2&nbsp;A copy
of the irrevocable instructions to the Transfer Agent instructing the Transfer Agent to deliver, on an expedited basis, a certificate
(or at the request of the Purchaser, book entry statement) evidencing a number of Shares equal to such Purchaser&rsquo;s Subscription
Amount divided by the Per Unit Purchase Price, registered in the name of such Purchaser; subject to the first sentence of Section 8,
a copy of the irrevocable instructions to the Transfer Agent instructing the Transfer Agent to deliver on an expedited basis via The
Depository Trust Company Deposit or Withdrawal at Custodian system (&ldquo;<B><U>DWAC</U></B>&rdquo;) Shares equal to the portion of
such Purchaser&rsquo;s Subscription Amount applicable to Shares, divided by the Per Unit Purchase Price, registered in the name of such
Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">8.1.2.3&nbsp;For
each Purchaser of Pre-Funded Warrants pursuant to Section 8, a Pre-Funded Warrant registered in the name of such Purchaser to purchase
up to a number of shares of Common Stock equal to the portion of such Purchaser&rsquo;s Subscription Amount applicable to Pre-Funded Warrants
divided by the Per Unit Purchase Price, with an exercise price equal to $0.00001, subject to adjustment as provided therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">8.1.2.4&nbsp;The
Company shall have provided each Purchaser with the Company&rsquo;s wire instructions, on Company letterhead and executed by the Chief
Executive Officer or Chief Financial Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">8.1.2.5&nbsp;A
duly executed and delivered Officers&rsquo; Certificate, in customary form reasonably satisfactory to the Placement Agent and its counsel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">8.1.2.6&nbsp;A
cold comfort letter from the Company&rsquo;s auditor, addressed to the Placement Agent in form and substance reasonably satisfactory in
all material respects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">8.1.2.7&nbsp;The
Prospectus and Prospectus Supplement (which may be delivered in accordance with Rule 172 under the Securities Act).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">9.</TD><TD STYLE="text-align: justify"><B><U>Conditions of the Obligations of the Placement Agent</U></B>. The obligations of the Placement Agent
hereunder shall be subject to the accuracy of the representations and warranties on the part of the Company set forth in the Securities
Purchase Agreement (on which the Company authorizes the Placement Agent to Rely), in each case as of the date hereof and as of the Closing
Date as though then made, to the timely performance by each of the Company of its covenants and other obligations hereunder on and as
of such dates, and to each of the following additional conditions:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">9.1.&nbsp;<B><U>Regulatory
Matters</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">9.1.1.&nbsp;<B><U>Effectiveness
of Registration Statement; Rule 424 Information</U></B>. The Registration Statement is effective on the date of this Agreement, and, on
the Closing Date no stop order suspending the effectiveness of the Registration Statement or any post-effective amendment thereto has
been issued under the Securities Act, no order preventing or suspending the use of any Preliminary Prospectus or the Prospectus has been
issued and no proceedings for any of those purposes have been instituted or are pending or, to the Company&rsquo;s knowledge, contemplated
by the Commission. The Company has complied with each request (if any) from the Commission for additional information. All filings with
the Commission required by Rule 424 under the Securities Act to have been filed by the Closing Date shall have been made within the applicable
time period prescribed for such filing by Rule 424.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ea028204301_ex10-2img2.jpg" ALT=""></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">9.1.2.&nbsp;<B><U>FINRA
Clearance</U></B>. On or before the Closing Date, the Placement Agent shall have received clearance from FINRA as to the amount of compensation
allowable or payable to the Placement Agent as described in the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">9.1.3.&nbsp;<B><U>Listing
of Additional Shares</U></B>. On or before the Closing Date, the Company shall have filed a notice with the Exchange with respect to the
Company&rsquo;s additional listing of the securities sold in the Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">9.2.&nbsp;<B><U>Closing
Deliverables</U></B>. The Company shall have delivered all closing deliverables to the Placement Agent as set forth in Section 8.1 as
of the time required and in form reasonably satisfactory to the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">9.2.1.&nbsp;<B><U>No
Material Changes</U></B>. Prior to and on the Closing Date: (i) there shall have been no Material Adverse Effect or development involving
a prospective Material Adverse Effect in the condition or prospects or the business activities, financial or otherwise, of the Company
from the latest dates as of which such condition is set forth in the Registration Statement, the Disclosure Package and the Prospectus;
(ii) no action, suit or proceeding, at law or in equity, shall have been pending or threatened against the Company or any affiliates of
the Company before or by any court or federal or state commission, board or other administrative agency wherein an unfavorable decision,
ruling or finding may materially adversely affect the business, operations, prospects or financial condition or income of the Company,
except as set forth in the Registration Statement and the Prospectus; (iii) no stop order shall have been issued under the Securities
Act and no proceedings therefor shall have been initiated or threatened by the Commission; and (iv) the Registration Statement and the
Prospectus and any amendments or supplements thereto shall contain all material statements which are required to be stated therein in
accordance with the Securities Act and the Securities Act Regulations and shall conform in all material respects to the requirements of
the Securities Act and the Securities Act Regulations, and neither the Registration Statement nor the Prospectus nor any amendment or
supplement thereto shall contain any untrue statement of a material fact or omit to state any material fact required to be stated therein
or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">9.2.2.&nbsp;<B><U>Additional
Documents</U></B>. At the Closing Date, Placement Agent&rsquo;s counsel shall have been furnished with such documents and opinions as
they may require in order to evidence the accuracy of any of the representations or warranties, or the fulfillment of any of the conditions,
herein contained; and all proceedings taken by the Company in connection with the issuance and sale of the Securities as herein contemplated
shall be satisfactory in form and substance to the Placement Agent and Placement Agent&rsquo;s counsel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ea028204301_ex10-2img2.jpg" ALT=""></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">10.</TD><TD STYLE="text-align: justify"><B><U>Reserved. </U></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">11.</TD><TD STYLE="text-align: justify"><B><U>Termination</U></B>. Notwithstanding anything to the contrary contained herein, the Company agrees
that the provisions relating to the payment of fees, reimbursement of expenses, indemnification and contribution, confidentiality, conflicts,
independent contractor and waiver of the right to trial by jury will survive any termination or expiration of this placement agent agreement.
Notwithstanding anything to the contrary contained herein, the Company has the right to terminate the placement agent agreement for cause
in compliance with FINRA Rule 5110(g)(5)(B)(i). Notwithstanding anything to the contrary contained in this placement agent agreement,
in the event that no Placement is completed for any reason whatsoever during the Engagement Period, the Company shall be obligated to
pay to Aegis its actual and accountable out-of-pocket expenses related to the Placement (including the fees and disbursements of Placement
Agent&rsquo;s legal counsel) and if applicable, for electronic road show service used in connection with the Placement. During the engagement
hereunder: (i) the Company will not, and will not permit its representatives to, other than in coordination with Aegis, contact or solicit
institutions, corporations or other entities or individuals as potential purchasers of the Securities and (ii) the Company will not pursue
any financing transaction which would be in lieu of the Placement. Furthermore, the Company agrees that during Aegis&rsquo;s engagement
hereunder, all inquiries from prospective investors will be referred to Aegis.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">12.</TD><TD STYLE="text-align: justify"><B><U>Publicity</U></B>. The Company agrees that it will not issue press releases or engage in any other
publicity, without Aegis&rsquo;s prior written consent, commencing on the date hereof and continuing until the final Closing of the Placement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">13.</TD><TD STYLE="text-align: justify"><B><U>Information</U></B>. During the Engagement Period or until the Closing, the Company agrees to cooperate
with Aegis and to furnish, or cause to be furnished, to Aegis, any and all information and data concerning the Company, and the Placement
that Aegis deems appropriate (the &ldquo;<B><U>Information</U></B>&rdquo;). The Company will provide Aegis reasonable access during normal
business hours from and after the date of execution of this placement agent agreement until the Closing to all of the Company&rsquo;s
assets, properties, books, contracts, commitments and records and to the Company&rsquo;s officers, directors, employees, appraisers, independent
accountants, legal counsel and other consultants and advisors. Except as contemplated by the terms hereof or as required by applicable
law, Aegis will keep strictly confidential all non-public Information concerning the Company provided to Aegis. No obligation of confidentiality
will apply to Information that: (a) is in the public domain as of the date hereof or hereafter enters the public domain without a breach
by Aegis, (b) was known or became known by Aegis prior to the Company&rsquo;s disclosure thereof to Aegis as demonstrated by the existence
of its written records, (c) becomes known to Aegis from a source other than the Company which information is not provided by the breach
of an obligation of confidentiality owed to the Company, (d) is disclosed by the Company to a third party without restrictions on its
disclosure or (e) is independently developed by Aegis as demonstrated by its written records. For the avoidance of doubt, except as otherwise
provided herein, all information which is not publicly available relating to the Company&rsquo;s proprietary technology is proprietary
and confidential.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ea028204301_ex10-2img2.jpg" ALT=""></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">14.</TD><TD STYLE="text-align: justify"><B><U>No Third Party Beneficiaries; No Fiduciary Obligations</U></B>. This placement agent agreement does
not create, and shall not be construed as creating, rights enforceable by any person or entity not a party hereto, except those entitled
hereto by virtue of the indemnification provisions hereof. The Company acknowledges and agrees that: (i) Aegis is not and shall not be
construed as a fiduciary of the Company and shall have no duties or liabilities to the equity holders or the creditors of the Company
or any other person or entity by virtue of this placement agent agreement or the retention of Aegis hereunder, all of which are hereby
expressly waived; and (ii) Aegis is a full service securities firm engaged in a wide range of businesses and from time to time, in the
ordinary course of its business, Aegis or its affiliates may hold long or short positions and trade or otherwise effect transactions for
its own account or the account of its customers in debt or equity securities or loans of the companies which may be the subject of the
transactions contemplated by this placement agent agreement. During the course of Aegis&rsquo;s engagement with the Company, Aegis may
have in its possession material, non-public information regarding other companies that could potentially be relevant to the Company or
the transactions contemplated herein but which cannot be shared due to an obligation of confidence to such other companies.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">15.</TD><TD STYLE="text-align: justify"><B><U>Indemnification, Advancement &amp; Contribution</U></B>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">15.1.&nbsp;<B><U>Indemnification</U></B>.
The Company agrees to indemnify and hold harmless Aegis, its affiliates and each person controlling Aegis (within the meaning of Section
15 of the Securities Act), and the directors, officers, agents and employees of Aegis, its affiliates and each such controlling person
(Aegis, and each such entity or person hereafter is referred to as an &ldquo;<B><U>Indemnified Person</U></B>&rdquo;) from and against
any losses, claims, damages, judgments, assessments, costs and other liabilities (collectively, the &ldquo;<B><U>Liabilities</U></B>&rdquo;),
and shall reimburse each Indemnified Person for all fees and expenses (including the reasonable fees and expenses of counsel for the Indemnified
Persons) (collectively, the &ldquo;<B><U>Expenses</U></B>&rdquo;) and agrees to advance payment of such Expenses as they are incurred
by an Indemnified Person in investigating, preparing, pursuing or defending any actions, whether or not any Indemnified Person is a party
thereto, arising out of or based upon (i) any untrue statement or alleged untrue statement of a material fact contained in (A) the Registration
Statement, Prospectus or any other offering documents (as from time to time each may be amended and supplemented), (B) any materials or
information provided to investors by, or with the approval of, the Company in connection with the marketing of the Placement, including
any &ldquo;road show&rdquo; or investor presentations made to investors by the Company (whether in person or electronically), or (C) any
application or other document or written communication (collectively called &ldquo;application&rdquo;) executed by the Company or based
upon written information furnished by the Company in any jurisdiction in order to qualify the Securities under the securities laws thereof
or to file for an exemption from such requirement or filed with the Commission, any state securities commission or agency, any national
securities exchange; or (ii) the omission or alleged omission therefrom of a material fact required to be stated therein or necessary
to make the statements therein, in the light of the circumstances under which they were made, not misleading, unless such statement or
omission was made in reliance upon, and in conformity with, information provided to the Company by Aegis in writing specifically for use
in the Registration Statement, Prospectus or any other offering documents with respect which or resulting from conduct by Aegis or another
Indemnified Party, as to which Aegis shall indemnify and hold harmless the Company, its officers, directors and controlling parties in
the manner set forth in this Section 15. The Company also agrees to reimburse and advance each Indemnified Person for all Expenses as
they are incurred in connection with such Indemnified Person&rsquo;s enforcement of his or its rights under this Section 15.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ea028204301_ex10-2img2.jpg" ALT=""></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">15.2.&nbsp;<B><U>Procedure</U></B>.
Upon receipt by an Indemnified Person of actual notice of an action against such Indemnified Person with respect to which indemnity may
reasonably be expected to be sought under this Section 15, such Indemnified Person shall promptly notify the Company in writing; provided
that failure by any Indemnified Person so to notify the Company shall not relieve the Company from any obligation or liability which
the Company may have on account of this Section 15 or otherwise to such Indemnified Person. The Company shall, if requested by Aegis,
assume the defense of any such action (including the employment of counsel designated by Aegis and reasonably satisfactory to the Company).
Any Indemnified Person shall have the right to employ separate counsel in any such action and participate in the defense thereof, but
the fees and expenses of such counsel shall be at the expense of such Indemnified Person unless: (i) the Company has failed promptly
to assume the defense and employ separate counsel reasonably acceptable to Aegis for the benefit of Aegis and the other Indemnified Persons
or (ii) such Indemnified Person shall have been advised that in the opinion of counsel that there is an actual or potential conflict
of interest that prevents (or makes it imprudent for) the counsel designated by and engaged by the Company for the purpose of representing
the Indemnified Person, to represent both such Indemnified Person and any other person represented or proposed to be represented by such
counsel, in which event the Company shall pay the reasonable fees and expenses of one counsel, plus local counsel, for all Indemnified
Parties, which counsel shall, if Aegis is a defendant, be designated by Aegis. The Company shall not be liable for any settlement of
any action effected without its written consent (which shall not be unreasonably withheld). In addition, the Company shall not, without
the prior written consent of Aegis, settle, compromise or consent to the entry of any judgment in or otherwise seek to terminate any
pending or threatened action in respect of which advancement, reimbursement, indemnification or contribution may be sought hereunder
(whether or not such Indemnified Person is a party thereto) unless such settlement, compromise, consent or termination (i) includes an
unconditional release of each Indemnified Person, acceptable to such Indemnified Party, from all Liabilities arising out of such action
for which indemnification or contribution may be sought hereunder and (ii) does not include a statement as to or an admission of fault,
culpability or a failure to act, by or on behalf of any Indemnified Person. The advancement, reimbursement, indemnification and contribution
obligations of the Company required hereby shall be made by periodic payments of the amount thereof during the course of the investigation
or defense, as every Liability and Expense is incurred and is due and payable, and in such amounts as fully satisfy each and every Liability
and Expense as it is incurred (and in no event later than 30 Calendar Days following the date of any invoice therefore).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">15.3.&nbsp;<B><U>Contribution</U></B>.
In the event that a court of competent jurisdiction makes a finding, final beyond right of review, that indemnity is unavailable to an
Indemnified Person, the Company shall contribute to the Liabilities and Expenses paid or payable by such Indemnified Person in such proportion
as is appropriate to reflect (i) the relative benefits to the Company, on the one hand, and to Aegis and any other Indemnified Person,
on the other hand, of the matters contemplated by this Section 15 or (ii) if the allocation provided by the immediately preceding clause
is not permitted by applicable law, not only such relative benefits but also the relative fault of the Company, on the one hand, and Aegis
and any other Indemnified Person, on the other hand, in connection with the matters as to which such Liabilities or Expenses relate, as
well as any other relevant equitable considerations; provided that in no event shall the Company contribute less than the amount necessary
to ensure that all Indemnified Persons, in the aggregate, are not liable for any Liabilities and Expenses in excess of the amount of commissions
and non-accountable expense allowance actually received by Aegis in the Placement. The relative fault shall be determined by reference
to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state
a material fact relates to information supplied by the Company on the one hand or Aegis on the other and the parties&rsquo; relative intent,
knowledge, access to information and opportunity to correct or prevent such statement or omission. The Company and Aegis agree that it
would not be just and equitable if contributions pursuant to this subsection 15.3 were determined by pro rata allocation or by any other
method of allocation which does not take account of the equitable considerations referred to above in this subsection 15.3. For purposes
of this paragraph, the relative benefits to the Company, on the one hand, and to Aegis on the other hand, of the matters contemplated
by this Section 15 shall be deemed to be in the same proportion as: (a) the total value received by the Company in the Placement, whether
or not such Placement is consummated, bears to (b) the commissions paid to Aegis under the Placement Agent Agreement. Notwithstanding
the above, no person guilty of fraudulent misrepresentation within the meaning of Section 11(f) of the Securities Act shall be entitled
to contribution from a party who was not guilty of fraudulent misrepresentation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ea028204301_ex10-2img2.jpg" ALT=""></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">15.4.&nbsp;<B><U>Limitation</U></B>.
The Company also agrees that no Indemnified Person shall have any liability (whether direct or indirect, in contract or tort or otherwise)
to the Company for or in connection with advice or services rendered or to be rendered by any Indemnified Person pursuant to this placement
agent agreement, the transactions contemplated thereby or any Indemnified Person&rsquo;s actions or inactions in connection with any
such advice, services or transactions, except to the extent that a court of competent jurisdiction has made a finding that Liabilities
(and related Expenses) of the Company have resulted exclusively from such Indemnified Person&rsquo;s gross negligence or willful misconduct
in connection with any such advice, actions, inactions or services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.</TD><TD STYLE="text-align: justify"><B><U>Equitable Remedies</U></B>. Each party to this placement agent agreement acknowledges and agrees
that (a) a breach or threatened breach by the Company of any of its obligations under the exclusivity provisions of Section 1 would give
rise to irreparable harm to Aegis for which monetary damages would not be an adequate remedy and (b) if a breach or a threatened breach
by the Company of any such obligations occurs, Aegis will, in addition to any and all other rights and remedies that may be available
to such party at law, at equity, or otherwise in respect of such breach, be entitled to equitable relief, including a temporary restraining
order, an injunction, specific performance of the terms of the exclusivity provisions of Section 1, as applicable, and any other relief
that may be available from a court of competent jurisdiction, without any requirement to (i) post a bond or other security, or (ii) prove
actual damages or that monetary damages will not afford an adequate remedy. Each party to this placement agent agreement agrees that such
party shall not oppose or otherwise challenge the existence of irreparable harm, the appropriateness of equitable relief or the entry
by a court of competent jurisdiction of an order granting equitable relief, in either case, consistent with the terms of this Section
16.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">17.</TD><TD STYLE="text-align: justify"><B><U>Governing Law; Venue</U></B>. This placement agent agreement will be deemed to have been made and
delivered in the State of New York, USA, and both the binding provisions of this placement agent agreement and the transactions contemplated
hereby will be governed as to validity, interpretation, construction, effect and in all other respects by the internal laws of the State
of New York, without regard to the conflict of laws principles thereof. Each of Aegis and the Company: (i) agrees that any legal suit,
action or proceeding arising out of or relating to this placement agent agreement and/or the transactions contemplated hereby will be
instituted exclusively in the courts located in the Borough of Manhattan, City of New York, County of New York, State of New York (ii)
waives any objection which it may have or hereafter to the venue of any such suit, action or proceeding, and (iii) irrevocably consents
to the jurisdiction of the courts located in the City of New York, County of New York and State of New York, in any such suit, action
or proceeding. Each of Aegis and the Company further agrees to accept and acknowledge service of any and all process which may be served
in any such suit, action or proceeding in such courts and agrees that service of process upon the Company mailed by certified mail to
the Company&rsquo;s address will be deemed in every respect effective service of process upon the Company, in any such suit, action or
proceeding, and service of process upon Aegis mailed by certified mail to Aegis&rsquo;s address will be deemed in every respect effective
service process upon Aegis, in any such suit, action or proceeding. Notwithstanding any provision of this placement agent agreement to
the contrary, the Company agrees that neither Aegis nor its affiliates, and the respective officers, directors, employees, agents and
representatives of Aegis, its affiliates and each other person, if any, controlling Aegis or any of its affiliates, will have any liability
(whether direct or indirect, in contract or tort or otherwise) to the Company for or in connection with the engagement and transaction
described herein except for any such liability for losses, claims, damages or liabilities incurred by the Company that are finally judicially
determined to have resulted from the bad faith or gross negligence of such individuals or entities. Aegis will act under this placement
agent agreement as an independent contractor with duties to the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ea028204301_ex10-2img2.jpg" ALT=""></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">18.</TD><TD STYLE="text-align: justify"><B><U>Miscellaneous</U></B>. The Company represents and warrants that it has all required power and authority
to enter into and carry out the terms and provisions of this placement agent agreement and the execution, delivery and performance of
this placement agent agreement does not breach or conflict with any agreement, document or instrument to which it is a party or bound.
The binding provisions of this placement agent agreement are legally binding upon and inure to the benefit of both the Company and Aegis
and their respective assigns, successors, and legal representatives. If any provision of this placement agent agreement is determined
to be invalid or unenforceable in any respect, such determination will not affect such provision in any other respect, and the remainder
of the placement agent agreement shall remain in full force and effect. This placement agent agreement may be executed in counterparts
(including electronic counterparts), each of which shall be deemed an original but all of which together shall constitute one and the
same instrument. The undersigned hereby consents to receipt of this placement agent agreement in electronic form and understands and agrees
that this placement agent agreement may be signed electronically. Signatures to this placement agent agreement transmitted in electronic
form will have the same effect as physical delivery of a paper document bearing the original signature, and if any signature is delivered
electronically evidencing an intent to sign this placement agent agreement, such electronic mail or other electronic transmission shall
create a valid and binding obligation of the undersigned with the same force and effect as if such signature were an original. Execution
and delivery of this placement agent agreement by electronic mail or other electronic transmission is legal, valid and binding for all
purposes.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If you are in agreement with
the foregoing, please sign and return to us one copy of this placement agent agreement. This placement agent agreement may be executed
in counterparts (including facsimile or .pdf counterparts), each of which shall be deemed an original but all of which together shall
constitute one and the same instrument.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature Page of CYN Registered Direct Shelf
Takedown Placement Agent Agreement Follows]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ea028204301_ex10-2img2.jpg" ALT=""></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature Page of CYN Registered Direct Shelf
Takedown Placement Agent Agreement]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.5in; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Very truly yours,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 35%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">Aegis Capital Corp.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">/s/ Robert Eide</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Robert Eide</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Chief Executive Officer</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>AGREED AND ACCEPTED</B>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The foregoing accurately sets forth our understanding and agreement
with respect to the matters set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Cyngn Inc.</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">/s/ Lior Tal</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Lior Tal</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Chief Executive Officer</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 12; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>6
<FILENAME>ea028204301ex99-1.htm
<DESCRIPTION>PRESS RELEASE ISSUED BY THE COMPANY ON MARCH 16, 2026
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Cyngn Inc. Announces $9.65 Million Registered Direct Offering,
Priced at the Market Under Nasdaq Rules</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt">MOUNTAIN VIEW, CALIF., MARCH 16, 2026 Cyngn Inc. (NASDAQ:
CYN) today announced that it has entered into definitive agreements in a registered direct offering with for the purchase and sale of
approximately $9.65 million of shares of Common Stock and pre-funded warrants at a price of $1.93 per share of Common Stock. A single
institutional investor acquired greater than ninety percent of the offering, with a high-net-worth individual purchasing the remaining
percent. The entire transaction has been priced at the market under Nasdaq rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">The offering consisted of the sale of 5,000,000 shares
of Common Stock (or Pre-Funded Warrants). The public offering price per share of Common Stock is $1.93 (or $1.92999 for each Pre-Funded
Warrant, which is equal to the public offering price per share of Common Stock to be sold in the offering minus an exercise price of $0.00001
per Pre-Funded Warrant). The Pre-Funded Warrants will be immediately exercisable and may be exercised at any time until exercised in full.
For each Pre-Funded Unit sold in the offering, the number of shares of Common Stock in the offering will be decreased on a one-for-one
basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Aggregate gross proceeds to the Company are expected to
be approximately $9.65 million. The transaction is expected to close on or about March 17, 2026, subject to the satisfaction of customary
closing conditions. The Company expects to use the net proceeds from the offering for general corporate purposes and working capital.
Following completion of the offering, the Company will have 16,896,4932 shares of Common Stock issued and outstanding, assuming the exercise
of all Pre-funded Warrants issued in the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Aegis Capital Corp. is acting as exclusive placement agent
for the offering. Kaufman &amp; Canoles, P.C. is acting as counsel to the Company. Greenberg Traurig, P.A. is acting as counsel to Aegis
Capital Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">The registered direct offering is being made pursuant to
an effective shelf registration statement on Form S-3 (No. 333-290079) previously filed with the U.S. Securities and Exchange Commission
(SEC) and declared effective by the SEC on September 18, 2025. A final prospectus supplement and accompanying prospectus describing the
terms of the proposed offering will be filed with the SEC and will be available on the SEC&rsquo;s website located at www.sec.gov. Electronic
copies of the final prospectus supplement and the accompanying prospectus may be obtained, when available, by contacting Aegis Capital
Corp., Attention: Syndicate Department, 1345 Avenue of the Americas, 27th floor, New York, NY 10105, by email at syndicate@aegiscap.com,
or by telephone at +1 (212) 813-1010.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Interested parties should read in their entirety the prospectus
supplement and the accompanying prospectus and the other documents that the Company has filed with the SEC that are incorporated by reference
in such prospectus supplement and the accompanying prospectus, which provide more information about the Company and such offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#8239;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">This press release shall not constitute an offer to sell
or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer,
solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">About Cyngn</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Cyngn develops and deploys autonomous vehicle technology
for industrial organizations like manufacturers and logistics companies. The Company addresses significant challenges facing industrial
organizations today, such as labor shortages and costly safety incidents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Cyngn&rsquo;s DriveMod technology empowers customers to seamlessly
bring self-driving technology to their operations without high upfront costs or infrastructure installations. DriveMod is currently available
on Motrec MT-160 Tuggers and BYD Forklifts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">The DriveMod Tugger hauls up to 12,000 lbs, travels inside
and out, and targets a typical payback period of less than 2 years. The DriveMod Forklift lifts heavy loads that use non-standard pallets
and is currently available to select customers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0"><B>Investor Contact:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0"><B></B>Natalie Russell, Interim CFO</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0">investors@cyngn.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0"><B>Media Contact:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0"><B></B>Luke Renner, Head of Marketing</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0">media@cyngn.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0"><B>Where to Find Cyngn</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="padding-right: 24.75pt">Website: https://cyngn.com</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="padding-right: 24.75pt">X: https://x.com/cyngn</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="padding-right: 24.75pt">LinkedIn: https://www.linkedin.com/company/cyngn</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="padding-right: 24.75pt">YouTube: https://www.youtube.com/@cyngnhq</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0; background-color: white">Forward-Looking Statements</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">This press release contains forward-looking statements
within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and
Section 21E of the Securities Exchange Act of 1934, as amended. Any statement that is not historical in nature is a forward-looking statement
and may be identified by the use of words and phrases such as &ldquo;expects,&rdquo; &ldquo;anticipates,&rdquo; &ldquo;believes,&rdquo; &ldquo;will,&rdquo;
&ldquo;will likely result,&rdquo; &ldquo;will continue,&rdquo; &ldquo;plans to,&rdquo; &ldquo;potential,&rdquo; &ldquo;promising,&rdquo; and similar
expressions. These statements are based on management&rsquo;s current expectations and beliefs and are subject to a number of risks, uncertainties
and assumptions that could cause actual results to differ materially from those described in the forward-looking statements, including
the risk factors described from time to time in the Company&rsquo;s reports to the Securities and Exchange Commission (SEC), including, without
limitation the risk factors discussed in the Company&rsquo;s annual report on Form 10-K filed with the SEC on November 14, 2025. Readers are
cautioned that it is not possible to predict or identify all the risks, uncertainties and other factors that may affect future results.
No forward-looking statement can be guaranteed, and actual results may differ materially from those projected. Cyngn undertakes no obligation
to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>7
<FILENAME>ea028204301ex99-2.htm
<DESCRIPTION>PRESS RELEASE ISSUED BY THE COMPANY ON MARCH 17, 2026
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibit 99.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"><B>Cyngn Inc. Announces Closing of $9.65 Million Registered Direct
Offering, Priced at the Market Under Nasdaq Rules</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">MOUNTAIN VIEW, CALIF., MARCH 17, 2026 Cyngn Inc. (NASDAQ:
CYN) today announced the closing of its previously announced registered direct offering for the purchase and sale of approximately $9.65
million of shares of Common Stock and pre-funded warrants at a price of $1.93 per share of Common Stock. A single institutional investor
acquired greater than ninety percent of the offering, with a high-net-worth individual purchasing the remaining percent. The entire transaction
was priced at the market under Nasdaq rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">The offering consisted of the sale of 5,000,000 shares
of Common Stock (or Pre-Funded Warrants). The public offering price per share of Common Stock was $1.93 (or $1.92999 for each Pre-Funded
Warrant, which is equal to the public offering price per share of Common Stock sold in the offering minus an exercise price of $0.00001
per Pre-Funded Warrant). The Pre-Funded Warrants are immediately exercisable and may be exercised at any time until exercised in full.
For each Pre-Funded Warrant sold in the offering, the number of shares of Common Stock in the offering were decreased on a one-for-one
basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Aggregate gross proceeds to the Company were approximately
$9.65 million. The transaction closed on March 17, 2026. The Company intends to use the net proceeds from the offering for general corporate
purposes and working capital. Following completion of the offering, the Company has 16,896,493 shares of Common Stock issued and outstanding,
assuming the exercise of all Pre-funded Warrants issued in the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B>Aegis Capital Corp. acted as exclusive placement agent
for the offering. Kaufman &amp; Canoles, P.C. acted as counsel to the Company. Greenberg Traurig, P.A. acted as counsel to Aegis Capital
Corp.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">The registered direct offering was made pursuant to an
effective shelf registration statement on Form S-3 (No. 333-290079) previously filed with the U.S. Securities and Exchange Commission
(SEC) and declared effective by the SEC on September 18, 2025. A final prospectus supplement and accompanying prospectus describing the
terms of the offering has been filed with the SEC and is available on the SEC&rsquo;s website located at www.sec.gov. Electronic copies
of the final prospectus supplement and the accompanying prospectus may be obtained by contacting Aegis Capital Corp., Attention: Syndicate
Department, 1345 Avenue of the Americas, 27th floor, New York, NY 10105, by email at syndicate@aegiscap.com, or by telephone at +1 (212)
813-1010.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Interested parties should read in their entirety the prospectus
supplement and the accompanying prospectus and the other documents that the Company has filed with the SEC that are incorporated by reference
in such prospectus supplement and the accompanying prospectus, which provide more information about the Company and such offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#8239;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">This press release shall not constitute an offer to sell
or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer,
solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">About Cyngn</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Cyngn develops and deploys autonomous vehicle technology
for industrial organizations like manufacturers and logistics companies. The Company addresses significant challenges facing industrial
organizations today, such as labor shortages and costly safety incidents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Cyngn&rsquo;s DriveMod technology empowers customers to seamlessly
bring self-driving technology to their operations without high upfront costs or infrastructure installations. DriveMod is currently available
on Motrec MT-160 Tuggers and BYD Forklifts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">The DriveMod Tugger hauls up to 12,000 lbs, travels inside
and out, and targets a typical payback period of less than 2 years. The DriveMod Forklift lifts heavy loads that use non-standard pallets
and is currently available to select customers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0"><B>Investor Contact:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0"><B></B>Natalie Russell, CFO</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0">investors@cyngn.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0"><B>Media Contact:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0"><B></B>Luke Renner, Head of Marketing</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0">media@cyngn.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0"><B>Where to Find Cyngn</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="padding-right: 24.75pt">Website: https://cyngn.com</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="padding-right: 24.75pt">X: https://x.com/cyngn</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="padding-right: 24.75pt">LinkedIn: https://www.linkedin.com/company/cyngn</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="padding-right: 24.75pt">YouTube: https://www.youtube.com/@cyngnhq</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0; background-color: white">Forward-Looking Statements</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 24.75pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">This press release contains forward-looking statements
within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and
Section 21E of the Securities Exchange Act of 1934, as amended. Any statement that is not historical in nature is a forward-looking statement
and may be identified by the use of words and phrases such as &ldquo;expects,&rdquo; &ldquo;anticipates,&rdquo; &ldquo;believes,&rdquo; &ldquo;will,&rdquo;
&ldquo;will likely result,&rdquo; &ldquo;will continue,&rdquo; &ldquo;plans to,&rdquo; &ldquo;potential,&rdquo; &ldquo;promising,&rdquo; and similar
expressions. These statements are based on management&rsquo;s current expectations and beliefs and are subject to a number of risks, uncertainties
and assumptions that could cause actual results to differ materially from those described in the forward-looking statements, including
the risk factors described from time to time in the Company&rsquo;s reports to the Securities and Exchange Commission (SEC), including, without
limitation the risk factors discussed in the Company&rsquo;s annual report on Form 10-K filed with the SEC on November 14, 2025. Readers are
cautioned that it is not possible to predict or identify all the risks, uncertainties and other factors that may affect future results.
No forward-looking statement can be guaranteed, and actual results may differ materially from those projected. Cyngn undertakes no obligation
to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>ea028204301_ex5-1img1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea028204301_ex5-1img1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  J 3(# 2(  A$! Q$!_\0
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M;*WOK%EMM($LH!1X6WEQ_O/\OT%>@3Z#=_VKK>HVEZD4^H6<5O$3&3Y+)O\
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D@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>ea028204301_ex5-1img2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea028204301_ex5-1img2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #< .(# 2(  A$! Q$!_\0
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M)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MB_NYKN[F>>XF8O)*YRS$]S4- PHHHH **** /M^BBB@D**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHK!UK6KA+M='T=$FU>5=Q+\QVL9_Y:2?
MT7JQ]LD !K6M7"7:Z-HR)-JTJ[B7YCM8S_RTD_HO5C[9(\X\;^-[/P%I\^A:
M%.;G7;@E[Z_D(9U8CEF/]_'0=%&/84>-_&]IX"T^?0M"N#<Z[<$O?7\A#.K$
M<LQ_OXZ#HHQ["O+(((M!A36=9C%SJMP/.LK&?YNO(GG![=U4_>ZGCJ#"""+0
M((]9UB,7.J7 \ZRL9_FQGD3S@]NZJ?O=3QUYZ[N[B_NYKN[F>>XF8O)*YRS$
M]S1=W=Q?WDUW=S//<S,7DE<Y9B>YJ&@84444 %%%% !1110!]OT444$A1110
M 4444 %%%% !1110 4444 %%%% !1110 445@ZUK4Z7:Z/HZ)-J\R[B7YCM8
M_P#GI)_1>K'VR0 &M:U<)=KH^CHDVKS+N)?F.UC/_+23^B]6/MDCSGQOXWM/
M 6GSZ%H5P;G7;@E[V_D(9U8CEF/]_'0=%&/84>-_&]IX"T^?0M#N#<Z]<'?>
MW\A#.K$<LQ_OXZ#HHQ["O*X((M!A36M9C%UJER/.LK&?YNO(GG!_A[JI^\>3
MQU!A!!%H,":SK,8N=4N1YUE8S_-UY$\X/;NJG[W4\=>>N[NXO[R:[NYGGN9F
M+R2N<EB>YHN[NXO[R:[NYGGN9F+R2N<EB>]0T#"BBB@ HHHH **** "BBB@#
M[?HHHH)"BBB@ HHHH **** "BBB@ HHHH **** "BBL'6M:GCNTT?1T2;5YE
MW?/S':Q]/,D]O1>K'VR0 &M:U<1W2Z/HZ)-J\R[B7YCM8^GF2>WHO5C[9(\Z
M\;>-K/P!I\VAZ'.;G7KD[[V^D(9E8CEF/]['1>BC'L*/&WC:S\ :?/HFB3FZ
MU^Y.^]OI"&96(Y9CTW8Z+T48]A7E4$$>A0IK6M(+K5+D>=96,_S9SR)YP?X>
MZJ?O=3QU!A!!'H4*:UK2"ZU2Y'G65C/\W7D3S@_P]U4_>/)XZ\]=W=Q?WDUW
M=S//<S,7DE<Y+$T7=W<7]Y-=W<SSW,S%Y)7.2Q-0T#"BBB@ HHHH **** "B
MBB@ HHHH ^WZ***"0HHHH **** "BBB@ HHHH **** "BBL'6M:GCNDT?1T2
M?5YEW?/S':Q]/-D]O1>K'VR0 &M:U/'=)H^CHD^KS+N^?F.UCZ>;)[>B]6/M
MDCSOQMXVL_ &G3Z)HEP;K7[D^9>WTA#,K$<LQZ;L=%Z*,>PH\;>-;3X?Z=-H
MFBSFZU^Y_>7M](0SJQ'+L?[V.B]%&/8'RF"&/0X4UO6T%UJER/.LK&?YLYY$
M\X/\/=5/WCR>.H,((8]#A36M:C%UJER/.LK&?YLYY$\X/\/=5/WCR>.O/7=W
M<7]Y-=W<SSW,S%Y)7.2QHN[NXO[R:[NYGGN9F+R2.<EC4- PHHHH **** "B
MBB@ HHHH **** "BBB@#[?HHHH)"BBB@ HHHH **** "BBB@ HHK!UO6YXKI
M-'T=$GU>9=WS\QVL?3S9,=O1>K'VR0 &MZU/'=)H^CHD^KS+N^?F.UCZ>;)C
MMZ+U8^V2///&OC6S^'VG3:+HLYNO$%S^\O+V0AF5B/OOVW8Z+T48[8!7QKXU
ML_A]ITVC:-.;KQ!<_O+R]DPS*Q'WW[;L?=7HHQVP#Y/##'HL2:WK:"ZU.Y_?
M65C/\V<\B><'^'/*J>6/)XZ@PAACT2)-;UM!=:I<_OK*QG^;.>1/.#_#GE5/
MWCR>.O/7=W<W]Y->7DSSW,S%Y)'.2QHN[NYO[R:\O)WGN9F+R2N<EC4- PHH
MHH **** "BBB@ HHHH **** "BBB@ HHHH ^WZ***"0HHHH **** "BBB@ H
MHK!UO6YXKI-'T=$GU>9=WS\QVT?3S9,=O1>K'@=R  UK6YXKI-'T=$GU>9=W
MS<QVT?3S9,=O1>K'CU(\]\:^-;/X?:=-HVC3F[\077[R\O9,,RL1]]NV['W5
MZ*,=L KXU\9V?P]TV;1]'N#=>(;K]Y=WLF&96(^^_;=C[J]%&.V,^30PQZ+$
MFN:X@N]3N?WUE8S_ #;L\B><'^'/*J>6/)XZ@PAACT6)-<UQ!=:G<_OK*QG^
M;=GD3S@_PYY53RQY/'7GKN[N=0O)KR\F>>YF8O)(YR6-%Y>7.H7DUY>3O/<S
M,7DD<Y+&H:!A1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?;]%%%
M!(4444 %%%% !116%K>MSQ72:/HZ)/K$R[@'YCMH^GFR8[>@ZL>!W( #6];G
MBNDT?1T2?6)EW /S';1]/-DQV]%ZL>!W(\^\:>,[+X>:;-I&D3_:_$-U^\N[
MR7#,K$???MNQ]U>BC'; )XT\9V7P\TV;2-(G^U^(;K]Y=WDN&96(^^_;=C[J
M]%&.W7R:*)-'B77==3[7J=U^^LK&?YMV>?/GS_#GE5/+'D\=08D42:-$NNZZ
MGVO4[K]]96,_S;L\^?.#_#GE5/+'D\=>>O+RYU"\FO+R=Y[F9B\DCG)8T7EY
M<ZA>37EY.\]S,Q>21SDL:AH&* 68*.23@5<U?2;_ $'47T_5+<VUVBAFB9@2
M 1D="1TJI$0)HR>@=2?SKW[QGJ'AO6_-BTS6].M;C[9:-J5P^QS-#@ ;"3R%
MP,J/0Y]P#Y^W#U%6+&SN-2OX+&RB::ZG<)%&O5B:^@=1U/PS'<Z-/>WVE33V
MFL>6)EE@9O(:-@"PC  4DKP0<<9-4;6\T;PY=:%'%K6C32C7KF2>2"1&$<,B
MR$ GMC*C/3/2@5SR9/ OB:76KC2(=)EFO;95:9(G5EC!&1EL[1],U2;PWK2:
M\FAOIEPNJ.<+;,N&/&<CMC )STKU%/$%OXKTGQ+H:>(++1M4EU4S173-Y$5S
M I 5=R^R]>IX/.35?P[/HWAO7M<U[5O&":I<V]LMK:W469)?,<88HK'YMO S
MTY/O0!YQ;>&-;O-;GT6WTZ:34H QEMA@,NW&>IQW'YU VB:DNCR:LUG(MA'/
M]F>8X 67^Z1US^%>TVVN^&C\0;+Q;9ZU:JMYI4L5P+AA&ZS)M"EU[%@.G^S6
M9K_B+P]XQ^'UO#!=6FE:CJ&JPR7\4C8$4F-KRX_N\ Y_/G- 'C6?TH[9[9QF
MO8]"N[#2?"<FE:'XF\/V5[:W4PU"YOH0ZWD>#L9,@[EZ<#T/XZ&G^(O#4?A>
MT4ZII"^'TTMH;W2&A'VF6ZQ]X<9Y/0_Y !X9V)[#K[4$$'!!!]"*]YL_'.D6
M]O:6(U'2OLB>&E)614;_ $Q<!48D<D?W?K7G_P 2=:M-?_X1R_BN;:>^;3%%
M^T  (EX)# =#R>*!G#4444 %%%% !1110!]OT444$A1110 445A:WK4\-RFD
M:1&D^L3KN ;_ %=LG3S9,=O0=6/ [D !K>MSPW2:1I$:3ZQ.NX!N8[9.GFR8
M[>@ZL>!W(\^\9^,[+X=Z;-I&D3_:_$5U^\N[R7#,K$???MG'W5Z*,=NKO&?C
M.R^'6FS:5I4_VSQ%=_O+J[EP65B/OOVSC[J] ,=NODD42:1$NO:ZOVO4KK]]
M96,_S;\\^?/_ +&>54\N>>G4&)%$FCQ+KNNI]KU.Z_?65C/\V_//GS]]F>54
M\L>3QUY^\O+G4+R:\O)WGN9FWR2.<EC1>7ESJ%[->7D[SW,S;Y)'.2Q_SV[5
M!0,**** "DP/04M% "8 Z 48'H*6B@ P",8HQ110 8HHHH ,4444 %%%% !1
M110 4444 %%%% 'V_11102%%%86MZU/#<II&D1I<:Q.NX!O]7;IT\V3'0>@Z
ML>!W( #6]:GAN4TC2(TGUB==P#?ZNV3IYLF.@]!U8\#N1P/C+QE9?#O39M*T
MJ?[9XCN_WEU=RX9@Q'WW]\?=3H!CMU/&7C*S^'6FS:5I4_VSQ'=_O+J[EPS!
MB/OOVSC[J= ,=NOS_<7$UW<27%Q*\LTC%G=SDL3U)- RU:ZH\6L#4[N&._F#
MF0K=$LKN>C-_>P><'@XYJ"\O+G4+V:\O)WGN9FWR2.<EC_GMVJ"B@84444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'V_116'K
M>M307,>DZ3&EQK$Z[E5O]7;IT\V3'1?0=6/ [D!(:WK4\-RFDZ1&EQK$Z[E5
MO]7;IT\V3'1?0=6/ [D<!XR\96?PZTV;2M+G^V>([O\ >75W+@L&(^^_;./N
MIT QVZN\8^,;+X<Z;+IFF3?;?$=Y^\N;J7!8,1]]_?'W4Z 8[=?GZYN9[RYD
MN;F5Y9Y6+O(YR6)ZDF@8EQ<37=Q)<7$KRS2,6=W.2Q/4DU'110,**** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^P]:U
MJ:"YCTG28TN-8G7<JM]RW3IYLF.B^@ZL>!W(X+QCXQLOASILNF:9-]M\27G[
MRYNI<%@Q'WW]\?=3H!CMUV]4N9?"?PRO-<T]M^J7$,=Q-=7 WO)(^T9/0< X
M4=!@<5\QW-S/>74MS<RO+/*Q=Y'.2Q/4DT""YN9[RYDN;F5Y9Y6+O(YR6)ZD
MFHJ**!A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
.4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>ea028204301_ex10-2img1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea028204301_ex10-2img1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !C 00# 2(  A$! Q$!_\0
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MQ!KE[8Q^'/!MPR#;X/T>'4H%A?Q)?JX73CSR2Z;OR7]:']IG_!!S_@J;<?\
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MTS1[9IOLEC#))%]MU;5;DV^E:'IT;BXU/6+VQTZV#SW42-_D1?MY_MF?$?\
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M\1:?J7B33[;2+:%K[3K^UU;4$74K^[4?-'_#?7_!./\ Z0;?LY_^)>?M2_\
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MANQ4*+?2M,M]X,\DTC@I5(.27,N5>\WWMLOU?FD?QMJJJJHH"JH"JJC 55
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M  ;\6M LK3^WX[>V8^?'X<\30SVOBSPC/('$N@:S:VKSR7UA?I%^EE?R7_\
M!&;_ ((L_P#!23_@EI^TW?>/M9^.?[-'C?\ 9]^*&@-X6^.7PT\,:]\4H]8U
M--,CN[OP5XU\+0:S\/;+1O\ A+_"&K7$]LGVZ[LXM2\,ZUKVER7<,SV$UO\
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M/^"OPP\77MK??\*ZM&O?%GAG3/%?C'1[1/%@EF\0VVB7^G?V/$^I^G_M]?L
M?$CX'_LZ>//VC/\ @G3^T9^TW\%OVE/@%X0U3XE:;H?B'X_?%?XW_#7XZ:/X
M)LW\0^)/ GQ+^'?QO\6_$#P[J]_K^D:;>?V)JFG6FF7D6NK:VTK-97LWD@6V
MOU^>^VW?_AS]Y*/\_P"?\YK^?C]G_P#;ONO^"I__  1;^*?[36F^*/'GP'^-
M?PY^&'QA/C>^^!OCSQ!X"U3PO\;_ (.> -4\2VFH^'M8TV[_ +2F\$>*(;CP
M_P"*[?PYK3WUK)IVK#0]2;4)],-])^6G[(>G?M)?&C_@@GXM_P""A,?[?O[8
M7@3]K;X?>'/CO\4;;XBZM^T'XL\0> /$"?"'Q/KMQ8>"O%GPS\72:YX#N_#^
MNZ)H(T%!;Z+:ZC'JU[!J!O;A//T^Z MO=I6DHOU?HMOSNK;G]J5'^?P_S_GM
M7XM?\$Z/V@OBQ_P4L_X)$?#WXR_'36?&_P ,?BCXZ\'>/;'7?'_P8\0:S\(O
M$FKZE\._$_B'0=+^(GA'4/#TEM+H*>*$T"UU2]T_3VF\/SW4NHV4%HVC21V,
M?XS?\$C?"'[1O[;'_!*?]HG]H[Q;^W[^VEX0_:<\ _$_XYZ7X"^+J?M"^,+_
M ,-:/9_#/P9X9\2^&M/\5?#C7;G4? .N^&IM2NK[_A)4O=$^WW%C=RM:W]G)
M:VQ0"V][+E:3\M6NG:SO^!_9]17XB_\ ! W]OSXU?\%!_P#@G]HOQ@_:"LX-
M0^*?@OXG>,_@]X@\9:%HUOI.G?$6/PCIGA;6M.\:'3+-(--LM2NK'Q7#HVNQ
MZ3;VVF2:[HFI7%I9V*3&RMR@3O%M-.Z=GMT^8G[7]A\4_P!L3_@HO\#/V9/@
M7\6-*^%%O^PW\/Y/VR/BEXYU7X;Z=\7=#LOC!\3U\0?"/]GGP3J?@S5]=\-Z
M9+K=IX+E^,7Q&L;J?5!<:.Z>&M8M(3=&UFA_*+]G;1_B9_P3"_X.+];^&/QC
M^(^F_$#P?_P5+^$EUXH/Q TWP/:?"_PYX@^,^G7>IZK9-#X(TO6-?TK2==M_
M$?AGQ%H,WV?5[J347^).G:C<!+C4#%%_25\#OV _V:/V=/BQXV^.'PJT#XAZ
M5\4?B:MO_P +,\4^(/CE\;?'4OQ'GL-.72=)O_'6F^.?B!XBT?Q/J>@Z:ILO
M#NHZKI]Q>:!:22V^CS6<,CH>1_:1_P""8G[%_P"UQ\5/"_QJ_:#^&?B/Q]\2
MO ?]GM\/O$9^,/QF\,M\.[C39;*ZM[[P#IWA#Q_H&E>#M2DO]-L-3O-2\/V-
MA?7^J6=OJ-Y<3W<22@&FM4]FK/\ -/Y-+Y;'X3?\%L/!'@[XF_\ !:W_ ((C
M_#KQ[%>7'A'QAJ'Q/T77K73O$?B#PCJ%S:W6L:*;2WL_$OA35=#\2:-<W&I0
MVD,%UHNL:??R.PMHK@+,Z/\ LO\ #S]E7]E7_@F[\5OBU^TOHWC+6?AYX'^/
M>A?L[?!#4_"_C7QE\2_BA>7?Q/M/B3XO\-^ IO#GB#Q[XK\=>,+J]\;:E\5]
M&\-)X1TQ#IUE<:7+XAQ!!<ZO/;L^*_\ P1Q_8 ^._C3P]\2/C7\+_B%\5?B'
MX0M[:T\(>./'/[1_[2&N^*?"5M97O]I6</A;6KCXK_;/#RVVH_\ $PB?2)+.
M5;\"\+FY'FUVNE_\$M?V+].^(_PM^*]]X&^)'C'QO\%/%5CXW^%NH?$G]HO]
MHWXG:;X.\6:7#<0:9KVF^'/'_P 5?$?AI]0T];J9[.>[TFY:VF*3Q;)(U8'?
MSM^ -W45?9-;>;?ZG\\W_!!&1?V"O^"GW_!3?_@GE\?2/!_Q2^+/CG2_BY\$
M]1\0R_V9;?%WP?X:\1_$?4+.]\'/>J@UR76?!WC[2_%%M':7$\VS3/$]D\7V
MWP]JD=O^G/\ P6L_X*(?MC_\$RO"/PQ^,OP?TS]F[XD_#GXK_%[PI\%K3P3\
M3/"/Q'L?&/A37M>\.ZQJ0\0?\);X7^(]EH_B+29KO0KMIM.D\,Z+>:?#<V\<
M=UJ @GF;].OVH?V&?V4/VS;+PY!^TA\%_#'Q#U7P5="_\"^,_.UCPM\2/ >H
M*[31WW@?XE^#=2\/^//"EQ%<L+M#H?B&RB-VD=Q)&\L:,/FSQW_P1Y_8F^,4
M'A33/V@M'^-_[2?ASP)?OJO@WP?^T#^TU\?_ (I>$/#NJ26DUB-3L_#WB'XA
M3:?=:C'93RVL5_JD>H7<=N[1"8(S*P-M.2DUVYET;V=NU]'UUN?D;_P=)1>,
M-._X)I?LM0_$K7/#>N>.+;]M#X('Q;KGA31+[PQX6O=83P)\5I=1N=$T/5=<
M\2:AI6E*P?[-#?:[J5RL$7F3W19F1?W3_:"\3?LH_%+5OAI^P'^T[X8TCQG;
M?M;_  K\?ZOX6\'>,=,CE\'>.K3X2IX*O/$_AZQU<7=O=V7CW3+3Q3I_C#PU
M'I7V?6+>R\/ZQK^E:C97NAQN:W[4_P#P36_8X_;5M/"&E?M-_#'6OBEX;\!Z
M?86'A#P=J'Q4^+>B^"M#?38+ZTM=7M_!_AGQQHOAZ?Q*MAJ-UILOBB]TZY\0
M3::ZV,NI-:QI$LWQ2_X)P_LE?&GX6_"SX2_$SP1XL\5Z+\#/$+^+/@MXMU'X
MN_%I_BY\*O$I8"+6/!'QE'C4?%#1[JVMUAL+91XKEMX],M;+3C ]E9VL,(*^
MB2TLVWZNW^6O],_FF\,?LE>/_P#@AW_P6+_8?^%/['WQ8\>>,/V1/^"AOBSQ
MCX1\9_LY^+]?;Q#<>$#X8L(KKQ)XD>W#(-0MO!=KJ^E^+O#WQ"?3K'Q+'I^F
M>(O"7B;4M=L9/MMQ_:!7QE\'/V"/V;O@O\6+CX^:9H/C+XA_'F3PS)X)L_C3
M\<?B=\0/C;\2?#W@R>19KGPEX/\ $7Q*\1>(I?!.@WTP,VJ6/A*'11K$DDC:
MN]]NP/LV@<I<UGUM9O17?>R5O+SM=ZL_C3_X)>7"?\$]?^"^O_!1']EK]H1C
MX*N_VU=0U/XE_LU^,/$<J6&B_%&VD^(GBKXA>&])\/ZI<F*PO]7UG1/'7B'2
MOL4%P]POBWP3J?AA(I-4FLH;G^O?XD?$7P3\(?A_XT^*?Q(\1Z9X1\ ?#SPQ
MK7C'QEXGUFYCM-,T+PYX?L)]3U;4KRXE956*VM+:5P@)DE?9#"CRNB'Q7]J#
M]C#]EO\ ;/\ "NF>#OVG/@KX,^+6E>'[_P#M;PM?:Y:7-EXJ\':OE'&K^"O&
MVA76E>,/!^J"2&"8WOAK7-,N'FM;661W>V@,?S?KO_!)C]D+QUHNB>$/B[_P
MT#\=_ASX<O-/O])^%7QQ_:H_:'^)WPO6YTAUETDZOX'\2_$:[T/Q7!ILD<3V
M=GXOMM>LXWBB8P.R T!)J33>CLD[+LDK^KLK^>I\H_M@>,/%O[?O[1'[!/[,
M7[.7Q ?X66.G^"M"_P""GOQ,\8>+?AQ:>-9O"WA/PQ_9^D?LO^%O%WPUUC7=
M"MI]5\6?%#Q/?>*I-!U+5K:XTB\^%;:DJS3::BM^6^J>&_B[_P $N_\ @X>_
M9]^*?QH^*^C_ !/\%?\ !3SX?7OPB^('Q&T/X8:5\&?#ES\1[+^P/"_AS3[[
MPII.O^(=&CUFQ\4:!\*[Z[UYM4^V:K'XVU>XN4647$DG]*OPS_X)_P#[,7P@
M^/?B+]IWP'X:\>:9\;_&%A#H_C#QIJ'QL^-/B(>*] L+?4;70_#/B'P[XB\?
M:KX5U3PQX5BU6\_X0[PY<:(VC>$9&CE\.66FRP1.F!^U9_P33_8W_;<\4^$_
M&'[3_P ,]=^*6K^ A&_@2&\^*WQ<\/:'X*OTFBGEUOPKX<\)>.= T'0O$5Y+
M;6+7_B+3M.@UJ^&F:4+F^D&FV0@!)]-;--/YZ_FD_D?A_P#\%_\ Y/\ @HC_
M ,$"&905_P"&R9U ?(1V_P"%F?LY@1Y#+DL64;5;?\RA?F*U^U6E_P#!-3]G
M>7]KR/\ ;D^)M_\ $OX]?M"^'[>\T[X4Z[\9O%MKXA\*_ ?0[VXU&<Z+\&?
M.A:)X9\(>%([<:K?)!K5YI.L^*M]Q)>2^()=0EENWP/C!_P26_8;_:"U[X<^
M*?C?\//B'\4_$OPALM,L?A?K_C+]HG]HC5=7\!G2)=/N+34O#-^_Q22XTW7Y
M+O2-+O[_ ,21/_;^J:AIUE?ZEJ5W=VT,R??G@KPCIG@+PKH?@[1;OQ%?Z5X?
ML4T^QO/%OBGQ'XV\1W$".[J^K^+/%VIZUXEUV[S(0U]K.JWUXZ!$>=E1  +Z
M)*]];^=Y7TTVMOU\S^6WQ'Q_P=R^ ?7_ (8$U @=R/\ A'/%@R.G?(!Z9!]#
MC^H_QVR1^"/&3NR)&GA7Q$[NYVHB+I%XS,[9PJJ,LS=AD^]? ^I?\$E_V'-6
M^/H_:HO_ (>_$2;]H]+J2XM_C6O[1'[0\/Q!LX9$N(/[(L-<@^*,<MAX;CL;
MJXTJ'PQ:)#X>BT>:32DTU=/9K<_9?QG^"_@CX^^!KWX<?$1_&!\):I+OU6S\
M%_$/QY\,[_5K5[.]L+G2=2U[X=>(_"^OW>AW]G?W,.IZ'-J3:7J*M']MM9S!
M"8TTG_7G<&[V\DD?SU?\&G!5O^"7WBLJ58']K_X[L"I!!#:;\/G4@\\,I5E/
M=2K#@@GZ)G\+_'K]M_\ X*0?M$_%KX#?'OP_\%/ 7["?A6W_ &*_">N^(/@C
MHWQQT?QC\5_B-:^&OBW^TY-I-CK_ (N\*6GA_4O"EM;_  >^'&J:A82WEU=/
MI_B#1[A;>W$ZWGW+^SG_ ,$Q?V./V1=!\8>%/V:? OCKX,^%/'6DZYI?B3PO
MX,^.OQUL_#MQ+XALM/T[4/$6GZ/<_$:ZL-#\:QV&EV-IIWCC0H-.\6Z3! $T
MW6+7+9]0_9@_8G_9W_8X@\96/[/7ACQ5X,TOQ_KVH>+?%NC:I\5/BIX\T;5O
M&.LWLNHZ_P",FTOX@^,O%%G:^+?$=Y+Y_B/Q)916^KZ^\<!U:[N_L\.QCD[R
MDUL[^MG^I_.+_P $)/\ A)/V!?\ @I)_P4=_X)+_ !)\0P:K;RZSI_[3?P1U
M8:7%X6TSQ/IVH6FDGQ+?>'/"T-YJ%IHB:YX0\4^![V30[#4+VTTE_!VLVD-Q
M(MF\\_H.@W-M%_P=L^.(I+F".6X_X)\:;;01/(JR37$>F^'[QX(E)!>9;1'N
MBBY86\<DOW48C]DO&?\ P2G_ &)/B!^T-+^UEXF^'OCNY_:1^V37-A\9-.^/
MOQ\T'QKH$$OVU%T7PS?Z%\2]-A\.>&+6VU&_L+/PKHUM9>';;3;NXTZ+3%LY
MI(6XC6_^",'_  3R\2?%F7X^:_\ "?X@:M\=)I(I9?C+=_M)?M+?\+.+06(T
MR!8_&T/Q;AUZ"W@TP#38;2WO8K2'3P+&.!;4>50#E=MZW<;.^NMDM^SM]S:L
M?H5XB^*_P^\)^/\ X<?"S7_$MG8?$#XM)XPG^'WA=H[J?4O$5IX TBUUOQEJ
M$"V\$L5KIWA^QO\ 3/M]_?RVMJMWJNE:?'+)?:C9V\O7ZYIW]L:+J^D>;Y']
MJ:7J&G>?MW>3]NM)K;S=N1N\OS-^,C.,9&:^1_@O^P#^R[\ _B]>_'SX?^#_
M !?<_&&^\#7OPV;Q]\1/C'\9?B_KMGX(U+5])UW4- TB3XK>/?&4&B6M]JFA
MZ5<W<NCP6-U<BSCAFG>!I(G^S*"3^.S_ (-C]=?]D/XP_M\?\$O?CXJ> OVC
MO!7Q@A^)?A7PWKFS39/B+X-L-#C\)ZOKO@PW1B/B"Q73]'\-^,K"73C=+?>%
M/%$.K6N^VTW59;;^JK]H/X__  P_9B^%'B;XS?%_7O[ \%^&3I5H[P0_;=8U
MO7O$6K67A[POX4\,Z2CQW&M^*?%/B'4].T+P]HMH3<:CJ=]!"A1#))'Y#^T[
M^P!^R+^V%JGA3Q/\>_@UHOB7X@> 95N/ 'Q8\/ZGXB^'GQA\"SQR&:%_"?Q6
M^'NK^&/'NC10S-)-%9VVOBP$LUPQM&-Q/YGG%M_P2^_92OO''PY^(GQ+MOC/
M\?O$WP?\1:3XP^%G_#1'[0_QN^,_A[P'XOT*>"ZT;Q9H7@WQOXYU/P>?$NF3
MV\,MCKVIZ'J&J6LB>9#=I(2Y!MW=]KVO;\;=KVZWW?D?SW?L\SWW[ W_  =!
M?M-:+\<PGACP;_P47\":_J'P&\=:NQL?#OB?5]=O? WC'2?#-EJMZ(K6;6X/
M$?A'Q5X#GTV*9KA->_X1RSCC>/7=*EN?Z@/VU_B]X#^ O[(G[2GQ?^)NMZ5X
M?\%>!?@K\1=7UG4-9EBBLI&;PQJ-EINE 3/&MS>Z]JUU8Z'IE@K"74=2U&UL
M809KA%-[]IW]D+]FG]LOP-:_#K]IKX/^$OBWX7TS45UK0$\06UU;ZWX4UR,1
MF+7O!OBO1[G3?%/@_7(C#"R:MX9UG2[_ #!#NG98T4?/,?\ P2P_9&U2Y\&?
M\+/TOXO?M!Z'\.=1T_6/ ?@;]I+]H+XU_'?X;^&M7TB1)-(U6/X=_$CQQKW@
MW6]1TDHJZ9>^*M&UZYL0-UK+%(!( &TTNC22?5:?=TWOU/PE_P""'?[,OQ'_
M &>_^" /[7/C#XGZ'J7A/4OVCOAO^TO\9_#'AS5X)K"\LOA\_P"S^O@WPGK$
MVFW*13:;%XHM_"MUXCTV&:-'FT#4-&U#E;U0OX]_#K]DW]HGQM_P;B?"+]H_
MX$_%3XR>,/#?PG^*WCOQ[\??V/\ 4_%.HZO\ _BM\'_!_P 5=2N-=-U\/-)@
ML-1NK'PY=Z38>*O&6@C5KO3]=\/-XPU*2UBU.TT]D_T"_CM^SY\+_P!I'X7Z
MK\&?BQIFOZE\-M?B%GK_ (:\,>./&WP[CU[2&L;O3;GP[K.H?#WQ!X8U74?"
M^H6-[/;:IX:N;Y]$U.'RDO[&X6"$)Y/^RG^P;^R]^Q+X7UWP)^S1X"U?X=_#
M_P 1---J/P^F^(WQ)\8^ X[N\EEEU*_TKPAXZ\6^)=!T/4-9:9AKEYH]C8SZ
MRBPIJ3W2PQA KGW?]Y2LU=-)-6?W]M]58\O_ &$OVI/@+^V#_P $^?A[\:/V
M<M'\.>#_ (=WGPEO?#4OPR\,V^G:=I_P@\4>&/#9T[Q+\+&TG3([>TTL>$+Y
M?LFG1QVMK#J&@RZ1KEE"-.U:TDD_G\_X-Y/V7?#W[7__  1U^*7P4\;_ !+^
M,/P^^'?BG]L'XY67CVQ^#/B[3O NK?$/PK?>%?AY9:GX'\1^)W\/:QXBL_">
MKV\TD.KVOA/4O#6IZE;2RV-UJSZ?<3VDG[X>"/\ @DI^PM\*[_XP7'P@^&7C
M#X,Z/\?(9XOBWX(^#WQN^-OPQ^'7B][J99;FZD\!>"_B!HWA?1;V:,2V+W7A
MS3-'F_LFYO-'5ETNZGM'] _9-_X)Q?LB?L-3:BO[*_P]\2?"71M7^W3:KX-T
MSXM?%[6_A_J&HZA%IEO<:Y=> O%7CG7?"+^(A:Z186D/B :.NL06D)MHKQ(9
M94<%=6DN[37ROOTZO^F8O[//Q#_X)L_LG_#F#]F3X _&3]E[X5>"/@7K.J_#
M^^^'6F_&+P':7WA'Q;9R1:GXETSQ4NK^)Y-<G\927FJ+?^);O7Y[G7+C4KR5
M]3G:Z\Q4*^?O$G_!!3_@DQXT\<?$7XC^,?V/?!WBKQC\4O'GB/XD>+M6UOQ1
M\0[@S^*/%MTNH^()M-M(_%T%GH^GZAJS7>L-I.G06^GP:EJ6HSVT$*W)C4H#
MW>KE?T7^9^P%%%%!(4444 %%%% !1110 4444 %%%% !1C_/Y_X]*** "BBB
H@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>ea028204301_ex10-2img2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea028204301_ex10-2img2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !' %0# 2(  A$! Q$!_\0
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M\/&:*>]\#>/=)*V'C7P/JWER.8[WP]K:7%O"TF#>Z8]AJ,8,-Y&2 ?:M%%%
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MC9PJ(X5%?>7_  4 ^)O@?X2^ /AC_P $W?@)XCT[Q+\./V=-7U3Q9^T/\1-
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9<44:A4CC10%1$4!550%50    **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>12
<FILENAME>cyn-20260316.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.4a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 9a05s7xRiXgen8uMYHRcOamDmaP9xJBzGYlBsG17HdlKPy8jONflvSnM6NGG0SgA -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:CYN="http://cyngn.com/20260316" elementFormDefault="qualified" targetNamespace="http://cyngn.com/20260316">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://cyngn.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="cyn-20260316_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="cyn-20260316_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>cyn-20260316_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.4a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>cyn-20260316_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.4a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="cyn-20260316.xsd#Cover" roleURI="http://cyngn.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://cyngn.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Mar. 16, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 16,  2026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40932<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CYNGN INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001874097<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">46-2007094<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1344 Terra Bella Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Mountain View<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94043<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">650<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">924-5905<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CYN<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ea0282043-8k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>cyn-20260316.xsd</File>
    <File>cyn-20260316_lab.xml</File>
    <File>cyn-20260316_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ea0282043-8k_cyngn.htm">ea0282043-8k_cyngn.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>22
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea0282043-8k_cyngn.htm": {
   "nsprefix": "CYN",
   "nsuri": "http://cyngn.com/20260316",
   "dts": {
    "schema": {
     "local": [
      "cyn-20260316.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "cyn-20260316_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cyn-20260316_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "ea0282043-8k_cyngn.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 23
   },
   "report": {
    "R1": {
     "role": "http://cyngn.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2026-03-16",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0282043-8k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2026-03-16",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0282043-8k_cyngn.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://cyngn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>23
<FILENAME>0001213900-26-029129-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-26-029129-xbrl.zip
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M:M0QB<),URN9BV5'Y"B'V-9_$?Z#@'=;G5O2;=U<=V]_$:)N/.YXU'2):\%
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MA>?-M("&)EGUH37-'!<=V?DX2_^JFP]T?S<YF@"D!VQOE=E5HGP)8*E6>&E
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MW/YL$VZ_;K,]$,EY+W&':(GE,7>'SY7L:_G\]X"WI;65EHVO@@E96ELNJA,
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M9=Q@&'O)VT[2@#)*2A!EIAB.1K?%N;"=4Q5606(O4^4@QFY1MZ@Q33D#B0W
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M+2C]AJ D"J:N# 2-H2O6NYC-.!\(>TEC(;,B',SX"6RN&R3KXC<!+!JC!WK
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M+-4ZWXR2P!B-7MB)OV'\0N]XZ,UT6&]57:MA?P1I0].1*K+X3PQA"4 ^#'W
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MWXN49X+OH(-E\L6*SF6_:T]T)GG?'&83YRZJ)()]F.D4&G7$:BEW@T+'5'#
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MNW.ZCU<B)X[!(@#S+'EG:@\C6/93BV^R2_L:8JD(/)VYIK)SC[5K&7K%XZ"
M2"?P"*-D'?&6HZ.!?=]S4%]!IR?FY ILT'DO&;8")H/)/"_F5,D&50^,.OO,
M8O97-G>3R[/3@3(B& \KR&!8ZBG670,KC&K2(0;!D$7L2D8AA[2E32-'1IIR
MTI./'Y8I(]R6(W1K;$KCVJZ0/TMR1S.857@29P5=F@:4EO-<&68+Y%GE09I;
M$+ZGI&4#[3-P/+K9KLTVW2'D,#])N>YZ[<'6\9 XMOQ%@'S-KD#P[;K2&&&!
M39C6A#C +G<-2_!L(!>-5<$9]T;>PZ]?';\[VD@EEDIWGC@M7$-9+(W!]QX[
MPAI$-N&R_YRA.RMY\^:=5.GERXG(3 Z2G^']YW $8-.==@V8[="S'A2LY.#K
M_?T4A%)6):]048)]7:?)\5'R[=.#_:?(Y!Q(-;S[R#<6BJ14W(Q!UZ0N<>:G
M7A""*WPTH_)18DS+X?&2&&QI&DX\ ^E#J!R*&RZ+*I;93"&'&-6-"<\)<?>8
MX^.HJI!ZF8F\K:Y#SG9Q,3,G)OGI-@>%#\J=)V>"X?JR:!4Q(+.?NN-#6^5-
M=K4"B>H=):<GSKP&1%W[4% PPK!]FNA0ZE.BXXWE'/B!F,>[!Y3%/(7]U5UA
MUDEH%$E WNMKR7TE_IB\X<M;]8,OM_!=KD92)!-B/,?_BN\P\MZ/=(-O$P9A
MJYI5 SEDPS!$,X6=UU%_[;(<U"]Z^%GZ7_ $W7YZ9A+<-$:B,T7%>XLH'2)#
MS">X<"ZV.Y)(L0Z51[;_$#]<H,>;U=VV+O/2TCY-LV4VM488G*J%W7AE7ITC
MFL*"_&)R/[K#HIC7@$>B8SR?/[1YWY#RZPUQB#;$NVXJ9&)PZT491.;%K)^2
M!A@:CCL<WR*KT*14R"SL_L8Q)K$A)I8"<$8E7LZ1YLBHHVY0F);NCJX/)];
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M@I;0+Y$,$BV&U4O^Z:J7#$@G D23.J1S!GWDY9P:F1-Y\O LR[ER I WBI.
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MQ+Q+NUV'PG6UEQQY"#B9<16&\+K%>HGCZ#+=D&W(%+E3&X5P)69S<T$$H\%
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M!GHP+( +ZM!X(\]6OEM=S5Y=("NLEVOFPONDH5NL7O75!.F ?&!)G3<% J]
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MGL$M1<S<+-K82E=21D3#V2Q]L_?BU?=^L-R+;X5UW&^.#ZNUVYL;F@Z'H<8
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M5RW)_39!WZV"!KKAWXI."A(+D'/A'*:4)#%&L/I[8Y8I40F-&#=J,_V*KX]
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MO;(7W":%J5'.4F((++6(TV@;X:57%LOD(NC(3@M?] EOX"5&^N$MZ/6.\9J
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M,RK*!JD !ZMI&PT#)K !64,/ ",PX\,Y@#.1G"DX6\3&;A=H./LF7=1M1<\
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M)<<CI92>&'%5E11-'GNO>^=?7(9<)?KPY#[Z(-&')_?1AYN,/GR-N#$:">@
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M\S(_Y_80 ?SAV.\STS)3W 8^N*FU-&S9-M9=GTN"NVN5Z&,EQ#W0&*N^HU4
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MN_8$37U,_YZ82*\R Z!@]7_;1IO;00=ZE9>$C4*LS1N;FJU2,&-@B"W,FI"
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M#E,L!3(SO2I1:3:.2-!P,GT1&TW*&%49^F]<LBOE$G3\:$8AZ=U3]LQ9P(M
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MWZ9%=3P1@7[>7W[8\]S/J,B+V@5YG[64+5.[?]GP@D@%6.>DAMWH%Y1A&X3
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MN.A*LB5>4RB\(T@Z:1Y.:H.1P(<+,TQ=-;_:!1!K:@P#+Y3WXN5T]E!RX,8
MV/<3CX;U,$J+7QR5<#7*60EF''>[XD@Y:GHAAYYWS75'O7Q?8>(;LK!.* $L
M[@P6M.5U:P>KDM9=&U06=9E.2%3TQV7M^_>PJ%. 9OT[*4(Z2_P&XH;TRG"
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MA5*'!,5"HN#%)N!EP)\$7^9CJWDTXF2"*YJ0I*+CN'T&'1X-;?"#M)+>)*Q
M7B[G\/\I*.],@A1@;,Q'H")3M!&493U.=?A3;AS4M]NZ!?QO$ <AZ$BCC G>
M%$B_X_=OE@A"+%V;/7 Y5/P/MY]*JA%?S98^8AK8J7T4B'<975,CLF56XPZ,
M\S2A5C]G+(^:,62("@ZI@1?=OF3M'55\IBPIJ$"Y%<6;9#0>W&8T_(S&@]N,
MQG?%Y"C/?S+V!OAVY#R#2'A6EA_J[FITRA=@1(9;8M'6I,E=4@PWPE]R33.C
MF64<IX'U%ZF&>,#F1KU8FQQRWH9"<5# ODFWZ,_?0][!!VZ[FQM*->KHE?&-
M>[;4 LQL $TC@/QM<)IV#LD)85H@FO;].A-:7OP]UIV']S?V%&< ),XI"U?/
MQ)B@?)&SD!K+NU _@J-?;@"RZ965;C7E+"5%;<*T0;3C$.R5'&-&=3@\E?%_
M:AH>3W6O: ?-P"E"AZC[K@KAT]U]81\EI=SRA* 6[K!IJFS$]5+ON%,Q#/!O
M8RF8]+P6*1I<A*=97I#WAW'RVM1A/#-71&\O9#Z@PV$>1BSAFFYS@-&MN/7*
MT$Q +6;'\=((:;C&5M4_98@:CT#X40<A3-4'3^.R 5H2@CW/W[ IN+ORG!-6
M JW.%#,-' RF#"N490'A<5D<0[R4+.Y(UU;K,I:"AQ$H ]:$$5!;0=1S3#VR
M WDZZ&ZY-: ^?-%%?%.&;E=6R4C7VLDDN(NCF9,R]153-,YB[4GK'X6[M<&H
M6KZ'1UIG .^V7TIM?TS0UN[B*S<(G^3EK%P:9\#^C.K<&05)@JF7LO>&9!X.
MA,X(]$W ;Y[LRQ0:)8QKQZT"^:#/]T'LK)%6R$+ N)GC)!]C13WYM"#H@FRQ
MWFG_8&MB8NU>J?VG##&,T2?D<^3T8;=<TU:.3G!^O#A@F+9)&CZW^F)R:BEQ
MAYF73W@W ZF%J,]EC@80R@I$H5/\4-+,Z(L3%=S$P@CSS;F$#"QUB1BX#-#N
M;779QW<$)11NL4YRD1$LGKRBR$TJ(0J_$<V=O;Q%@2&A%K:YM<YFF[<Q_^NJ
M0B3!Y5)\FUO;-*#4)\""]=EH$9\$W(5HDM7C*I7S[$=<E"D)/KY6 =7931&V
M-DDW9EN%;T18&H#RN92-/I^P 7!S+V4I]D6="Y(X-?)R _O!TMDW3LFX+$HG
MA4?M%^=H1:]$;U -!AET8R!%,EZ9 *1'9Z^TAK-%[BXD)GS/QAEFN)<4&<0C
MD\)YYUG'5-+BYH'-N)2."IDO(_-\RTHX-I3566'6U@:5=ELLNNV*V)KZ',;+
M38/+NMO08L)>ABJ=VEDQTEC;2J^YDW"X_2(;L\XK,/? >%TB_XR]_-P4@\3<
M3B+-<W-,P8YPN! 6-3"\D]Y[":PTQMN68%)PNT=0/(#MML_#WP6)V?9/FG:!
M%7:4D-'/NG<C>\ZAJ718XL_TZ>@=542.5C%W5Z.6#^!M&U$P+*@G!^^7<W,@
MECY46:<NW*B$P9_@PP<.T40-[+UC95_.@JX\-8>LQ_NCG>^VPG#!?99A3*D-
MJ3'RO=.6\;69<5MG6B- Y6F).X:(\@Y7.CP7#E(=^^Y^W=9ZH1KV/!EZWMM]
M^/"O&("6H@#3RXVX[$8G>YB%;G(']U1;%^+H(=[,"+>K\+=7:=&_L:@(G<S2
MYWAG;A&&O+N<YV"F% D]Z?E+N;2'_\Q>V67>< <DO2><_7Z=3>Z8X4HEK205
M;,,!D;Y-^;<54!?!>C0Y?F62>]L=WBZD<#!VXRS-NSQS]CK6D44!+VA$Y9*V
M!,W1U6YT6#B;(79;%\&& X=B)F Y2AWT!NF0S#XVJQT2BP_VMST8T-HM,=4J
MG'53,4X[7PR.C\X@<#PDN*"IEC*\(</*JSG/6:(DH,1*;4V =F;!CS+8&Y38
MF 1J5E8#^EAC+C6I!*NJN'O6&XI@I@NK8<<AU6V14Z8M3VE&:5-"RJ[)KS /
MQV%N!-!]&?>RCXL5:^KULF29(]"4F>Z,1%\(3< ]2S'^1+/0*\(:J;12"*@-
M%D+. Q7"$*#U=7AK[-_K+N<GW"7B.';R[>!1M^'[S^__Z4'Z^W,6L4F^[*?;
M?)F?+_OI-E]V,P&XY94.KC+Z\#G<'%ON#TWU5NU/0;Q%@-QCHAK@+9F5>I11
M4>N$_>J319[U=VOY@PM!$>9I*]CAV%&,=[X@<X'SH QEGQ83+X-%&J[&^7$3
M!(U2;P$UFO/WFJ"#>^SER@E/2R%L:?[DE-@[3HZ6!V?MNVH;RA;I>AD$?5YF
M$[7V)N5RU,1.?D^S).)5]AG?[1K\M98XYIXH"5 O1TRY>A.7$"P.BK]C+5O5
M<C9B0:4>E_,1J/G:ZR#!O@P*#6$2&HN)>-MJ9 L<!+WQP^LY=AAW/9U@L<^W
MF1XU3ZH:YSCVBOJG)8;6<W=+7_(#Q\DBPWHF7F58KDV^MA=O:]H]#K80T*O3
M3+P"55N8"N^#@U!*B]&T80IJBS-6Y$.CC;ZL5H8DVJ'3YX-(^Q<7N))WXP5U
M.0S-<V4:K-TV[W0-SJ9]J T_VEMJWUNG8VF#;GXC^8A\ ;&KY5D*&DV/,PY?
M+RI#]XTY:X=9,+*6)^P4V8I>1-.8I$')A.,1@'0T2R0@(^L2M0G#:4+"UYHH
M[$1G0L"I +$ ;A2AU>D@'(=U1*,G!PG+_2JKLM_3PEJ 62)-*")(#3(CLUHL
M3=GQ3^,-+R(YL- 4)\N1S$C2MN;H+9 :ZQ#KM;VIE@.[.Y0/M V418&C8UU5
M,9-8D@A.%$%IGM=<0-*7DZ4MY;6Z!?,UAZ\O3(#*C?[I>%-V(1LJ[$2<[83>
M)^>!P/Z,7_C7MLD*R:EPQYMC@!.Y:IV ;,+(G<&K\7O(.UHOW79ME,ANDT R
MEN):TY_ X0"GLD7=XN"!<2"#@J_;[0ICVYHF3YV8CF,S3W7"P9^-1#/?Q4I6
M2JFF3=I?6;&EJ7M<<S51#G0<?$K&F]]S5".V;4.=N?\-@F_;71K+A'A+[1=,
ME#LP^H,0VH41G#..*=NH6A4I\F?W[F!H%JA;R.Z9&Q,TMZRZ%6!N,^BZ>A9;
MB.Z$USL6?.EJHRT-9\:15,1K-;Q7ON5DX7M[Q10ZC&4[F43M)TJU"P^;51T@
M3,BQ4<UX718D;)^SWJ%KP=*ZEF4QZBA,MD7=[1T5$T)',F8Z=Z8F7J*WZZ9Y
M\*AM.Q1E_9*,D4+G%"D\2E>,3:\[+W1PD.106A,W\LXB.%EC]DSZ!7A'N*+B
MDW;%/6XW7BT;M)%W50GZ&-73D>LN6HU\Q%.!S#ZU0/5\MS4.<9%K&0P,&JRB
M@SY7Z/^6.SL<^"XLUR&!XDM1!'BZ6#2$<\'V>OWJ*M2^?+1QX$P?N.,E>3[W
M)N5>X;LP>&6M+G=86Q%;BP&_78BZL4YE8@@&=UE@SG4*JB=T_V('YA8\)=RB
MF:#58<D/]_LX'SM+D:X/!ZIB.PIQ'%PF:9D4U"+8 :_G(U6[*5"4C;:J0TJA
M^N!\+Y.5[MK(0Z"B&FQQ"JN5O 9)LCB<^TD=!-SU>HR/X>#:K(_H<XV/X> 3
MK(]IV_J(K/'1(OU&IH6,C%]O6ZPC[SK3PFZFY#5;:W0,BN%@G441\LSF!H7W
MN$W,B8WROI]I3GB+ZC F>&E8V-)M5*R)T'69%&L>MVU3MK;VJ^,8]]H39K=Y
MK<$D@>NU+A ?_DKF17>99  -SGN6,JZB5.561DXXC2L304T!#A%4Q(Y#QX 4
M/E2*1__/HZ0G"&L+F#_Y)A*6WXA=M4FJ\F^WJ4H_5?FWVU3E=\/@!Q:A[L6R
MF"1SZHBFJC^U&=WTUQ537K$9\6NR$-PLSY(1D6KX;V0R8FV-#M:DHF6*"]N%
MU!+*K;E+,*5\#M?ST@E)7$EI>Q"Q>ZN21$SA-EC%=K*!4Y.)_\'09@;F4^4L
MF":DNBMV%X.QCCC*4S)U\VR,X 2HF+1C/C:]YS'7'*XTIL,+ M?"S$TKIXQZ
MT.'TD"?CN%"6: DX'I44*PKM7+O?I+F</7!W(':0CZ:TRD:1?:=,Y%0KD/F3
M+2D_-T"2'@5=*A,$M.I '[>&S43'-FQ9A#(AA^T?C._:A3E+@J=EE0F-3#M]
M,4(S*9TH+EHK9IY',L:V%YN/=-9T?^^OABN%M]P449AXA<N)4]SKSTNJCUV
M66J0^<;\.\W.!KDZ2@E^QKGQ]AYTN\.J;?\2O(YJEA39OYRLASC)YK.N,0E\
M5G!KEWE=:@+/;DMKJ]D@#M+ -C^3KR+3K\7GU=GDR8;[RAG5#:E'-5V7D8_D
MRW(^Y_8'Z^_SVYISDRB*O#W5HV6-*>4Z<I-*'9&&X<#'I/(W)&YM!X<+=BA<
M8,5@9S1@6YLXW".)5W/' ERLS:87:#CC!">R.[LOER!-?=FAZ*]+Z/AA_^D
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MQ6I.Q@A06',PJ&L;3#V(@"ELA*50MH>1N83E;/T:5GP<]6;:L_5[(NWNSL#
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M5V*$Q97IB"$)OCH-S;&HBP "4$2:RM8PKDQ=W=<5F,%,NHHR=)D[ K#D'1*
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M5VV.>@5LT-]%A#^4H+^G^"]02P,$%     @ S(-Q7.TH@6S"#   PC   !4
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MH$Q&EH4X!!@M5JD\CLGN*!J#3P] A*^(;$4@745XY!'%KMG"9'3S*_M>:"T
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M_G;A?U!+ 0(4 Q0    ( ,R#<5P1+YXN)P,  -8+   0              "
M 0    !C>6XM,C R-C S,38N>'-D4$L! A0#%     @ S(-Q7%4: *#]"@
M?X8  !0              ( !50,  &-Y;BTR,#(V,#,Q-E]L86(N>&UL4$L!
M A0#%     @ S(-Q7&>?)K)8!P  S5<  !0              ( !A X  &-Y
M;BTR,#(V,#,Q-E]P<F4N>&UL4$L! A0#%     @ S(-Q7 T?YM7Q%0  ,78
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M              "  59- 0!E83 R.#(P-#,P,65X-2TQ+FAT;5!+ 0(4 Q0
M   ( ,R#<5P[N:=G$0T  %8Q   5              "  7MA 0!E83 R.#(P
M-#,P,65X.3DM,2YH=&U02P$"% ,4    " #,@W%<[2B!;,(,  #",   %0
M            @ &_;@$ 96$P,C@R,#0S,#%E>#DY+3(N:'1M4$L%!@     *
-  H E@(  +1[ 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>ea0282043-8k_cyngn_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cyn-20260316.xsd" xlink:type="simple"/>
    <context id="AsOf2026-03-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
        </entity>
        <period>
            <startDate>2026-03-16</startDate>
            <endDate>2026-03-16</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="AsOf2026-03-16" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2026-03-16" id="Fact000004">0001874097</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2026-03-16" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2026-03-16" id="Fact000010">2026-03-16</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2026-03-16" id="Fact000011">CYNGN INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2026-03-16" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2026-03-16" id="Fact000013">001-40932</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2026-03-16" id="Fact000014">46-2007094</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2026-03-16" id="Fact000015">1344 Terra Bella Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2026-03-16" id="Fact000016">Mountain View</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2026-03-16" id="Fact000017">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2026-03-16" id="Fact000018">94043</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2026-03-16" id="Fact000019">650</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2026-03-16" id="Fact000020">924-5905</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2026-03-16" id="Fact000021">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2026-03-16" id="Fact000022">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2026-03-16" id="Fact000023">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2026-03-16" id="Fact000024">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2026-03-16" id="Fact000025">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2026-03-16" id="Fact000026">CYN</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2026-03-16" id="Fact000027">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2026-03-16" id="Fact000028">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="AsOf2026-03-16" id="Fact000029">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
